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Summary 
Enzymatic treatment of biomass is an environmentally friendly method to obtain a range of value-
added products, such as biofuels, animal feed or food ingredients. The objective of this PhD study 
was to biocatalytically produce biofunctional food ingredients – human milk oligosaccharides 
decorated with sialic acid from casein glycomacropeptide obtained from dairy side streams. In 
addition, the biocatalysts employed in this study, i.e., a sialyltransferase and a sialidase, were 
subjected to protein engineering to alter the enzyme’s regioselectivity and to improve hydrolase 
activity, respectively.  
A recombinant Pasteurella multocida sialyltransferase (EC 2.4.99.-), namely PmST, exhibiting 
promiscuous trans-sialidase activities was examined. The enzyme catalysed α-2,3- and α-2,6-
sialylation of lactose using either 2-O-(p-nitrophenyl)-α-D-N-acetylneuraminic acid or casein 
glycomacropeptide as a sialyl donor. This is the first study reporting α-2,6-trans-sialidase activity of 
this enzyme. Using response surface design allowed identification of two differently optimised 
conditions for PmST-catalysed production of 3'-sialyllactose and 6'-sialyllactose, giving maximum 
yields of 2.8 mM and 3.3 mM from casein glycomacropeptide (9 mM bound sialic acid), 
respectively. The k
cat
/K
m
 value for PmST catalysing 6'-sialyllactose synthesis using 3'-sialyllactose 
as donor was 23.2±0.7 M
-1
 s
-1
. Further, the enzyme was capable of catalysing synthesis of both 3'- 
and 6'-sialylated galactooligosaccharides with use of galactooligosaccharides as acceptors. 
Secondly, we examined the regioselectivity of five designed mutants of PmST catalysing synthesis 
of 3'- and 6'-sialyllactoses using casein glycomacropeptide and lactose as substrates. The mutants 
PmST
E271F
, PmST
R313Y
 and PmST
E271F/R313Y
 preferentially catalysed synthesis of 3'-sialyllactose 
over 6'-sialyllactose. The best mutant PmST
E271F/R313Y
 for α-2,3-trans-sialylation gave a maximum 
3'-sialyllactose yield of 4.5 mM from casein glycomacropeptide (9 mM bound sialic acid). Another 
mutant PmST
P34H
 displayed a distinct preference for 6'-sialyllactose synthesis throughout the 
reaction, though the total sialyllactose yield was consistently and significantly lower than that using 
the wild type enzyme. PmST
P34H
 had a 980-fold increase in α-2,6-sialyltransferase activity 
compared to the wild type enzyme, while its α-2,3-sialyltransferase activity was almost abolished. 
The k
cat
/K
m
 value for PmST
P34H
 catalysing 6'-sialyllactose synthesis using 3'-sialyllactose as donor 
was 31.2 M
-1
 s
-1
. Moreover, both the wild type enzyme and PmST
P34H
 were capable of catalysing 
the hydrolysis and transfer of α-2,6 bound sialic acid. 
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While enzymatic synthesis of 3'-sialyloligosaccharides can be efficiently catalysed by notably 
Trypanosoma cruzi α-2,3-trans-sialidase, the synthesis of 6'-sialyloligosaccharides using cheap 
sialyl donor has been hampered by the lack of efficient enzymes. The combinatory study of 
mutagenesis and reaction conditions in this work has provided new tools for the efficient synthesis 
of 6'-sialyloligosaccharides. 
The third part of the work aimed to improve the hydrolase activity of a sialidase from 
Micromonospora viridifaciens (EC 3.2.1.18) that can catalyse cleavage of α-2,3, α-2,6 and α-2,8 
sialyl linkages. The enzyme and its mutants were expressed in Bacillus subtilis and secreted to the 
culture medium. Twenty amino acid residues within 10 Å of the sialic acid binding site were 
targeted for site-saturation mutagenesis and evaluated on the artificial substrate 2-O-(p-
nitrophenyl)-α-D-N-acetylneuraminic acid and the natural substrate casein glycomacropeptide. A 
much higher proportion of mutants displayed increased sialidase activity on the artificial substrate 
than on the natural one. The most proficient mutant showed a 27-fold increase in activity on the 
artificial substrate, whereas no mutants displayed more than a 2-fold activity increase on the natural 
one. By analysing the stability of mutants with use of the PoPMuSiC software, it was suggested that 
the enzyme almost reached proficiency optimum towards the natural substrate, while its increased 
activity on the artificial substrate correlated with major chemical variation and decreased stability, 
consistent with a trade-off between stability and activity as commonly observed in protein 
engineering. 
6


Resumé 
Enzymatisk behandling af biomasse er en miljøvenlig metode til at fremstille en række 
værdiskabende produkter, såsom biobrændsel, foder og fødevareingredienser. 
Formålet med dette ph.d.-studie var at producere biofunktionelle fødevareingredienser enzymatisk – 
med fokus på humane mælkeoligosakkarider, der blev dekoreret med sialinsyre fra kasein 
glycomakropeptid som findes i en sidestrøm fra mejeriproduktionen.  Desuden blev det forsøgt vha. 
mutagenese at ændre regioselektiviteten hos en sialyltransferase og at forbedre hydrolyseaktiviteten 
hos en sialidase.  
PmST, en rekombinant Pasteurella multocida sialyltransferase (EC 2.4.99-.), der har forskellige 
trans-sialidaseaktiviteter blev undersøgt. Både med 2-O-(p-nitrophenyl)-α-D-N-acetylneuraminsyre 
og kasein glycomakropeptid som sialyldonor var enzymet i stand til at katalysere α-2,3- og α-2,6-
sialylering af laktose. Dette studie er det første, der demonstrerer α-2,6-trans-sialidaseaktivitet for 
dette enzym. Reaktionsbetingelserne for PmST-katalyseret syntese af 3'- og 6'-sialyllaktose blev 
optimeret vha. responsflade-design, og under de optimale betingelser var udbyttet hhv. 2.8 mM og 
3.3 mM med kasein glycomakropeptid (9 mM bundet sialinsyre) som donor. For PmST-katalyseret 
syntese af 6'-sialyllaktose med 3'-sialyllaktose som donor var k
cat
/K
m
 23.2±0.7 M
-1
 s
-1
. Endvidere 
var enzymet i stand til at katalysere både α-2,3- og α-2,6-sialylering af galaktooligosakkarider. 
Derudover undersøgte vi regioselektiviteten hos fem PmST-mutanter i forhold til syntese af 3'- og 
6'-sialyllaktose med kasein glycomakropeptid og laktose som substrater. Mutanterne PmST
E271F
, 
PmST
R313Y
 og PmST
E271F/R313Y
 katalyserede fortrinsvis syntese af 3'- sialyllaktose, hvor den bedste 
mutant PmST
E271F/R313Y 
gav et maksimalt udbytte af 3'-sialyllaktose på 4.5 mM med kasein 
glycomakropeptid (9 mM bundet sialinsyre) som donor. En anden mutant, PmST
P34H
, udviste en 
klar præference for syntese af 6'-sialyllaktose syntese om end det samlede udbytte af sialyllaktose 
var konsekvent og signifikant lavere end ved anvendelse af vildtype-enzymet. Desuden udviste 
PmST
P34H 
en 980 gange højere α-2,6-sialyltransferase aktivitet end vildtype-enzymet, hvorimod α-
2,3-sialyltransferase aktiviteten var svært reduceret. For PmST
P34H
-katalyseret syntese af 6'-
sialyllaktose med 3'-sialyllaktose som donor var k
cat
/K
m
 31.2 M
-1
 s
-1
. Desuden var både vildtype-
enzymet og PmST
P34H
 i stand til at katalysere hydrolyse og overførsel af α-2,6-bundet sialinsyre. 
Mens enzymatisk syntese af 3'-sialyloligosakkarider effektivt kan katalyseres af især Trypanosoma 
cruzi α-2,3-trans-sialidase, er syntese af 6'-sialyloligosakkarider under anvendelse af en billig 
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sialyldonor hæmmet af manglen på effektive enzymer. Den kombinerede undersøgelse af 
mutagenese og reaktionsbetingelser i dette studie har givet nye værktøjer til effektiv syntese af 6'-
sialyloligosakkarider. 
Endelig blev det forsøgt at forbedre hydrolyseaktiviteten for en sialidase fra Micromonospora 
viridifaciens (EC 3.2.1.18), der katalyserer hydrolyse af α-2,3-, α-2,6- og α-2,8-bindinger. Enzymet 
og mutanter deraf blev udtrykt i Bacillus subtilis, hvor det blev secerneret til vækstmediet. På 
baggrund af krystalstrukturen blev tyve aminosyrer inden for 10 Å af sialinsyrebindingsstedet 
udvalgt til ‘site-saturation’ mutagenese. Disse mutanter blev evalueret for hydrolaseaktivitet med 
det unaturligee substrat 2-O-(p-nitrophenyl)-α-D-N-acetylneuraminsyre og det naturlige substrat 
kasein glycomakropeptid. Det blev fundet, at en langt større fraktion af mutanterne udviste øget 
hydrolyseaktivitet med det unaturlige substrat i forhold til det naturlige substrat. Den bedste mutant 
udviste 27 gange højere hydrolyseaktivitet med det unaturlige substrat, hvorimod ingen mutanter 
havde mere end to gange højere aktivitet med det naturlige substrat. Mutanternes stabilitet blev 
analyseret ved hjælp af PoPMuSiC algoritmen, og dette indikerede at sialidasen havde en nær-
optimal aktivitet med det naturlige substrat, hvorimod øget aktivitet med det unaturlige substrat 
korrelerede med større kemisk variation og nedsat stabilitet. Dette er i overenstemmelse med en 
trade off mellem stabilitet og aktivitet som er blevet observeret i protein optimering.
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Abbreviations 
ATP adenosine-5'-triphosphate 
BCA bicinchoninic acid 
BSA bovine serum albumin 
CAZY carbohydrate-active enzymes 
cGMP  casein glycomacropeptide 
CMP-Neu5Ac  cytidine-5'-monophosphate-N-acetylneuraminic acid 
CMP-3F(e)Neu5Ac cytidine-5'-monophosphate-3-equatorial-fluoro-N-acetylneuraminic acid 
CTP cytidine-5'-triphosphate 
CV column volume 
DANA 2-deoxy-2,3-dehydro-N-acetylneuraminic acid  
Fuc fucose 
FUT fucosyltransferase 
Gal galactose 
GalNAc N-acetylgalactosamine  
GalT galactosyltransferase 
GH glycoside hydrolase 
Glc glucose 
GlcNAc N-acetylglucosamine 
GNE uridine-5'-diphosphate-N-acetylglucosamine-2-epimerase/N-
acetylmannosamine kinase
GlcNAcT N-acetylglucosaminyltransferase 
GOS  galactooligosaccharides 
GMP guanosine-5'-monophosphate 
GT  glycosyltransferase 
GTP guanosine-5'-triphosphate 
HMOs  human milk oligosaccharides 
HPAEC-PAD  high-performance anion exchange chromatographywith pulsed 
amperometric detection    
KDN 3-deoxy-D-glycero-D-galacto-2-nonulopyranos-1-onic acid 
κ-CN κ-casein 
LC-MS capillary liquid chromatography/mass spectrometry 
LNAc N-acetyllactosamine 
LNDFH lacto-N-difucohexaose 
LNnDFH lacto-N-neodifucohexaose  
LNFP  lacto-N-fucopentaose 
LNnFP lacto-N-neofucopentaose  
LNnH lacto-N-neohexaose 
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LNT lacto-N-tetraose 
LNnT lacto-N-neotetraose 
LOS lipooligosaccharide 
LST sialyl-lacto-N-tetraose 
MALDI-MS  matrix-assisted laser desorption/ionization mass spectrometry 
Man mannose 
ManNAc N-acetylmannosamine 
Mu-Neu5Ac 4-methylumbelliferyl-N-acetyl-α-D-neuraminic acid 
N-His
6
-tag  N-terminal His
6
-tag  
Neu5Ac  N-acetylneuraminic acid 
Neu5Gc N-glycolylneuraminic acid  
neuraminic acid  5-amino-3,5-dideoxy-D-glycero-D-galacto-nonulopyranos-1-onic acid 
NMR nuclear magnetic resonance spectroscopy 
PEP  phosphoenolpyruvate 
Ph-β-Neu5Ac phenyl-β-Neu5Ac 
PmST Pasteurella multocida sialyltransferase 
pNP-Neu5Ac  2-O-(p-nitrophenyl)-α-D-N-acetylneuraminic acid 
RSM  response surface methodology 
SAS Neu5Ac synthase 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Sia-GOS  sialylated galactooligosaccharides 
SiaT sialyltransferase 
SL sialyllactose 
SLN sialyl-N-acetyllactosamine 
TcTS Trypanosoma cruzi trans-sialidase 
TLC  thin-layer chromatography 
TrSA Trypanosoma rangeli sialidase 
TrSA
5
 Trypanosoma rangeli sialidase with 5 mutations 
TrSA
6
 Trypanosoma rangeli sialidase with 6 mutations 
TrSA
13
 Trypanosoma rangeli sialidase with 13 mutations 
U unit 
UDP-GlcNAc uridine-5'-diphosphate-N-acetylglucosamine 
UTP uridine-5'-triphosphate 
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1. INTRODUCTION 
1.1 HUMAN MILK OLIGOSACCHARIDES (HMOs) 
1.1.1 Structure and biosynthesis of HMOs  
Oligosaccharides are the third largest abundant component in human milk after lactose and fat.The 
content of HMOs varies during lactation with a level of >20 g/L in colostrum and 5-14 g/L in 
mature milk (Coppa et al., 1999; Gabrielli et al., 2011; Kunz et al., 2000). The building blocks of 
HMOs comprise five monosaccharaides, i.e. glucose (Glc), galactose (Gal), fucose (Fuc), N-
acetylglucosamine (GlcNAc) and N-acetylneuraminic acid (Neu5Ac).Lactose (Galβ-1,4Glc) forms 
the reducing end of HMOs. Gal in lactose can be sialylated in α-2,3 and α-2,6 linkages to form 3'- 
and 6'-sialyllactoses (SLs) (Fig. 1.1), or fucosylated in α-1,2 and α-1,3 linkages to form 2'-
fucosyllactose (2'-FL, Fucα1-2Galβ1-4Glc) and 3-FL (Galβ1-4(Fucα1-3)Glc), respectively. These 
trisaccharides constitute the short chain HMOs. To form more complex structures of HMOs, lactose 
is elongated with N-acetyllactosamine (LNAc) repeat units (Galβ1-3/4GlcNAc). Lactose and/or 
polylactosamine backbone can be further sialylated and/or fucosylated in various linkages (Bode, 
2009). About 180 different oligosaccharide species have been identified from a pooled human milk 
sample, containing nearly 46% fucosylated and 17% sialylated oligosaccharides (Niñonuevo et al., 
2006). Conversely, bovine milk contains no neutral oligosaccharides e.g. lacto-N-tetraose (LNT, 
Galβ1-3GlcNAcβ1-3Galβ1-4Glc) and fucosylated oligosaccharides but mainly sialylated 
oligosaccharides with a 20-fold lower level compared to the human milk counterpart (Table 1.1). 
     
Fig. 1.1 Structures of 3'-SL (A) and 6'-SL (B). 
The chemical structures of HMOs have been studied using reversed-phase high performance liquid 
chromatography (RP-HPLC) (Chaturvedi et al., 1997; Leo et al., 2010; Sumiyoshi et al., 2003), 
high-performance anion exchange chromatography (HPAEC) (Kunz et al., 1996; Finke et al., 1999; 
Thurl et al., 1996), capillary electrophoresis (CE) (Bao and Newburg, 2008; Shen et al., 2000), 
A B 
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associated with nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS) 
techniques (Kogelberg et al., 2004; Niñonuevo et al., 2008; Stahl et al. 1994; Wu et al., 2011). 
Particularly, a method using matrix-assisted laser desorption/ionization-Fourier transform ion 
cyclotron resonance mass spectrometry (MALDI-FTICR MS) allowed precise identification and 
quantification of individual HMO species (Niñonuevo et al., 2006; LoCascio et al., 2009).  
Table 1.1 Major oligosaccharides of human milk and bovine milk
a
. 
Oligosaccharide Human milk (g/L)
b
 Bovine milk (g/L)
c
 
Lacto-N-tetraose 0.5-1.5 - 
Lacto-N-fucopentaose I 1.2-1.7 - 
Lacto-N-fucopentaose II 0.3-1.0 - 
Lacto-N-fucopentaose III 0.01-0.2 - 
Lacto-N-difucohexaose 0.1-0.2 - 
6'-sialyllactose 0.3-0.5 
0.03-0.06
d
 
3'-sialyllactose 0.1-0.3 
Neu5Ac-lacto-N-tetraose a 0.03-0.2 Traces 
Neu5Ac-lacto-N-tetraose c 0.1-0.6 Traces 
Neu5Ac
2
-lacto-N-tetraose 0.2-0.6 Traces 
In total 5.0-8.0 Traces 
a
 Table is adapted from Kunz et al. (2000). 
b
 Data are obtained from Kunz and Rudloff (1993) and Montreuil et al., 1960. 
c
 Data are obtained from Parkkinen and Finne (1987) and Martín-Sosa et al. (2003).  
d
 The value denotes the total concentration of 3'- and 6'-SLs. 
Biosynthesis of HMOs is suggested to be an extension of lactose synthesis that occurs in the Golgi 
(Bode, 2012). It starts with activation of cytosolic Glc to UDP-Glc which is then converted to UDP-
Gal. Rudloff et al. (2006) suggested that exogenous Gal might directly be incorporated to lactose 
and HMOs without prior conversion to Glc and reconversion to Gal. Eventually, both UDP-Gal and 
Glc are transported into the Golgi and are linked to the lactose synthase complex that consists of “A” 
and “B” proteins. In combination with “B” protein α-lactalbumin, “A” protein β-1,4-
galactosyltransferase (β-1,4GalT) shifts its acceptor specificity from GlcNAc to Glc and thus 
catalyses the transfer of UDP-Gal to Glc to form lactose (Ramakrishnan et al., 2002). The 
biosynthetic steps for extending lactose to form different HMOs remain poorly understood. 
However, Kobata (2003) suggested that extension of the lactose core might be fulfilled by 
concerted action of N-acetylglucosaminyltransferases (GlcNAcT) and GalT that enable synthesis of 
two major tetrasaccharide structures LNT and lacto-N-neotetraose (LNnT, Galβ1-4GlcNAcβ1-
3Galβ1-4Glc). HMO fucosylation involves three fucosyltransferases (FUTs), i.e. FUT2 catalyses 
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the transfer of α-1,2 bound Fuc to terminal Gal, FUT3 catalyses the transfer of α-1,4 bound Fuc to 
internal GlcNAc preferentially on type 1 chains (Galβ1-3GlcNAc-), and FUTX (an unknown FUT) 
catalyses the transfer of α-1,3 bound Fuc to terminal Glc or subterminal GlcNAc on type 2 chains 
(Galβ1-4GlcNAc-) (Chaturvedi et al., 2001; Gabrielli et al., 2011; Kumazaki and Yoshida, 1984; 
Johnson and Watkins, 1992; Stahl et al., 2001; Thurl et al., 1997). Little knowledge has been 
obtained for sialyltransferase (SiaT) types that are responsible for HMO sialylation. However, 
Tsuchida et al. (2003) reported that two α-2,6-SiaTs (namely ST6GalNAc V and VI) were able to 
facilitate α-2,6-sialylation of subterminal GlcNAc.  
1.1.2 Physiological properties of HMOs 
The structural diversity and complexity confer unique biological functions to HMOs. Firstly, HMOs 
serve as prebiotics that promote the growth of desired bacteria in the intestine of infant. For 
example, a mixture of ~10 HMOs containing GlcNAc is the growth-promoting “bifidus factor” for 
Bifidobacterium bifidum (György et al., 1954; Petschow and Talbott, 1991). Short-chain HMOs 
(degree of polymerization <7) are preferentially consumed by Bifidobacterium longum subsp. 
infantis (LoCascio et al., 2007 and 2009). Metabolites from bacterial degradation of HMOs, e.g., 
short-chain fatty acids and lactic acid, create an environment that favors the growth of commensals 
over potential pathogens (Gibson and Wang, 1994; Ogawa et al., 1992). Recently, sequencing of the 
B. infantis genome revealed a 43 kb gene cluster encoding glycosidases (sialidase, fucosidase, 
galactosidase and hexosaminidase), oligosaccharide transport-related genes as well as glycan-
binding proteins that are responsible for HMO metabolism (Sela et al., 2008). Secondly, HMOs act 
as “decoys”, namely bacterial lectin ligand analogues, to block pathogen attachment (Newburg et al., 
2005). Parkkinen et al. (1983) reported that sialylated HMOs abolished the binding activity of 
Escherichia coli strains that cause newborn meningitis. The α-1,2-fucosylated HMOs might reduce 
the diarrhea incidence by preventing Campylobacter jejuni from binding to human epithelial surface 
(Ruiz-Palacios et al., 2003; Morrow et al., 2004). Fucosylated HMOs might also reduce human 
immunodeficiency virus (HIV)-1 mother-to-child transmission by competing with the viral 
envelope glycoprotein (gp120) for binding to dendritic cell-specific ICAM3-grabbing non-integrin 
(DC-SIGN) (Hong et al., 2009). The antiadhesive effect of HMOs also applies to protozoan 
parasites like Entamoeba histolytica that causes amoebic dysentery or amoebic liver abscess 
(Jantscher-Krenn et al., 2012). Thirdly, HMOs can modify the intestinal epithelial cell surface 
glycome to impact pathogen attachment. Angeloni et al. (2005) reported that 3'-SL-induced changes 
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in the cell-surface glycans led to a 90% reduction in enteropathogenic E. coli adhesion by regulating 
the expression of genes that encode enzymes involved in glycan assembly. Fourthly, HMOs directly 
affect the infant immune system by altering protein-carbohydrate interactions at a systemic level. 
For instance, Bode et al. (2004a and 2004b) reported that sialylated HMOs might serve as anti-
inflammatory components to lower the incidence of inflammatory diseases by affecting leukocyte-
endothelial cell and leukocyte-platelet interactions. Lastly, Neu5Ac and Fuc moieties derived from 
degraded HMOs are readily available for synthesis of biologically active substances such as 
gangliosides and cerebral glycoproteins involved in neuronal growth and morphology, and might 
therefore improve memory-storage and learning ability (Krug et al., 1994; Matthies et al., 1996; 
Wang, 2009; Wang et al., 2003). 
1.2 SIALIC ACID 
Sialic acids are a family of α-keto acids with a nine-carbon backbone. Over 50 sialic acid forms 
have been elucidated, which are derivatives of neuraminic acid (5-amino-3,5-dideoxy-D-glycero-D-
galacto-nonulopyranos-1-onic acid). The structural modification of sialic acids generally occurs at 
carbon 5, i.e., the C-5 position commonly has an acetamido giving Neu5Ac, or a hydroxyacetamido 
giving N-glycolylneuraminic acid (Neu5Gc), or a hydroxyl moiety giving 3-deoxy-D-glycero-D-
galacto-2-nonulopyranos-1-onic acid (KDN) (Fig. 1.2). These three molecules (Neu5Ac, Neu5Gc 
and KDN) can be further modified by substitutions at the hydroxyl groups on C-4, C-7, C-8 and C-9 
with O-acetyl, O-methyl, O-sulfate, and lactyl and phosphate groups. The carboxylate group of 
sialic acids is deprotonated at physiological pH (pKa of 2.6) and confers the net negative charge 
that dominates physiological properties of the family (Schauer, 1997 and 2004; Varki, 1999; Vimr 
et al., 2004). 
Sialic acids usually occupy the terminal position of cell surface-exposed glycoconjugates and are 
involved in many biological and pathological processes, including cell-cell and cell-molecule 
interactions. Due to their negative charge, sialic acids are involved in the binding and transport of 
positively charged molecules (e.g. Ca
2+
) as well as in the repulsion of cells, e.g. erythrocytes 
(antiadhesive effect), and influence the physicochemical properties of glycoproteins such as mucins. 
The negative charge of sialic acids also protects glycoproteins from enzymatic, mainly proteolytic 
attack. Sialic acids play the most important role as a mask to prevent biological recognitions, or in 
opposite, to represent recognition determinants. For instance, by shielding recognition sites such as 
penultimate monosaccharides or antigenic proteins, sialic acids often render cells as “self” to avoid 
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or resist host innate immunity; as well, sialic acids serve as receptors in the adhesion of pathogenic 
viruses, bacteria, and protozoa; and they are also believed to regulate cell adherence and mobility 
during embryogenesis and malignant growth (Schauer, 2000a and b and 2009; Traving and Schauer, 
1998).  
 
Fig. 1.2 Chemical structures of three naturally abundant sialic acids. (A) Neu5Ac; (B) Neu5Gc; (C) Kdn.  
De novo biosynthesis of sialic acid differs in eukaryotes and bacteria. In most eukaryotes, it takes 
place in cytosol involving three enzymes in a four-step process. The first two steps are catalysed by 
a bifunctional enzyme uridine-5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc)-2-epimerase/N-
acetylmannosamine (ManNAc) kinase (named GNE), i.e., the UDP-GlcNAc-2-epimerase activity 
of GNE catalyses the conversion of UDP-GlcNAc to ManNAc; the kinase function of GNE 
subsequently phosphorylates ManNAc to form ManNAc-6-P. The latter two steps comprise 
condensation and dephosphorylation reactions catalysed by Neu5Ac 9-phosphate synthase (NANS) 
and Neu5Ac-9-phosphate phosphatase (NANP) respectively to produce sialic acid. Only a limited 
number of pathogenic bacteria and commensals which are mostly related to human are able to 
synthesize sialic acid. De novo biosynthesis of sialic acid in bacteria begins with the conversion of 
UDP-GlcNAc to ManNAc catalysed by UDP-GlcNAc-2-epimerase. ManNAc is then converted to 
sialic acid and inorganic phosphate catalysed by Neu5Ac synthase (SAS) in the presence of 
phosphoenolpyruvate (PEP). Sialic acid activation and transfer processes are conserved from 
bacteria through humans. In eukaryotes, sialic acid synthesized in the cytosol is transferred to the 
nucleus and activated by cytodine-5'-monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac) 
synthetase to form CMP-Neu5Ac, which is then transferred to the Golgi and used by SiaTs for the 
formation of sialoglycoconjugates. Degradation of sialoglycoconjugates is carried out in lysosome 
by sialidases, and released sialic acid go back into the cytosol and are subjected to another cycle of 
sialoglycoconjugate production, or are broken down by sialic acid lyase to form ManNAc and 
pyruvate. Similarly, sialylation in bacteria is mainly catalysed by SiaTs; as well, desialylation is 
carried out by sialidases or sialic acid lyase (Angata and Varki, 2002; Buschiazzo and Alzari, 2008; 
Li and Chen, 2012; Traving and Schauer, 1998). 
A B 
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Exceptionally, some protozoan species, such as Trypanosoma cruzi (the causative agent of Chagas’ 
disease), use an α-2,3-trans-sialidase (TcTS) to catalyse the transfer of sialic acid residues directly 
from the hosts to terminal β-Gal residues of the parasite mucins and form their own surface 
sialoglycoconjugates (Colli, 1993; Previato, 1985). A few bacterial pathogens have evolved 
scavenging pathways to obtain sialic acids, including donor scavenging (only described in Neisseria 
gonorrheae) where CMP-sialic acid is scavenged from the hosts (Parsons et al., 1994), and 
precursor scavenging (e.g., Haemohilus influenzae and Pasteurella multocida) where free sialic acid 
is obtained directly from the hosts (Schilling et al., 2001; Steenbergen et al., 2005). 
1.3 BACTERIAL SIALIDASE 
Sialidases, or neuraminidases (EC 3.2.1.18) belong to a class of glycoside hydrolases (GHs) that 
catalyse the release of terminal sialic acid residues from a variety of sialoglycoconjugates in diverse 
organisms, including animals, microorganisms and viruses. Sialidases may be extracellular, 
membrane-bound or intracellular in bacteria. The enzymes are used to scavenge sialic acids as 
carbon and energy sources from sialylated substrates, or function as virulence factors that contribute 
to the recognition of sialic acids exposed on the cell surface of the hosts (Corfield, 1992; Roggentin 
et al., 1993; Taylor, 1996; Vimr, 1994).  
1.3.1 Structural and biochemical properties 
The monomeric molecular weights of bacterial sialidases generally range between 40 kDa and 150 
kDa. Most of the enzymes are monomers, whereas sialidases from Clostridium chauvoei (dimer), 
Bacteroides fragilis SBT3182 (trimer) and Trichomonas fetus (tetramer) are exceptions (Table 1.2). 
Bacterial sialidases can be divided into small and large subtypes on the basis of molecular weight, 
i.e., small sialidases possess only a catalytic domain and large sialidases include additional domains 
that assist with carbohydrate-binding and enzyme location. Micromonospora viridifaciens secretes a 
small or large sialidase derived from the same gene, dependent on the carbon source: in the 
presence of colominic acid and milk casein, the small form of sialidase domain (41 kDa) and the 
large form (68 kDa) with an immunoglobulin fold and a Gal-binding domain following the catalytic 
domain are secreted, respectively (Fig. 1.3A) (Gaskell et al., 1995; Sakurada et al., 1992). The 
overall amino acid sequence homologies among bacterial sialidases are less than 30%, nevertheless, 
the catalytic domains share a common six-bladed β-propeller fold, in which each blade is made 
from a four-stranded antiparallel β-sheet (Fig. 1.3A). The enzymes usually contain three to five  
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copies of an Asp-box (S/T-X-D-X-G-X-T-W/F, X representing any amino acid), a surface-exposed 
turn located between the third and fourth strands of each sheet. These Asp-boxes occupy 
topologically equivalent positions in the fold, and are remote from the active site, suggesting they 
are probably not involved in catalysis. Another conserved motif “RIP”, which has variations like 
“FRIP”, “YRIP” or “DRIP”, contains one of the catalytic triad of Arg residues that interacts with 
the carboxyl group of the sialic acid substrate (Kim et al., 2011; Roggentin et al., 1993; Taylor et al., 
2008; Vimr, 1994). The active site of the enzymes also contains a nucleophile pair of Tyr/Glu 
working as a charge-relay system where the Tyr residue performs the direct nucleophile attack, and 
an Asp residue that acts as the acid/base catalyst (Fig. 1.3B). 
       
Fig. 1.3 Structure of Micromonospora viridifaciens sialidase (PDB code 1EUU). (A) Overall structure of the 
large form of the enzyme (68 kDa). The catalytic domain (41 kDa) is shown in yellow, the immunoglobulin 
fold in orange and the Gal-binding domain in red. The four Asp boxes in the catalytic domain are highlighted 
in blue. (B) Close view of the active site of the enzyme. The carbon atoms of the conserved amino acid 
residues and the ligand 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Neu5Ac2en, DANA) are shown in 
blue- and salmon-colored sticks, respectively.    
Retaining bacterial sialidases, grouped in carbohydrate-active enzymes (CAZY) family GH 33, 
work through a classical ping-pong (double displacement) mechanism involving glycosylation and 
deglycosylation steps (Fig. 1.4). In the first step, with the aid of Glu the nucleophile (Tyr) attacks 
the anomeric carbon to displace the aglycon and form a covalent sialyl-enzyme intermediate, while 
the catalytic acid (Asp) protonates the glycosidic oxygen as the bond cleaves. In the second step, a 
water molecule is deprotonated by the catalytic base (Asp) in order to attack the anomeric center of 
A B 
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the sialyl-enzyme intermediate and restore the nucleophile Tyr (Buschiazzo and Alzari, 2008; 
Damager et al., 2008; Brás et al., 2012; Newstead et al., 2008; Watts et al., 2003).  
The optimum temperatures of characterized bacterial sialidases are in the range of 37-58 °C, and the 
optimum pH values generally lie in a weakly acidic range (4.5-7.0). The kinetic properties can be 
affected significantly by difference in assay conditions. In general, the K
m
 values with SL as the 
substrate range between 0.5 mM and 5 mM (Table 1.2). Bacterial sialidases are promiscuous in 
their choice of sialoglycoconjugates, capable of hydrolysing either α-2,3, α-2,6, or α-2,8 bound 
sialic acid. In general, they preferentially hydrolyse 3'- or 6'-SL over colominic acid (polysialic acid 
with α-2,8 linkage), exceptions being sialidases from Actinomyces viscosus, B.bifidum, B. fragilis 
and M. viridifaciens. Most bacterial sialidases have a preference for 3'-SL rather than 6'-SL, 
especially Streptococcus pneumoniae sialidase is highly specific to α-2,3 sialyl linkage. A. 
ureafaciens, A. viscosus and M. viridifaciens sialidases, however, cleave α-2,6 bound sialic acid 
residues more efficiently than α-2,3 sialyl linkage (Table 1.2) (Abrashev and Dulguerova, 2000; 
Corfield, 1992; Kim et al., 2011; Roggentin et al., 1993; Saito and Yu, 1995). 
1.3.2 Bacterial sialidase-catalysed trans-sialylation for sialyloligosaccharide synthesis  
Conventional chemical synthesis remains a challenging task for production of 
sialyloligosaccharides because it involves multiple protection/deprotection and purification steps to 
achieve regioselectivity and stereoselectivity. To overcome these limitations, sialidase-catalysed 
trans-sialylation has been applied as an alternative for sialyloligosaccharide production (Desmet and 
Soetaert, 2011; Kim et al., 2011; Brás et al., 2012). The trans-sialylation reactions work through the 
double displacement mechanism of retaining sialidases, in which the covalent sialyl-enzyme 
intermediate is intercepted by an acceptor molecule other than water (Fig. 1.4). By use of 
appropriate selection of enzyme and reaction conditions, sialidases can catalyse highly regio- and 
stereo-specific bond formation.  
The use of bacterial sialidases from e.g. A. ureafaciens, B. fragilis, C. perfringens, Salmonella 
typhimurium, and Vibrio cholerae as catalysts for synthesis of sialyloligosaccharides has been 
reported (Table 1.3). 2-O-(p-nitrophenyl)-α-D-N-acetylneuraminic acid (pNP-Neu5Ac) is more 
commonly used as a sialyl donor compared to other sialyloglycoconjugates because the leaving 
group pNP can be rapidly and irreversibly released by the enzyme during the glycosylation step 
(Kim et al., 2011; Seeberger et al., 2009). Bacterial sialidases catalyse preferentially formation of α-
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2,6 sialyl linkage over α-2,3 linkage, except that S. typhimurium sialidase displays a distinct 
preference for α-2,3-trans-sialylation. Usually, bacterial sialidase-catalysed trans-sialylation 
reactions are carried out under mild conditions (pH 5.0-5.5, temperature 26-37 °C, in some cases 
with 10-30% co-solvent), and most reactions proceed at least for 5 h. The yields are generally low 
(<30%) because the products also undergo sialidase-catalysed hydrolysis. In order to drive the 
reactions towards the direction of trans-sialylation rather than hydrolysis, the use of high 
acceptor:donor ratio has been attempted with success. 
 
Fig. 1.4 Proposed catalytic mechanism for retaining sialidases. R
1
, glycoside; R
2
, glycoside or H. 
Regioselectivity of glycosidase in transglycosylation reaction is highly correlated to its specificity 
in hydrolysis reaction (Ajisaka and Yamamoto, 2002). This rule applied to S. typhimurium sialidase 
that is highly specific for catalysing both transfer and hydrolysis of α-2,3 sialyl linkage. However, 
several exceptions have been found, e.g., both V. cholerae and C. perfringens sialidases catalyse 
preferable formation of α-2,6 sialyl linkage over α-2,3 linkage, but their preference is reversed in 
hydrolysis reactions. One rationale for the regioselectivity difference between trans-sialylation and 
hydrolysis reactions could be that α-2,3-sialyloligosaccharides are rapidly hydrolysed and thus do 
not accumulate in the trans-sialylation reactions. Furthermore, regioselective trans-sialylation can 
also be controlled by the following factors: (1) Donor specificity. When the donor pNP-Neu5Ac 
was replaced with colominic acid or Neu5Acα2-8Neu5Ac, V. cholerae and C. perfringens sialidases 
catalysed formation of α-2,6 sialyl linkage rather than a mixture of isomers (Ajisaka et al., 1994). (2) 
Aglycon stucture of acceptor. By use of the acceptor methyl α-D-galactopyranoside (αGal-OCH
3
), 
the regioisomeric ratio of (α-2,6:α-2,3) for V. cholerae sialidase increased 2-3 times compared to 
the corresponding ratios obtained by use of other galactoside acceptors (Thiem and Sauerbrei, 1991). 
The ratio between α-2,6- and α-2,3-sialylated products also varied depending on the acceptor 
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structures used in S. typhimurium sialidase-catalysed reactions (Schmidt et al., 2000). (3) Reaction 
conditions, including acceptor concentration, temperature, pH and reaction time. A five-time 
increase of the concentration of the acceptor βGal-OCH
3
 resulted in a 5.6-time increase in the 
regioisomeric ratio (α-2,6:α-2,3) for V. cholerae sialidase (Thiem and Sauerbrei, 1991). The 
regioselectivity was also favoured at higher temperature and prolonged reaction time in either V. 
cholerae or C. perfringens sialidase-catalysed reaction (Schmidt et al., 2000). Such influences could 
be correlated to product build-up and subsequent degradation. Similarly, the ratio of (α-2,6:α-2,3) in 
the B. fragilis sialidase-catalysed trans-sialylation decreased 11.6-fold by extending reaction time 
from 3 h to 20 h, which was due to accumulation of 3'-SL and degradation of 6'-SL (Tanaka et al., 
1995). Moreover, using the promiscuous trans-sialidase activity of a P. multocida SiaT (PmST), the 
reaction could be driven to either α-2,3- or α-2,6-trans-sialylation under combinatorial control of pH 
and reaction time (Guo et al., 2014/chapter 2).
1.4 BACTERIAL SIALYLTRANSFERASE 
Sialyltransferases (EC 2.4.99.-) catalyse the transfer of a sialic acid from an activated sugar 
nucleotide donor CMP-sialic acid to a variety of acceptor molecules, usually at the 3- or 6-position 
of a terminal Gal or N-acetylgalactosamine (GalNAc) residue, or the 8- or 9-position of a terminal 
sialic acid residue. Bacteria expressing SiaTs are usually pathogens that display 
sialooligosaccharides structurally identical to mammalian glycolipids on their cell surface in order 
to evade the host’s immune response (Audry et al., 2011; Li and Chen, 2012; Moran et al., 1996; 
Schwardt et al., 2006).  
1.4.1 Structural and biochemical properties 
Based on sequence homology, all bacterial SiaTs reported so far have been classified into four 
glycosyltransferase (GT) families (GT 38, 42, 52 and 80) in the CAZY database (Coutinho et al., 
2003; Yamamoto et al., 2008). GT38 contains exclusively bacterial polySiaTs, while GT 42, GT52 
and GT 80 contain bacterial lipooligosaccharide (LOS) SiaTs (Table 1.4).  
The tertiary structures of bacterial SiaTs characterized so far fall into GT-A and GT-B folds. C. 
jejuni α-2,3/2,8-SiaT (Cst-II) and α-2,3-SiaT (Cst-I) both belonging to GT42 adopt a modified GT-
A structure, i.e. a single α/β/α sandwich consisting of an N-terminal Rossmann nucleotide-binding 
domain and a C-terminal lid-domain that encompasses the active site region (Fig. 1.5A) (Chiu et al., 
2004 and 2007). On the other hand, P. multocida α-2,3/2,6-SiaT (Δ24PmST1), Vibrionaceae 
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Photobacterium sp. a-2,6-SiaT (Δ16psp26ST) and Photobacterium phosphoreum 
lipooligosaccharides α-2,3/2,6-SiaT (ΔNpp23ST) all belonging to GT80 as well as Neisseria 
meningitides α-2,3/2,6-SiaT (NST) belonging to GT52 display a modified GT-B structure 
consisting of two separate Rossmann domains with a deep nucleotide-binding cleft located between 
the two domains (Fig. 1.5B) (Iwatani et al., 2009; Kakuta et al., 2008; Lin et al., 2011; Ni et al., 
2007).  
Table 1.4 Relationship between enzyme activities and bacteria. Regiospecificity for SiaT reaction is listed as 
well as reported side trans-sialidase (TS)/sialidase (SA) activity. 
GT family Origin Enzyme activities Reference 
SiaT activity TS/SA activity 
38 Escherichia coli K1 α-2,8-SiaT - Cho and Troy, 1994; 
Steenbergen et al., 1992 
Escherichia coli K92 α-2,8/2,9-SiaT Shen et al., 1999 
Neisseria meningitides group B α-2,8-SiaT Edwards et al., 1994;  
Freiberger et al., 2007 
Neisseria meningitides group C α-2,9-SiaT Peterson et al., 2011 
42 Campylobacter jejuni α-2,3/2,8-SiaT  
(Cst-II
c
) 
α-2,8-TS;  
α-2,8-SA 
Chiu et al., 2004; 
Cheng et al., 2008 
α-2,3-SiaT (Cst-I
a
) - Chiu et al., 2007 
Haemophilus influenzae α-2,3/2,8-SiaT (lic3B) Fox et al., 2006 
Pasteurella multocida α-2,3-SiaT (PmST3) Thon et al., 2012 
52 Haemophilus influenzae α-2,3-SiaT (lic3A) - Hood et al., 2001 
Neisseria gonorrhoeae α-2,3-SiaT Gilbert et al., 1996 
Neisseria meningitides α-2,3-SiaT Gilbert et al., 1997 
α-2,3/2,6-SiaT
a
 
 
Wakarchuk et al., 2001 
Lin et al., 2011 
Pasteurella multocida α-2,3-SiaT (PmST2) Thon et al., 2011 
80 Haemophilus ducreyi α-2,3-SiaT - Li et al., 2007 
Pasteurella multocida α-2,3/2,6-SiaT 
(Δ24PmST1
a
; 
PmST) 
α-2,3/2,6-TS; 
α-2,3/2,6-SA 
Guo et al., 2014 and  
chapter 3 
Ni et al., 2007; 
Yu et al., 2005 
Photobacterium damsela  α-2,6-SiaT α-2,6-TS; 
α-2,6-SA 
Cheng et al., 2010; 
Yamamoto et al., 1996 
and 1998b 
Photobacterium leiognathi  α-2,6-SiaT α-2,6-SA Mine et al., 2010b 
Photobacterium leiognathi  α-2,6-SiaT - Yamamoto et al., 2007 
Photobacterium phosphoreum α-2,3-SiaT
a
 α-2,3-SA Tsukamoto et al., 2007; 
Iwatani et al., 2009 
Photobacterium sp.  α-2,3-SiaT α-2,3-SA Tsukamoto et al., 2008; 
Kakuta et al., 2008 α-2,6-SiaT
a
 - 
Vibrio sp.  α-2,3-SiaT  Takakura et al., 2007 
a
 Enzyme structures have been solved. 
Despite sequence and structure differences among bacterial SiaTs, the enzymes are inverting GTs 
that catalyse the formation of α-sialyl linkage from β-linked sialic acid in CMP-sialic acid donor 
substrate through a direct displacement mechanism (Fig. 1.6). A catalytic residue functions as a 
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general base that deprotonates the hydroxyl group of the acceptor to activate it as a nucleophile for 
attack of anomeric center of the sialic acid moiety in the donor. Through a single oxocarbenium 
ion-like transition state, SiaTs catalyse the synthesis of sialyl linkage between acceptor and donor 
substrates with inversion of the configuration at C2. In SiaTs from GT42, a His residue (H202 in 
Cst-I and H188 in Cst-II) is a potential general base, while an Asp residue in SiaTs from GT80 
(D141 in Δ24PmST1), and from GT52 (D528 in NST), serves as a general base. A second catalytic 
residue serves as a general acid to protonate the oxygen on the phosphate of the nucleotide sugar 
and thereby facilitates the departure of the CMP leaving group. In Cst-I and Cst-II proteins, two 
conserved tyrosine residues assist the departure of the phosphate group, while in case of SiaTs from 
GT80 and GT52 a His residue is a general acid to stabilize the CMP leaving group (Li and Chen, 
2012; Iwatani et al., 2009; Kakuta et al., 2008; Lin et al., 2011; Ni et al., 2007). Two conserved 
motifs (D/E-D/E-G and H-P) are present throughout SiaTs from GT38, GT52 and GT80, and in 
SiaTs from GT80 and GT52 the H-P motif contains the catalytic acid (His). The motif D/E-D/E-G 
contains the catalytic base (Asp) in SiaTs (GT80), however the conserved motif is not located 
within the active site of NST (GT52) (Freiberger et al., 2007; Lin et al., 2011; Yamamoto et al., 
2008).  
           
Fig. 1.5 Structures of Campylobacter jejuni Cst-II (PDB code 1RO7) and Pasteurella multocida Δ24PmST1 
(PDB code 2IHK) in complex with CMP-3F-Neu5Ac. (A) Cst-II adopts a modified GT-A fold; (B) 
Δ24PmST1 adopts a modified GT-B fold. For both structures, N-terminal and C-terminal domains are 
colored in light pink and marine, respectively, and the ligand CMP-3F-Neu5Ac is shown in green-colored 
sticks. 
The monomeric molecular weights of bacterial SiaTs generally lie between 40-60 kDa. Most 
enzymes are monomers, but there are exceptions, such as N. meningitidis α-2,3-SiaT (dimer), and 
A B 
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Cst-I and Cst-II (tetramer) (Chiu et al., 2004 and 2007; Gilbert et al., 1997). Bacterial SiaTs are 
usually membrane-associated proteins. In particular, α-2,3-SiaTs from N. meningitidis and N. 
gonorrhoeae have been verified to be surface-exposed outer-membrane proteins (Gilbert et al., 
1996; Shell et al., 2002). SiaTs from marine bacteria Photobacterium sp. are predicted to be 
lipoproteins that are translocated across the cytoplasmic membrane to the periplasma (Takakura et 
al., 2007; Tsukamoto et al., 2007 and 2008; Yamamoto et al., 1998b and 2007). Bacterial SiaTs are 
metal-independent GTs. In some cases the SiaT activity can be stimulated by divalent ions (Gilbert 
et al., 1996 and 1997; Peterson et al., 2011; Willis et al., 2008), however for P. damsela α-2,6-SiaT, 
∆24PmST1 and Haemophilus ducreyi α-2,3-SiaT, the activity is inhibited by increasing the 
concentration of Mn
2+
 (Li et al., 2007; Sun et al., 2008; Yu et al., 2005). Moreover, SiaTs from 
marine bacteria are normally more active in a high concentration of NaCl (Mine et al., 2010b; 
Takakura et al., 2007; Tsukamoto et al., 2007 and 2008; Yamamoto et al., 2007). The kinetic 
properties of bacterial SiaTs can be affected by the assay conditions (Freiberger et al., 2007; 
Mandrell et al., 1993; Regan et al., 1999). In general, the apparent K
m
 values for CMP-Neu5Ac 
range between 0.02 mM and 1.4 mM, however, the lowest K
m
 for CMP-Neu5Ac reported so far is 
5.3 μM for N. gonorrhoeae SiaT (Mandrell et al., 1993). The optimum pH values fall between 5.0 
and 8.0. Particularly, marine bacteria SiaTs display optimum pH values in the acidic range except 
Photobacterium leiognathi α-2,6-SiaT (optimum pH at 8.0) (Yamamoto et al., 2007), and the 
temperature optima for marine bacteria SiaTs are in the range of 25-35 °C. 
 
Fig. 1.6 Proposed catalytic mechanism for inverting SiaTs (GT80). R, glycoside. 
A few bacterial SiaTs are bifunctional enzymes, capable of synthesizing two types of sialyl linkages, 
including Cst-II, E. coli α-2,8/2,9-polySiaT, H. influenzae α-2,3/2,8-SiaT, N. meningitidis α-2,3/2,6-
SiaT, ∆24PmST1 and PmST (Table 1.4). Some bacterial SiaTs have flexible donor substrate 
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specificity. For instance, Cst-II (Cheng et al., 2008), ∆24PmST1 (Yu et al., 2005), α-2,6-SiaTs from 
P. damsela (Kajihara et al., 1999; Yu et al., 2006b) and Photobacterium sp. JT-ISH-224 (Drouillard 
et al., 2010) are capable of using CMP-Neu5Ac, CMP-Neu5Gc, CMP-KDN or their derivatives (e.g. 
with sialic acid modifications at C-5 or C-9) as donor substrates for production of 
sialyloligosaccharides. Further, bacterial SiaTs have promiscuous acceptor substrate specificity. 
Marine bacteria SiaTs are less specific for the type of the second sugar from the non-reducing 
terminus and for the linkage between the terminal and second sugars as compared to the 
mammalian counterparts. For instance, α-2,3-SiaTs from P. phosphoreum, Photobacterium sp. JT-
ISH-224 and Vibrio sp. JT-FAJ-16 can catalyse the transfer of sialic acid to both α- and β-
galactosides (Mine et al., 2010b; Takakura et al., 2007; Tsukamoto et al., 2007 and 2008; 
Yamamoto et al., 2007), and P. damsela α-2,6-SiaT acts on both fucosyl- and sialyl-trisaccharides 
(Yamamoto et al., 1996).  
Several SiaTs have been shown to also catalyse trans-sialidase/sialidase activities, including Cst-II 
(Cheng et al., 2008), Photobacterium damsela α-2,6-SiaT (∆15Pd2,6ST) (Cheng et al., 2010), 
∆24PmST1 (Yu et al., 2005) and its homologue PmST (Guo et al., 2014). Generally, promiscuous 
activities share the main active site features with the native activity (Khersonsky and Tawfik, 2010). 
In case of ∆24PmST1 and PmST, it has been suggested that their α-2,3-sialidase as well as α-2,3-
trans-sialidase activities follow a retaining mechanism, in which D141 is a possible general 
acid/base and His311 is a possible nucleophile (Guo et al., 2014; Sugiarto et al., 2011). In some 
cases, the same catalytic residue can act in a different protonation state in the native compared to 
the promiscuous function (Khersonsky and Tawfik, 2010). The different activities of Δ24PmST1 
have different pH optima: the α-2,3-SiaT (pH 7.5-9.0), α-2,3-trans-sialidase (pH 5.5-6.5) and α-2,3-
sialidase activities (pH 5.0-5.5), possibly being involved in modulating charges and consequently 
functionalities of critical residues (Sugiarto et al., 2011; Yu et al., 2005). Moreover, promiscuous 
activities are generally less efficient than the native activity, however the difference in k
cat
/K
m 
value 
falls in a broad range (1-9 orders of magnitude) (Khersonsky and Tawfik, 2010). In case of these 
SiaTs, the trans-sialidase and sialidase activities are 5-3150 folds less efficient as compared to the 
native function (Cheng et al., 2008 and 2010; Guo et al., 2014; Yu et al., 2005).  
1.4.2 Bacterial SiaT-catalysed synthesis of sialyloligosaccharides 
Compared to bacterial sialidases, bacterial SiaTs have the advantage of achieving high yields and 
formation of regiospecific products, but its application for larger-scale production of 
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sialyloligosaccharides can be hampered by prerequisite of the expensive donor substrate CMP-sialic 
acid (Desmet and Soetaert, 2011; Schmidt et al., 2000). This drawback might be overcome by use 
of an in situ CMP-Neu5Ac regeneration system, which uses PEP, adenosine-5'-triphosphate (ATP) 
and CMP as synthetic substrates and nucleoside monophosphate kinase (NMK), pyruvate kinase 
(PK), CMP-Neu5Ac synthetase and pyrophosphatase (PPase) as catalysts (Ichikawa et al., 1991b). 
Mimicking the natural way for synthesis of sialyloligosaccharides, a one-pot multi-enzyme 
enzymatic approach has been developed with or without in situ cofactor regeneration system. A 
typical one-pot multi-enzyme sialylation starts from sialic acid aldolase-catalysed condensation 
reaction that converts sialic acid precursors, i.e. ManNAc, mannose (Man) or C-2/C-6 modified 
derivatives to sialic acids or C-5/C-9 modified derivatives. These compounds are subsequently 
activated by a CMP-sialic acid synthetase to form CMP-sialic acid, which is then used by a suitable 
SiaT to catalyse the formation of sialyloligosaccharides (Ichikawa et al., 1991a; Yu et al., 2006b). 
Moreover, taking the advantage of flexible donor- and acceptor-substrate specificity of bacterial 
SiaTs, e.g. ∆24PmST1 (Yu et al., 2005), ∆15Pd2,6ST (Yu et al., 2006a) and Cst-II (Yu et al., 2009), 
Chen group has expanded the usage of one-pot multi-enzyme system for production of a large 
number of complex sialyloligosaccharides, including those with natural and non-natural sialic acid 
forms, different (α-2,3, α-2,6 or α-2,8) sialyl linkages and different underlying glycans. Isolation of 
intermediates is not required in the one-pot reaction, and typical yields for preparative-scale (>20 
mg) synthesis are between 60% and 90%.  
In addition, the use of SiaTs in bacterial cell factory allowed production of sialyloligosaccharides 
(examples are given in section 1.7). 
1.5 CASEIN GLYCOMACROPEPTIDE (cGMP) 
For industrial scale production of HMOs, it is paramount to identify a suitable, abundant and cheap 
sialyl donor. cGMP, the waste product from cheese manufacturing is a particular interesting 
candidate. It is the hydrophilic C-terminal fragment of bovine κ-casein (κ-CN), generated by 
chymosin cleavage of κ-CN between Phe105 and Met106. The soluble cGMP is released in the 
whey fraction, whereas the remaining part para-κ-CN precipitates into the cheese curd (Delfour et 
al., 1965). cGMP, containing 64 amino acids (residues 106-169 of κ-CN) (Fig. 1.7), is one of the 
most abundant proteins in whey with a concentration of 20-25% (Thomä-Worringer et al., 2006). 
Moreover, cGMP is unique in its amino acid composition as it is devoid of aromatic amino acids, 
31


low in basic, acidic, and hydroxyl amino acids but rich in branched chain amino acids (Farrell et al., 
2004). It is an acidic peptide with pI between 4 and 5. 
 
Fig. 1.7 Amino acid sequence of cGMP with variants A (T126 and D148) and B (I126 and A148). Figure is 
adapted from Thomä-Worringer et al., 2006. Var. represents variant. 
cGMP is a heterogeneous group of polypeptides mainly due to its genetic variance and post-
translational modifications (O-glycosylation and phosphorylation). Originating from the precursor 
bovine κ-CN, two genetic variants (A and B) dominates in cGMP where two substitutions, i.e. Thr 
or Ile at position 126, and Asp or Ala at position 148, occur respectively (Fig. 1.7). All O-
glycosylation and phosphorylation sites are exclusively situated in the cGMP region of κ-CN 
(Farrell et al., 2004; Mercier et al., 1973). Five mucin-types of carbohydrate moieties composed of 
Neu5Ac, Gal and GalNAc, have been identified in cGMP: monosaccharide GalNAc-O-R (0.8%), 
disaccharide Galβ1-3GalNAc-O-R (6.3%), trisaccharide Neu5Acα2-3Galβ1-3GalNAc-O-R (18.4%), 
trisaccharide Galβ1-3(Neu5Acα2-6)GalNAc-O-R (18.5%), and tetrasaccharide Neu5Acα2-3Galβ1-
3(Neu5Acα2-6)GalNAc-O-R (56%) (Saito and Itoh, 1992). Glycosylation of cGMP differs in the 
numbers of glycosylation sites. The glycans may be attached to six (in variant A) or five (in variant 
B) different Thr residues (Pisano et al., 1994) and probably also to one Ser residue (Kanamori et al, 
1981; Zevaco and Ribadeau-Dumas, 1984). Fourteen glycosylated forms in addition to aglyco-
forms have been identified in variant A (Mollé and Léonil, 1995).  
Another source of heterogeneity is the variable level of phosphorylation, ranging from 1 to 3 
phosphate groups identified per molecule (Mercier, 1981; Mollé and Léonil, 1995; Vreeman et al., 
1986). Under certain conditions of pH and ionic strength, cGMP also displays heterogeneity in 
apparent molecular mass, which is much higher at neutral pH (20-50 kDa) than its theoretical value 
(7-9 kDa). This phenomenon is attributed to polymerization occurring at pH>4.5 and 
depolymerization occurring at more acidic pH ranges (Kawasaki et al., 1993; Morr and Seo, 1988; 
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Tanimoto et al., 1990). In contrast, Minkiewicz et al. (1996) suggested that the presence of 
hydrophilic and ionizable carbohydrate moieties leads to internal electrostatic and steric repulsion, 
thereby enlarging the voluminosity of cGMP. 
cGMP shows a strong absorption at 205-217 nm but not at 280 nm due to the absence of aromatic 
amino acids. Therefore, differences in UV absorption at 210/280 nm are frequently used to 
characterize cGMP (El-Salam et al., 1996). The chromatography based methods for characterization 
of cGMP include size exclusion chromatography (Kawakami et al., 1992; Morr and Seo, 1988; 
Vreeman et al., 1986), ion exchange chromatography (Doultani et al., 2003; Léonil and Mollé, 1991; 
Nakano and Ozimek, 1999), reversed-phase chromatography (Coolbear et al., 1996; López-Fandiño 
et al., 1993) and hydrophobic interaction chromatography (Nakano and Ozimek, 2000), associated 
with NMR, MS and fourier transformed infrared spectroscopy (FTIR) techniques (Burgardt et al., 
2014; Minkiewicz et al., 1996; Mollé and Léonil, 1995; Smith et al., 2002). Ion exchange 
chromatography is widely used for preparative-scale separation of cGMP from whey (Burton et al., 
1987; Kawasaki and Dosako 1992; Saito et al., 1991), coupled with membrane filtration (Holst and 
Chartterton, 1999; Kawasaki et al., 1993; Kreuß et al., 2008). In particular, the pH-dependent 
molecular mass of cGMP can be used to influence its permeation behavior during the membrane 
filtration process. 
1.6 BIOCATALYTIC PRODUCTION OF HMOs 
Elephant milk oligosaccharides are the most structurally similar to HMOs (Kunz et al., 1999), 
however, large-scale use of these oligosaccharides is unfeasible. By use of biocatalytic synthesis 
approaches, HMO tri- and tetrasaccharides have been produced in kg quantities, however, the use of 
HMOs as bioactive substances in infant food, pharmaceuticals or for clinical trials is still limited by 
the ability to synthesize more complex structures in sufficient quantity and purity (Bode, 2012; 
Kunz et al., 2000). In general, two approaches are employed for biocatalytic production of HMOs, 
comprising in vivo production using metabolically engineered microorganisms (usually E. coli cells) 
and in vitro production using single or multiple enzymatic catalysis. 
1.6.1 Production of lacto-N-oligosaccharides 
In vivo production of lacto-N-oligosaccharides was illustrated by the study of Priem et al. (2002). A 
β-galactosidase-deficient E. coli strain was engineered by overexpressing one or two GT genes. 
Lactose added in the medium was internalized by β-galactoside permease and then glycosylated. 
33
	

Using β-1,3-GlcNAcT gene resulted in production of 6 g/L lacto-N-trisaccharide II (GlcNAcβ1-
3Galβ1-4Glc), while using β-1,3-GlcNAcT and β-1,4-GalT genes, LNnT and lacto-N-neohexaose 
(LNnH, Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc) were produced with a yield of >5 
g/L.  
Enzymatic synthesis of LNT and LNnT involved β-1,3-GlcNAcT and β-galactoside as catalysts 
(Murata et al., 1999a; Miyazaki et al., 2010). The former enzyme from bovine serum catalysed the 
transfer of GlcNAc from UDP-GlcNAc to lactose for formation of lacto-N-trisaccharide II, which 
was then converted to LNT or LNnT using the donor pNP-Gal and Bacillus circulans β-1,3- or β-
1,4-galactosidase, respectively. An alternative approach for LNT synthesis employed 
Aureobacterium sp lacto-N-biosidase-catalysed transglycosylation with pNP-Galβ1-3GlcNAc as 
donor and lactose as acceptor (Murata et al., 1999a). 
1.6.2 Production of SL and more complex sialylated HMOs 
Endo et al. (2000) established a coupled-cell method using permeabilized cells (surfactant-treated) 
of a Corynebacterium ammoniagenes strain and three engineered E. coli strains. The C. 
ammoniagenes strain was responsible for synthesis of uridine-5'-triphosphate (UTP) from orotic 
acid, and the three E. coli strains overexpressed the genes of cytidine-5'-triphosphate (CTP) 
synthetase, CMP-Neu5Ac synthetase and N. gonorrhoeae α-2,3-SiaT respectively. This allowed 
production of 36 g/L 3'-SL from orotic acid, Neu5Ac and lactose.A single-cell method was 
established using a metabolically engineered E. coli strain (β-galactosidase-deficient) that was 
modified by inactivation of the gene encoding sialic acid aldolase and addition of CMP-Neu5Ac 
synthetase and N. meningitides α-2,3-SiaT genes (Priem et al., 2002). This allowed production of 
2.6 g/L 3'-SL from lactose and Neu5Ac that were internalized by β-galactoside permease and sialic 
acid permease, respectively. To avoid the use of expensive Neu5Ac, a pathway for de novo 
synthesis of Neu5Ac from UDP-GlcNAc was introduced in E. coli K12 by co-expressing the genes 
encoding UDP-GlcNAc-2-epimerase and SAS and disrupting ManNAc kinase and Neu5Ac aldolase 
genes. Using CMP-Neu5Ac synthetase and N. meningitides α-2,3-SiaT genes, 25.5 g/L 3'-SL was 
produced with continuous supply of lactose (Fierfort and Samain, 2008). Similarly, using 
Photobacterium sp. α-2,6-SiaT gene led to production of 34 g/L 6'-SL (Drouillard et al., 2010). The 
whole-cell-based approach takes advantage of the metabolic machinery of the microorganisms, but 
one of the limitations is that acceptor substrates are restricted to those molecules that can be 
transported into the cells or synthesised in vivo.  
34


Providing CMP-Neu5Ac and lactose as substrates, application of Photobacterium sp. JT-ISH-224 
α-2,3-SiaT (Mine et al., 2010a) or P. damsela JT060 α-2,6-SiaT (Yamamoto et al., 1998a) led to in 
vitro production of 3'- or 6'-SL with a yield of >60%. Multiple enzymatic production of SL usually 
uses the one-pot multiple-enzyme system (mentioned in section 1.5.2), e.g., 3'-SL was produced 
from Neu5Ac and lactose in a yield of 79% using sialic acid aldolase, CMP-Neu5Ac synthetase and 
Δ24PmST1 as catalysts (Yu et al., 2005). An interesting method was established for in situ 
generation of CMP-Neu5Ac from Neu5Ac and CTP using a fusion enzyme with CMP-Neu5Ac 
synthetase and N. meningitides α-2,3-SiaT activity. Providing lactose, Neu5Ac, PEP, ATP and 
CMP, 67.8 g 3'-SL was produced in a 100 g scale reaction after 6 days (Gilbert et al., 1998).  
Examples concerning bacterial sialidase-catalysed production of SL are given in Table 1.3, mostly 
using irreversible sialyl donor pNP-Neu5Ac. Application of TcTS allowed production of 3'-SL in a 
yield of 87% from pNP-Neu5Ac (Singh et al., 2000) and 75% from fetuin (Lee et al., 2002), 
respectively. For preparative-scale production of SL, the cheap donor substrate cGMP from dairy 
side-stream is preferable, e.g., the use of A. ureafaciens sialidase, B. infantis sialidase, or TcTS 
contribute to production of 0.2-0.8 mg/L SL, respectively (Mcjarrow et al., 2003; Pelletier et al, 
2004). To maximize the yields, reaction condititions such as pH, temperature, time and ratio of 
donor versus acceptor concentration should be identified to favor trans-sialylation over hydrolysis 
reaction (Desmet and Soetaert, 2011). Trans-sialylation catalysed by TcTS (Holck et al., 2014) or 
two Trypanosoma rangeli sialidase (TrSA) mutants (Jers et al., 2014; Michalak et al., 2014) under 
optimised reaction conditions led to production of >1.5 g/L 3'-SL. In addition, using the additional 
α-2,3/2,6-trans-sialidase activity of PmST led to production of 1.8 g/L 3'-SL and 2.1 g/L 6'-SL at 
two differently optimised conditions (Guo et al., 2014). With the attempt to lower hydrolysis and 
enzyme cost as well as to enhance product yield, two studies using membrane reactor for 
continuous SL production were conducted, where Streptococcus sp. sialidase (Masuda et al., 2000) 
or a mutant enzyme derived from TrSA, namely TrSA
6
 (TrSA with 6 mutations) (Zeuner et al., 
2014) was used as catalyst. The former enzyme gave a total SL (3'- and 6'-SLs) yield of 2.03% from 
colominic acid in a 160-h continuous reaction, while the latter gave a 3'-SL yield of 74% from 
cGMP after seven consecutive runs (7×60 min). 
With cGMP as donor substrate, 3'-sialyl-LNT (LST a) was produced from LNT using TcTS (Holck 
et al., 2014) or TrSA
6
 (Michalak et al., 2014). TcTS was also used for catalysing α-2,3-sialylation 
of LNnT from the donor 3'-SL (Johnson, 1999), and TrSA
6
 was used for catalysing α-2,3-sialylation 
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of LNT, LNnT, lacto-N-fucopentaose I (LNFP I, Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc) and 
LNFP V (Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc) (Michalak et al., 2014).  
1.6.3 Production of FL and more complex fucosylated HMOs 
Koizumi et al. (2000) established a coupled-cell approach using a C. ammoniagenes strain 
responsible for formation of guanosine-5'-triphosphate (GTP) from guanosine-5'-monophosphate 
(GMP) and recombinant E. coli strains overexpressing guanosine-5'-diphosphate (GDP)-Fuc 
biosynthetic genes and Helicobacter pylori α-1,3-FUT gene. Providing GMP, Man and LNAc, an 
HMO intermediate Lewis X (Galβ1-4(Fucα1-3)GlcNAc) was produced with a yield of 21 g/L in a 
30-h reaction. A method for in vivo production of fucosylated HMOs (Drouillard et al., 2006; 
Dumon et al., 2001 and 2004) was established based on that used for in vivo production of LNnT 
(Priem et al., 2002). In this system, the E. coli strain was further engineered to provide GDP-Fuc by 
inactivating a gene involved in colanic acid synthesis and overexpressing a gene encoding a positive 
regulator of the colanic acid operon. UsingN. meningitidisβ-1,3-GlcNAcT and β-1,4-GalT genes 
and H. pylori FUT gene led to production of 0.5 g/L 3-FL, 1.7 g/L lacto-N-neofucopentaose I 
(LNnFP I, Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glc), 3 g/L LNnFP V (Galβ1-4GlcNAcβ1-3Galβ1-
4(Fucα1-3)Glc) or 1.7 g/L lacto-N-neodifucohexaose II (LNnDFH II, Galβ1-4(Fucα1-3)GlcNAc1-
3Galβ1-4(Fucα1-3)Glc) from exogenous lactose. Further, the concentration of 3-FL was increased 
to 14 g/L with expressing only FUT gene and addition of more lactose (Drouillard et al., 2006). A 
different method using a metabolically engineered E. coli strain was patented (Huefner et al., 2010). 
A Fuc-salvage pathway for converting Fuc to GDP-Fuc was introduced in the β-galactosidase-
deficient E. coli strain by adding the genes encoding B. fragilis Fuc kinase and Fuc-1-P-
guanyltransferase and deleting the fuculose-1-phosphate aldolase gene. Using either α-1,2- or α-1,3-
FUT gene from H. pylori led to 2'- or 3-FL production, respectively. 
With LNT or LNFP I as acceptor substrate, several human FUTs were able to catalyse trans-
fucosylation for production of LNFP I or lacto-N-difucohexaose I (LNDFH I, Fucα1-2Galβ1-
3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glc), respectively (Nimtz et al., 1998; Miyazaki et al., 2010). 
Albermann et al. (2001) reported a method for multiple enzymatic synthesis of 2'-FL that involved 
three enzymes, i.e., GDP-D-Man-4,6-dehydratase and GDP-4-keto-6-deoxy-D-Man-3,5-epimerase-
4-reductase were responsible for converting GDP-Man to GDP-Fuc, which was subsequently used 
by H. pylori α-1,2-FUT for production of 2'-FL with a yield of 65%. Studies employing fucosidase 
for production of FL are limited. An example was given by Murata et al. (1999b) where application 
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of Alcaligenes sp. fucosidase contributed to production of 3'-FL (Fucα1-3Galβ1-4Glc), giving a 
yield of 34%. This is however not the isomer found in human milk. 
1.7 GLYCOSIDASE ENGINEERING FOR IMPROVED GLYCOSIDE SYNTHESIS 
Improvement of transglycosylation efficiency of natural glycosidase can be achieved by protein 
engineering. The strategies for engineering glycosidases generally consist of rational design on the 
basis of available structural information as well as directed evolution with use of powerful 
screening approaches (Hancock et al., 2006). Using site-directed mutagenesis, the first strategy has 
been applied for Bifidobacterium adolescentis α-galactosidase (H497M) (Hinz et al., 2005), 
Rhodothermus marinus β-1,3-glucanase (M133C) (Neustroev et al., 2006), Mucor hiemalis endo-β-
N-acetylglucosaminidase (Y271F) (Umekawa et al., 2008), Serratia marcescens chitinase 
(D313N/F396W) (Zakariassen et al., 2011), Thermotoga neapolitana β-glucosidase (N220F) 
(Lundemo et al., 2013), et al. These mutations play a role in either disfavoring the positioning of 
hydrolytic water molecule or favoring binding of incoming carbohydrate molecule in the aglycon 
subsite, thereby increasing transglycosylation activity. A noteworthy example is conferring trans-
sialidase activity to the strict α-2,3-sialidase TrSA through five mutations 
(M96V/A98P/S120Y/G249Y/Q284P) (Paris et al., 2005). The five mutations (giving a mutant 
enzyme TrSA
5
), selected by comparison to TcTS, defined a trans-sialidase-like binding site for the 
acceptor and modulated the sialic acid position, thereby contributing to ~1% trans-sialidase activity 
of that of TcTS. An additional single mutation I37L (giving TrSA
6
) or G342A further increased the 
activity by 10-fold. Jers et al. (2014) reported that replacing a seven-amino-acid-motif on the edge 
of the acceptor binding cleft of TrSA
6
 by that of TcTS (giving TrSA
13
, TrSA with 13 mutations) 
reduced hydrolysis to promote trans-sialidase activity. They hypothesized that the reduced 
hydrolysis was due to disruption of the water network. Using free-energy computations, 
Pierdominici-Sottile et al. (2014) proposed five additional mutations based on TrSA
5
 for enhancing 
the transfer activity, but this mutant was not tested experimentally.  
Directed evolution, on the other hand, can be used for improving transglycosylation activity without 
prior knowledge of structure-function relationships. This strategy has been applied for enzymes 
such as Thermus thermophilus β-galactosidase (F401S/N282T; F401S/A205T/H365Y) (Feng et al., 
2005; Koné et al., 2009), Thermotoga maritima α-1,2-fucosidase (T264A/Y267F/L322P) (Osanjo et 
al., 2007), Neissera polysaccharea amylosucrase (V389L/N503I; R20C/F598S; N387D; E227G) 
(van der Veen et al., 2004 and 2006), Thermoanaerobacterium thermosulfurigenes cyclodextrin 
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glucanotransferase (S77P) (Kelly et al., 2008), and Thermobacillus xylanilyticus α-
arabinofuranosidase (F26L/S319P/D471N) (Arab-Jaziri et al., 2013). Clearly, improvement of the 
transglycosylation/hydrolysis ratio is a prerequisite for obtaining mutants with good synthetic 
capability (Osanjo et al., 2007). Thus, the screening method typically contains two steps that enable 
rejection of mutants with high hydrolysis activity but keep those with increased transfer activity, 
taking advantage of the release of chromophoric or fluorophoric reaction products that are easily 
monitored. A good example was given by Koné et al. (2009) where a digital screening approach 
was used for engineering T. thermophilus β-galactosidase. Notably, some beneficial mutations are 
located in the second-shell around active site but can induce subtle conformational changes within 
the active site, while others are located further away (Feng et al., 2005; Kelly et al., 2008; Koné et 
al., 2009; Osanjo et al., 2007; van der Veen et al., 2004). The latter cases imply the difficulty of 
engineering glycosidases on a rational basis. 
Glycosynthases represent a large group of retaining glycosidase mutants, in which the catalytic 
residue (Asp or Glu) is replaced by a non-nucleophile residue (typically Ala, Ser or Gly). The 
mutated enzymes lose the hydrolysis activity but can catalyse transglycosylation using an activated 
donor, such as a glycosyl fluoride with inverted anomeric configuration, in a quantitative yield 
(Bojarova and Kren, 2009; Williams and Withers, 2002). The first glycosynthase, derived from 
Agrobacterium sp. β-glucosidase (E358A), was able to catalyse the condensation of α-glucosyl 
fluoride with a range of carbohydrate alcohols in high yields (Mackenzie et al., 1998). The 
glycosynthase concept was firstly extended to an inverting glycosidase, Bacillus halodurans exo-
xylanase. In this case saturation mutagenesis at the catalytic base D263 allowed generation of nine 
glycosynthase mutants, among which the mutant D263C gave the highest activity (Honda and 
Kitaoka, 2006). The application of glycosynthase technology could be expanded for HMO synthesis 
as manifested by a fucosynthase derived from B. bifidum α-1,2-fucosidase (Wada et al., 2008). The 
catalytic base mutant (D766G) was able to catalyse production of 2'-FL with a yield of 6% from a 
fucosyl fluoride. Using a similar approach led to creating a nucleophile mutant (Y370G) of M. 
viridifaciens sialidase, which acted as an inverting sialidase and catalysed the transfer of Neu5Ac 
from phenyl-β-Neu5Ac (Ph-β-Neu5Ac) to lactose giving a SL yield of ~13% (>90% of the product 
was the α-2,6-isomer) (Watson et al., 2006). However, the application of glycosynthase for large-
scale production of oligosaccharides is restricted by the prerequisite of the unstable and hardly 
commercially available donors (i.e., glycosyl fluorides and aryl glycosides).
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1.8 HYPOTHESES AND OBJECTIVES 
HMOs are structurally complex sugars that have a range of unique biological functions for human 
health. There is a potentially commercial use of HMOs for supplementation of infant formula. 
Large-scale production of HMOs decorated with α-2,3 bound sialic acid has been developed by use 
of several α-2,3-sialidases/trans-sialidases, especially TcTS. This PhD study was focused on 
biocatalytic production of sialylated HMOs, notably SL, containing both α-2,3 and α-2,6 sialyl 
linkages by use of other biocatalysts than TcTS, as well as improving catalytic proficiencies of the 
employed biocatalysts (i.e., sialyltransferase and sialidase) by protein engineering. 
The general hypotheses of this work were formulated as follows: 
- P. multocida SiaT, displaying additional trans-sialidase activities, can be used for production 
of sialylated HMOs using cGMP as a sialyl donor. 
- The regioselectivity of P. multocida SiaT can be altered towards either α-2,3- or α-2,6-trans-
sialylation by optimization of reaction conditions and/or protein engineering.  
- Protein engineering can be used to improve hydrolytic sialidase activity of M. viridifaciens 
sialidase that catalyses cleavage of α-2,3, α-2,6 and α-2,8 sialyl linkages. 
The main objectives of this work were: 
- To identify optimum reaction conditions for P. multocida SiaT-catalysed production of 3'- 
and 6'-SLs. 
- To modulate the regioselectivity of P. multocida SiaT via site-directed mutagenesis for 
effective production of 3'- or 6'-SL, respectively. 
- To apply site-saturation mutagenesis for improving hydrolase activity of M. viridifaciens 
sialidase. 
A previous study (Yu et al., 2005) has reported that a P. multocida α-2,3/2,6-SiaT has trans-
sialidase activity. In paper I, a P. multocida SiaT (a homologue enzyme with three amino acid 
differences compared to the former one) displaying α-2,3- and α-2,6-trans-sialidase activities was 
examined, and the reaction conditions were investigated for maximal production of 3'- and 6'-SLs 
with use of cGMP and lactose as substrates. The later work (paper II) aimed to alter the 
regioselectivity of this SiaT notably towards α-2,6-trans-sialylation via site-directed mutagenesis. 
Based on analysis of crystal structures of an α-2,3 and an α-2,6 SiaT, a His residue (corresponding 
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to Pro residue in P. multocida SiaT) was suggested to determine α-2,6-regiospecificity in SiaTs 
(Kakuta et al., 2008). In this work, we introduced a single mutation P34H in the P. multocida SiaT 
and tested the mutant in both trans-sialylation and sialyltransferase reactions. In addition, another 
four mutations (E271F, R313Y, E271F/R313Y and M144D) that significantly decreased sialidase 
activity but maintained SiaT activity (Sugiarto et al., 2011 and 2012) were also introduced in the 
enzyme and the derived mutants were tested in trans-sialylation reactions.  
M. viridifaciens sialidase exhibits hydrolase activity for cleavage of α-2,3, α-2,6 and α-2,8 sialyl 
linkages. The work (paper III) was focused on improving hydrolase activity of M. viridifaciens 
sialidase by protein engineering. 20 amino acids in or near the sialic acid binding site were targeted 
for site-sauturation mutagenesis and mutant libraries were tested on a natural substrate (cGMP) and 
an artificial substrate (pNP-Neu5Ac), respectively. Using the PoPMuSiC software, the stability 
change ΔΔG, a measure of potential chemical variation was analysed for each amino acid.The 
correlation between computed ∆∆G and activity of mutants gave an assessment of the evolvability 
of catalytic proficiency of the sialidase towards the artificial substrate and the natural one, 
respectively. 
40


2. ENZYMATIC PRODUCTION OF 3'- AND 6'-SIALYL GLYCANS 
This chapter is extended in the form of paper I and II. 
2.1 Hypotheses and objectives 
cGMP, the waste product from cheese manufacturing, is an abundant and cheap sialyl donor for 
large-scale production of sialylated HMOs. Biocatalytic synthesis of α-2,3-sialyl-HMOs and 
analogues thereof (e.g., SL, LST, and Sia-GOS) from cGMP have been catalyzed by TcTS (Holck 
et al., 2014; Pelletier et al., 2004; Sallomons et al., 2013), or TrSA mutants (Jers et al., 2014; 
Michalak et al., 2014). In this study, a Pasteurella multocida SiaT was found to possess 
promiscuous α-2,3- and α-2,6-trans-sialidase activities. We hypothesized that this enzyme can be 
used for production of both α-2,3- and α-2,6-sialyl glycans from cGMP. The objectives of this study 
were to identify optimal reaction conditions for efficient and regioselective synthesis of α-2,3- and 
α-2,6-sialyloligosaccharides as well as to modulate the regioselectivity of the enzyme towards either 
α-2,3- or α-2,6-trans-sialylation by protein engineering. 
2.2 Experimental considerations 
Paper I 
We first observed that when using pNP-Neu5Ac or cGMP as donor and lactose as acceptor, PmST 
was able to catalyse synthesis of not only 3'-SL but also 6'-SL. 3'-SL was the dominant product 
while 6'-SL was formed in a much lower rate. We thereafter examined the possibilities of 
maximally producing these two compounds by PmST catalysis. Statistically designed experiments 
were conducted, considering lactose concentration (50-150 mM), pH (4.4-6.4) and temperature (30-
50 °C) at different reaction times (up to 8 h).  
During the PmST-catalyzed trans-sialylation reaction, we found that the initial product of 3'-SL was 
converted to 6'-SL, indicating a uniquely promiscuous trans-sialidase activity of PmST. The kinetic 
analysis of this activity was done by reacting the enzyme under the optimal condition (pH 5.4-40 °C) 
on different concentrations of 3'-SL (up to 400 mM) with lactose concentration being constant (100 
mM).  
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The trans-sialylation ability of PmST was also examined with GOS served as acceptors. The 
synthesized Sia-GOS were treated by an α-2,3-sialidase and then analysed by MALDI-MS to 
demonstrate the presence of both α-2,3 and α-2,6 sialyl linkages in the products. 
Paper II 
Four mutants (E271F, R313Y, E271F/R313Y and M144D) derived from a PmST homologue 
enzyme possessed significantly decreased sialidase activity but maintained SiaT activity (Sugiarto 
et al., 2011 and 2012). These mutantions were introduced to PmST to examine their effect on trans-
sialidase activity. Another mutation P34H that potentially determines α-2,6-regiospecificity (Kakuta 
et al., 2008) was also introduced to PmST. We then evaluated trans-sialylation ability of the five 
PmST-derived mutants under the optimal condition (pH 5.4-40 °C, 5% cGMP and 100 mM lactose) 
as identified in the study of Paper I. With respect to the P34H mutant, its native α-2,6-SiaT activity 
as well as pH effect on its α-2,6-trans-sialidase activity were also examined. 
Three mutants (E271F, R313Y and E271F/R313Y) exhibited α-2,3-trans-sialylation preference and 
the P34H mutant predominantly catalysed synthesis of α-2,6 sialyl linkage. In order to evaluate the 
impact of donor linkage on the product formation rate for each mutant, we isolated the individual 
activities, that is, use 3'-SL as donor to monitor 6'-SL production and vice versa, and use the 
alternative donor 3'-SLN and 6'-SLN to follow production of 3'-SL and 6'-SL respectively. The 
kinetic parameter for α-2,6-trans-sialidase activity (using 3'-SL as donor) of P34H was also 
estimated. 
2.3 Main results and conclusion 
pH was the only factor influencing PmST-catalysed 3'-SL production and the interaction effect for 
pH × temperature was significant throughout the reaction. Curvature effects for both temperature 
and pH (i.e., pH × pH, temp × temp interactions) were also observed. For shorter reaction times (0.5 
h and 2 h), the optimum condition for 3'-SL production was pH 5.4 and 40 °C. After 4 h, the 
optimum shifted toward pH 6.4 and 50 °C. 
For 6'-SL production, none of the individual factors showed significant effect on the yield except 
pH at 0.5 h. However, curvature effects for pH and temperature (i.e., pH × pH, temp × temp) were 
significant. The interaction effect for pH × temperature was significant at the initial stage (0.5 h and 
2 h). The optimum condition for 6'-SL production was pH 5.4 and 40 °C throughout the reaction. 
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When reacting the enzyme at 40 °C using 5% cGMP and 100 mM lactose as substrates, the 
maximum yield of 3'-SL (2.75 mM) was achieved at pH 6.4 after 6 h, and the largest concentration 
of 6'-SL (3.33 mM) was achieved at pH 5.4 after 8 h. 6'-SL was formed from α-2,3 bound sialic 
acid in cGMP as well as from 3'-SL produced in the reaction. For favoring production of either SL 
isomer, it was key to terminate the reaction at an appropriate time. 
The k
cat
/K
m
 value for α-2,6-trans-sialidase activity (using 3'-SL as donor) of the enzyme at the 
optimized condition was 23.22 M
-1
 s
-1
. When GOS served as acceptors, the enzyme was able to 
catalyse synthesis of both 3'- and 6'-Sia-GOS. 
The PmST
M144D
 mutant exhibited very low trans-sialidase activity. The mutant enzymes PmST
E271F
, 
PmST
R313Y
 and PmST
E271F/R313Y
 all preferentially catalysed synthesis of 3'- SL over 6'- SL. The best 
PmST
E271F/R313Y
 gave a maximal yield of 3'-SL (~4.5 mM) after 10 h, with <0.1 mM 6'-SL produced. 
When a total SL yield of ~50% was obtained from cGMP, the regioisomeric ratio (α-2,3:α-2,6) and 
the transfer ratio for PmST
E271F/R313Y
 were 128-  and 5-folds higher than those for the wild type 
enzyme, respectively.  
When using 3'-SLN as donor for 3'-SL production, PmST
E271F
 maintained its α-2,3-trans-sialidase 
activity, while PmST
R313Y
 and PmST
E271F/R313Y
 retained 77% and 67% of the wild-type-level 
activity. When using 3'-SL as donor, PmST
E271F/R313Y
 exhibited the lowest α-2,6-trans-sialidase 
activity. This mutant enzyme displayed a larger reduction in α-2,6- compared to α-2,3-trans-
sialidase activity, effectively shifting the specificity towards α-2,3-trans-sialylation. 
The PmST
P34H
 mutant displayed a distinct preference for 6'-SL synthesis during the entire course of 
reaction, however, the total SL yield was consistently and significantly lower than that of the wild 
type enzyme. Further, PmST
P34H
 acquired a substantially higher α-2,6-SiaT activity (980-fold) than 
the wild type enzyme, while this increase was accompanied by loss of α-2,3-SiaT activity. The 
ability of this mutant enzyme to use α-2,3 bound sialic acid as donor for α-2,3-trans-sialylation was 
almost abolished as well. However, using this donor for α-2,6-trans-sialylation gave a wild-type-
level activity. The k
cat
/K
m
 value for α-2,6-trans-sialidase activity (using 3'-SL as donor) of 
PmST
P34H
 at pH 5.4 and 40 °C was 31.2 M
-1
 s
-1
, similar to that of the wild type enzyme. Both the 
wild type enzyme and PmST
P34H
 were capable of catalysing the hydrolysis and transfer of α-2,6 
bound sialic acid.  
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This study  examined a  recombinant  Pasteurella  multocida sialyltransferase exhibiting  dual  trans-
sialidase activities. The enzyme catalyzed trans-sialylation  using either 2-O-(p-nitrophenyl)--d-N-
acetylneuraminic acid  or casein  glycomacropeptide  (whey  protein)  as  the sialyl  donor and lactose  as
the acceptor, resulting  in production of  both 3′-sialyllactose  and  6′-sialyllactose.  This is the ﬁrst study
reporting -2,6-trans-sialidase  activity  of  this  sialyltransferase  (EC  2.4.99.1  and  2.4.99.4).  A  response
surface design  was used to evaluate the effects  of three reaction parameters (pH,  temperature,  and
lactose concentration)  on  enzymatic production of 3′-  and  6′-sialyllactoses  using 5%  (w/v)  casein  glyco-
macropeptide (equivalent  to 9 mM  bound sialic  acid) as  the donor.  The  maximum yield of  3′-sialyllactose
(2.75 ±  0.35  mM)  was achieved  at a  reaction condition  with pH  6.4, 40 ◦C, 100 mM  lactose after  6  h;  and
the largest  concentration  of  6′-sialyllactose  (3.33  ± 0.38  mM)  was  achieved  under  a condition  with pH
5.4, 40 ◦C, 100  mM  lactose  after  8 h. 6′-sialyllactose  was presumably  formed from -2,3 bound sialic  acid
in the  casein  glycomacropeptide  as  well as from 3′-sialyllactose  produced  in the  reaction.  The kcat/Km
value for  the  enzyme using  3′-sialyllactose  as  the donor  for  6′-sialyllactose  synthesis  at pH  5.4 and  40 ◦C
was determined  to be  23.22  ±  0.7  M−1 s−1.  Moreover, the enzyme was  capable  of catalyzing  the synthesis
of both  3′-  and  6′-sialylated  galactooligosaccharides,  when  galactooligosaccharides  served  as  acceptors.
© 2013 Elsevier B.V. All rights reserved.
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1. Introduction
Human milk oligosaccharides (HMOs) are the third most abun-
dant component (5–10 g/L) in human milk (Bode, 2009). About
180 different HMOs species have been identiﬁed recently in a
pooled human milk sample from ﬁve individuals, and nearly 16%
of the total oligosaccharide abundances were found correspond
to sialylated oligosaccharides (Ninonuevo et al., 2006). The  struc-
tural diversity and complexity confer unique biological functions
on HMOs. Sialylated HMOs, consisting of N-acetylneuraminic acid
(Neu5Ac) attached to galactose or N-acetylgalactosamine (GalNAc)
through -2,3 or -2,6 linkage, are known to have both anti-
infective and immuno-modulating effects (Bode, 2012). They are
also believed to inﬂuence brain development and cognitive capac-
ity in the newborn infant (Wang, 2009; Wang et al., 2003). The
sialyllactose (3′- and 6′-sialyllactoses) content ranges from 0.4 to
0.8 g/L and the isomers of monosialylated and disialylated lacto-N-
tetraose are present in lower amounts in human milk (Kunz et al.,
2000). In contrast, only trace amounts of sialylated oligosaccharides
0168-1656/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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are present in bovine milk, and consequently in the derived infant
formula. Therefore, synthesis of sialylated HMOs  for supplemen-
tation of infant formula has been suggested (Bode, 2009; Espinosa
et al., 2007).
A variety of  methods based on microbial systems have been
developed for synthesis of sialylated HMOs, starting with the
synthesis of  sialyllactose. Endo and  coworkers established a
coupled-microbial method using Corynebacterium ammoniagenes
and three engineered Escherichia coli strains overexpressing the
genes of cytidine-5′-triphosphate (CTP) synthetase, cytidine-5′-
monophospho-N-acetylneuraminic acid (CMP-NeuAc) synthetase
and Neisseria gonorrhoeae -2,3-sialyltransferase (SiaT), respec-
tively (Endo et al., 2000). This allowed production of 57 mM
3′-sialyllactose from a  12-h reaction using orotic acid, Neu5Ac and
lactose. A single-cell method was  established by engineering E. coli
K12 that enabled production of 4.1 mM 3′-sialyllactose from lactose
and Neu5Ac supplemented to the medium (Priem et al., 2002). This
strain was  further reﬁned to  allow de novo synthesis of Neu5Ac.
Using either Neisseria meningitides -2,3-SiaT or Photobacterium
sp. -2,6-SiaT gene led to production of 40.3 mM 3′-sialyllactose
(Fierfort and Samain, 2008) or 53.7 mM 6′-sialyllactose (Drouillard
et al., 2010), respectively. Despite these promising results, the
application of  the cell-based systems to  a wide range of diverse
acceptor molecules might be hampered by the need for efﬁcient
uptake or in vivo production of the acceptor.
As an alternative, several enzymatic methods have been devel-
oped. An interesting approach involved a  fusion protein having
both CMP-Neu5Ac sythetase and -2,3-SiaT activities, which was
utilized to produce 3′-sialyllactose from lactose, Neu5Ac, phos-
phoenolpyruvate (PEP), adenosine-5′-triphosphate (ATP) and CMP
(Gilbert et al., 1998). When providing CMP-Neu5Ac and lactose
as substrates, a Pasteurella multocida -2,3/2,8-SiaT was  capa-
ble of synthesizing 3′-sialyllactose with a yield of 2.7 mM after
a 16-h reaction (Endo and  Koizumi, 2004). Besides the use of
SiaTs, trans-sialidases/sialidases have also been employed. The Bac-
teroides fragilis sialidase catalyzed trans-sialylation from colominic
acid to  lactose, resulting in synthesis of both 3′- and 6′-sialyllactoses
with a  total yield of 0.14% (Tanaka et al., 1995). Using casein glyco-
macropeptide (cGMP) from dairy streams and lactose as substrates,
sialyllactose was  produced from either Arthrobacter ureafaciens
or Biﬁdobacterium infantis sialidase-catalyzed reaction (Mcjarrow
et al., 2003). As well, methods for enriching bovine milk with 3′-
sialyllactose and 3′-sialylated galactooligosaccharides (3′-Sia-GOS)
produced by the Trypanosoma cruzi -2,3-trans-sialidase-catalyzed
trans-sialylation were patented (Pelletier et al., 2004; Sallomons
et al., 2013).
Previously, a P. multocida -2,3/2,6-SiaT (tPm0188Ph) has been
produced in E. coli by Yu et al. (2005). The recombinant tPm0188Ph
was  found to be  a  multifunctional enzyme, i.e.,  an -2,3-SiaT that
catalyzes the transfer of  a  sialic acid residue from CMP-Neu5Ac
to galactosides and forms -2,3 sialyl linkage; an -2,6-SiaT that
forms -2,6 sialyl linkage much less efﬁciently; a sialidase that
cleaves -2,3 but not  -2,6 sialyl linkage; a  trans-sialidase that
transfers sialic acid from -2,3-sialosides (not -2,6-sialosides) to
galactosides. In  this study, a P. multocida sialyltransferase (PmST)
gene (Genbank accession number AAK02272), which possesses
three amino acid differences (N105D, Q135R, and  E295G) com-
pared to tPm0188Ph, was  overexpressed in E. coli. The objective
of the work was  to examine the PmST-catalyzed trans-sialylation
in order to  preliminarily assess the efﬁcacy of its  trans-sialidase
activities for producing sialosides. In  a  reaction mixture con-
taining cGMP, lactose and  recombinant PmST, we  observed that
3′-sialyllactose but also 6′-sialyllactose were formed. Thereafter,
using response surface methodology (RSM), we examined the
effects of pH,  temperature and lactose concentration on production
of 3′- and 6′-sialyllactoses.
2. Materials and methods
2.1. Chemicals and  reagents
Phusion DNA polymerase, T4 DNA  ligase, NcoI,  Eco31I and
KpnI were purchased from Thermo Scientiﬁc (Waltham, USA).
Protein standards for  sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) were obtained from Bio-Rad (Her-
cules, USA). 85% orthophosphoric acid and  25% ammonium were
obtained from VWR  (Denmark). 3′-sialyllactose sodium salt and 6′-
sialyllactose sodium salt were purchased from Carbosynth (UK).
2-O-(p-nitrophenyl)--d-N-acetylneuraminic acid (pNP-Neu5Ac,
containing a  trace amount of Neu5Ac) was  provided by Depart-
ment of  Chemistry, DTU. cGMP was  supplied by Arla Foods (Viby,
Denmark). The sialic acid content was  0.18 ± 0.011 mmol  per gram
of cGMP. Before use  impurities of low molecular weight in the
cGMP solution were removed by ﬁltration through a  Ultracel regen-
erated cellulose membranes (5 kDa cutoff) (Merk Millipore, USA).
GOS were purchased from Gulio Gross (Trezzano, Italy). All other
chemicals were purchased from Sigma–Aldrich (St. Louis, USA).
2.2. Strain and plasmid
A  gene encoding a putative P. multocida SiaT lacking the residues
2–25 (Genbank accession number AAK02272) was  synthesized by
Geneart (Life technologies, Germany) (the nucleotide and amino
acid sequences given in Fig. S1). E. coli DH5 was  used for the main-
tenance and manipulation of  plasmids. The expression host E. coli
BL21(DE3)plysS (Novagen, USA) and the expression vector pETM-
11 (EMBL, Germany) were utilized for  the expression of PmST.
2.3. DNA manipulation and  strain construction
The  gene encoding PmST was  PCR ampliﬁed using primers
5′-ATCGGGTCTCCCATGAAAACAATCACGCTGTATCTGG and  5′-
CGGGGTACCTTACAGCTGTTTCAGGCTATCCCAA (restriction sites
underlined). The PCR product was  digested with Eco31I and KpnI
and inserted in pETM-11 between NcoI  and KpnI  in frame with
an N-terminal His6-tag (N-His6-tag). The resulting recombinant
plasmid was  used to  transform E.coli BL21(DE3)plysS.
2.4. Expression and puriﬁcation of PmST
E. coli BL21(DE3)plysS harboring the recombinant plasmid was
cultured in auto-induction medium ZYM-5052 (Studier, 2005) for
24 h with shaking at 30 ◦C. The cell  pellets were harvested by cen-
trifugation (20 min  at 5000 g) and re-suspended in binding buffer
(20 mM  citrate-phosphate buffer, 100 mM NaCl, 15 mM imidazole,
pH 7.4). Cells were lysed by sonication and centrifuged at  5000 g for
20 min. The supernatant was  subjected to  sterile ﬁltration through a
0.45 m ﬁlter and subsequently loaded onto a  5 mL  Ni2+-sepharose
HisTrap HP column (GE healthcare, UK). The puriﬁcation was  car-
ried out using the method described by Silva et al., 2011. The
fractions containing N-His6-tagged PmST were collected and then
desalted using PD-10 desalting columns (GE Healthcare) to remove
imidazole. Protein concentrations were determined using the BCA
protein assay (Thermo scientiﬁc) with BSA as the standard.
2.5. Response surface design of  trans-sialylation reactions
A  quadratic central composite face centered design was  used to
generate factor combinations and multiple linear regression mod-
els were ﬁtted to  the data using MODDE  7.0 (Umetrics AB, Sweden).
The investigated factors were as follows: pH 4.4, 5.4 and 6.4; tem-
peratures 30 ◦C, 40 ◦C and 50 ◦C; and lactose concentrations 50  mM,
100 mM and 150 mM.  Each experimental design consisted of 17
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runs with three center points and was  conducted at  0.5 h,  2 h,  4 h,  6 h
and 8 h, respectively. The cGMP concentration was  ﬁxed as 5% (w/v),
equivalent to 9 mM bound sialic acid. Reactions were initiated by
addition of 0.35 mg/mL  PmST and terminated by heating at 90 ◦C  for
10 min. After centrifugation (5  min  at 20,000 g), the supernatants
were subjected to ﬁltration through vivaspin 500 (5  kDa cutoff)
(Sartorius AG, Germany) and the concentrations of 3′-sialyllactose,
6′-sialyllactose and  sialic acid in the permeates were determined
by HPAEC-PAD as described below. All reactions were performed
in duplicate.
2.6. Kinetic study of trans-sialidase activity for  6′-sialyllactose
synthesis
The -2,6-trans-sialylation reaction was  assayed at  40 ◦C in
50 mM citrate-phosphate buffer (pH 5.4) using 3′-sialyllactose as
the donor and  lactose as the acceptor. The  reactions were done with
various concentrations of 3′-sialyllactose (20 mM,  50 mM,  100 mM,
200 mM,  300 mM  and 400 mM)  and  a  ﬁxed concentration of lactose
(100 mM) and initiated by addition of 0.35 mg/mL  PmST. The ini-
tial velocity of  each reaction was  measured within 1 h. All reactions
were performed in duplicate. Because the measurements were car-
ried out at substrate concentrations far below the Km value, the
kcat/Km value was  derived from a  linear ﬁt  v  = [E0][S0](kcat/Km).
2.7. Enzymatic production and puriﬁcation of Sia-GOS
An 8-h reaction (10 mL)  was  carried out at 40 ◦C in 20 mM
citrate-phosphate buffer (pH 5.4) using 5% cGMP as the donor and
150 mM GOS as the acceptor. The reaction was  initiated by addi-
tion of 0.35 mg/mL  PmST and terminated by heating at 90 ◦C for
10 min. After centrifugation (5 min  at 20,000 g), the supernatant
was  subjected to ﬁltration through vivaspin 20  (10 kDa cutoff) and
subsequently applied to a  5 mL  HiTrap Sepharose FF column (GE
Healthcare). The separation was  done using an  ÄKTA puriﬁer at
a ﬂow rate of 5 mL/min while monitored at 214 nm.  The column
was  equilibrated with 5  column volume (CV) of  deionized water
(A). After sample loading, the unbound compound was  removed
by washing with 3 CV of A, and the target product was  eluted
with a linear gradient from 0%  to 8.5% of 1 M  ammonium formate
(B). The fractions containing potential Sia-GOS were collected and
lyophilized repetitively to remove ammonium formate. The prod-
uct structures were determined by MALDI-MS as described below.
2.8. Thin-layer chromatography (TLC)
The TLC method for determination of 3′-  and 6′-sialyllactoses
and sialic acid was  modiﬁed based on Maru et al. (1992).
2  L of samples or standards comprising -lactose, Neu5Ac,
3′-sialyllactose and 6′-sialyllactose were applied to a  TLC sil-
ica gel 60  plate (Merck Millipore). The plate was  developed
with the solvent 1-propanol–water–25% ammonium solution
(37.5:15:10) for 2 h. Afterwards, the plate was  stained by immer-
sion with diphenylamine–aniline–phosphoric acid as dyeing
reagent (Anderson et al., 2000) followed by heating at 120 ◦C for
15 min.
2.9. High-performance anion exchange chromatography
(HPAEC-PAD)
A  Dionex ICS-3000 system consisting of DP-3000 gradient
pump, ED-3000 electrochemical detector coupled to an AS-3000
autosampler (Dionex Corp., USA) was  used for  HPAEC-PAD analysis.
Oligosaccharides were separated using a CarboPacTM PA100 ana-
lytical column (4 mm  × 250 mm)  with CarboPacTM PA100 guarded
column (4  mm × 50 mm)  (Dionex Corp.) at  30 ◦C.  A three-eluent
system comprising deionized water (A), 500 mM NaOH (B), and
500 mM  sodium acetate (C)  was  used. The separation program
started with 40% of B and 14% of  C at 0 min, followed by a linear
increase of C to 50% for the next 12  min. A 5-min re-equilibration
step was  run with 40% of B and 14% of C. The ﬂow rate was  kept
at 1 mL/min through the entire program. -lactose, Neu5Ac, 6′-
sialyllactose and 3′-sialyllactose were eluted at  retention times of
approximately 1.94 min, 3.18 min, 4.02 min  and 4.3 min, respec-
tively. Calibration was  performed with a  series of standard
solutions (concentration range 0.01–1 mM)  treated by heating at
90 ◦C  for 10 min. The peak area was  used for  quantiﬁcation.
2.10. Capillary liquid chromatography/mass spectrometry
(LC–MS)
An  Agilent 1100 LC/Agilent 6340 ion trap MS system
was  used for LC–MS analysis. Oligosaccharides were sepa-
rated using a Hypercarb porous graphitic carbon (PGC) column
(0.32 mm × 150 mm, 5 m) (Thermo scientiﬁc) at 30 ◦C. Samples
in 10 mM ammonium bicarbonate were loaded onto the column.
Gradient elution was  achieved using a  binary solvent system con-
sisting of 10 mM  ammonium bicarbonate (A), adjusted to pH 8.5
with ammonium hydroxide, and 100% of acetonitrile (B)  at a ﬂow
rate of 5 L/min. The gradient was  initiated at 98:2 (% A:B) for 5 min,
followed by a  linear increase to 42:58 (%  A:B) at 33 min. This con-
centration of B was  held for 3 min. Subsequently the eluent was
returned to 98:2 (% A:B) at 40 min  and the system was  equilibrated
for 10  min  prior to the next injection. The mass spectrometry was
performed in negative ion mode, and was  scanned in the range m/z
150–2200 (2 microscans, maximum accumulation time of 150 ms,
an ion count of 200,000).
2.11. Matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS)
Mass-spectrometric analysis of the oligosaccharides was  per-
formed on a 4800 Plus MALDI TOF/TOFTM (AB SCIEX) mass
spectrometer. 0.8 L  of the sample followed by 0.8 L  of  matrix
solution (20 mg/mL  2,5-dihydroxybenzoic acid (DHB) in 70%
acetonitrile/0.1% triﬂuoroacetic acid/water) was  applied to  an  Opti-
TOF 384 well plate. The instrument was  operated in positive ion
reﬂector mode and the m/z range from 200 to 3000 was  monitored.
A total of 1500 laser shots were applied to  each sample in MS mode.
The laser intensity was  set to 4800. The MS  data were analyzed
manually using Data Explorer (version 4.6). For identiﬁcation of
6′-Sia-GOS, the sample was  incubated with 0.5 g of  Trypanosoma
rangeli -2,3-sialidase mutant (Paris et al., 2005)  at 37 ◦C in 50 mM
ammonium acetate (pH 6.0) for 19  h, prior to  the analysis.
3. Results
3.1. Expression and puriﬁcation of PmST
The  N-terminal amino acid residues 2–25 predicted to be a sig-
nal sequence by TMHMM  Server v.2.0 (CBS, DTU)  were excluded
from the PmST gene. The N-His6-tagged PmST was  produced in
E. coli BL21(DE3)plysS cultured in auto-induction medium ZYM-
5052. About 75  mg of  soluble protein was  puriﬁed from cell  lysate
obtained from 1 L of  culture using a  Ni2+-sepharose column. The
theoretical molecular weight of  the His6-tagged PmST was  48  kDa.
As displayed by SDS-PAGE (Fig. 1),  the recombinant protein exhib-
ited a single band with a  similar molecular weight.
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Fig. 1. SDS-PAGE of the puriﬁed N-His6-tagged PmST.  Lane 1, protein standards;
lane 2, the recombinant PmST puriﬁed by afﬁnity chromatography using a  Ni2+-
sepharose column.
3.2. Trans-sialidase activities of recombinant PmST
The trans-sialylation catalyzed by PmST (0.35 mg/mL) was  per-
formed using 10 mM pNP-Neu5Ac or 5% cGMP as the donor, and
50 mM  lactose as the acceptor at pH 6.0 and 37 ◦C. The reac-
tions were sampled at 0.5 h, 2 h,  4 h,  6  h and  8 h, respectively. As
detected by TLC, PmST catalyzed the sialylation of lactose to  form
3′-sialyllactose, but unexpectedly also 6′-sialyllactose was  gener-
ated from the reaction with both pNP-Neu5Ac (Fig. 2A) and cGMP
(Fig. 2B) as the donors. 3′-sialyllactose was  the dominant product
detectable after 0.5 h,  and 6′-sialyllactose was  formed at a lower
rate detectable after 2 h. The two  products generated from the 8-
h reaction using cGMP as the donor were further conﬁrmed as
3′-sialyllactose and 6′-sialyllactose by LC–MS analysis (Fig. S2).
3.3. Inﬂuence of the reaction parameters on 3′-sialyllactose and
6′-sialyllactose production
In order to identify the optimum reaction conditions for enzy-
matic production of 3′-  and 6′-sialyllactoses, a  statistically designed
experiment was  set up, considering the factors temperature
(30–50 ◦C), pH (4.4–6.4) and lactose concentration (50–150 mM)
at  different reaction times (0.5 h, 2 h, 4 h,  6  h and 8 h). Further,
this should probe the possibility to  favor regioselective trans-
sialylation.
Multiple linear regression analysis of  the response surface
model data showed that among the reaction factors, pH was  the
only factor inﬂuencing the 3′-sialyllactose synthesis. In  addition,
Table 1
The optimum conditions and maximum yields for 3′-  and 6′-sialyllactoses at differ-
ent time points as estimated from the response surface models.a
Time (h) 3′-Sialyllactose 6′-Sialyllactose
pH T (◦C) Yield (mM) pH T (◦C) Yield (mM)
0.5 5.4 41 1.68 5.2 37 0.087
2 5.5 40 2.28 5.4 39 0.69
4 6.4 50 2.38 5.4 39 1.48
6 6.4 50 2.78 5.4 39 2.40
8 6.4 50 2.15 5.4 39 2.87
a The donor  was  5% cGMP (9 mM  bound sialic  acid), and the acceptor was 100 mM
lactose.
the interaction effect for  pH × temperature was  signiﬁcant
throughout the reaction (Table S1). Curvature effects for both tem-
perature and pH (i.e.,  pH × pH, temp × temp interactions) were
also observed (Table S1). For the shorter reaction times (0.5 h and
2 h) (Figs. 3A and S3A;  Table 1),  the optimum condition for 3′-
sialyllactose production was  pH 5.4 and 40 ◦C; however, at longer
reaction times (4–8 h), the optimum shifted toward the highest pH
(6.4) and temperature (50 ◦C) tested (Figs. 3B, S3B and C;  Table 1).
This shift in optimum is presumed to be related to the inherently
confounding effect on 3′-sialyllactose concentration resulting from
an initial product build-up and subsequent consumption.
For 6′-sialyllactose production, the individual factors showed
no signiﬁcant effect on the yield except pH at 0.5 h, while curva-
ture effects for  pH and temperature (i.e., pH × pH,  temp × temp)
were signiﬁcant (Table S2). At the initial stage of  the reaction
(0.5 h and 2 h), the interaction between pH and temperature
signiﬁcantly affected 6′-sialyllactose production (Table S2). The
modeled pH–temperature optimum was  5.4–39 ◦C, similar to that
observed for 3′-sialyllactose production at shorter reaction times,
and remained constant between 0.5 h and 8 h with the yield
increasing over time (Figs. 3C and S4; Table 1).
The summary of the ﬁt and the predictability of the models
were satisfactory with the values of Q2 and R2 within the range of
0.55–0.94 and 0.79–0.98, respectively, indicating reasonably trust-
worthy models (Tables S1 and  S2).
3.4. Time course study of  trans-sialylation reactions
The  RSM experiments identiﬁed pH 5.4 at 40 ◦C as the optimum
condition when considering reaction rates for  the trans-sialidase
activities indicating that the application of  this condition and care-
ful control of reaction time could be one way to  regulate the ratio
between 3′- and 6′-sialyllactoses. It also suggested, however, that
changing pH to 6.4 had a more negative impact on 6′-  sialyllactose
than 3′-sialyllactose production indicating an alternative route for
regioselective trans-sialylation.
Fig. 2. TLC proﬁle of trans-sialylation catalyzed by PmST. (A) The reaction was performed with 10  mM pNP-Neu5Ac as the donor and 50 mM lactose as the acceptor; (B) the
reaction was performed with 5% cGMP (9  mM bound sialic acid) as the donor and 50  mM lactose as the acceptor. Lane 1, standards; lanes  2–7, the  samples collected at 0  h,
0.5 h, 2 h, 4 h, 6 h and 8 h,  respectively.
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Fig. 3. Response surface plot showing the effect of pH and temperature on the production of 3′-sialyllactose (mM)  at 2 h  (A) and 4 h  (B), and the production of 6′-sialyllactose
(mM) at 2 h  (C). The lactose concentration is constant at the center level (100 mM).  5% cGMP was used in all reactions.
To explore the correlations among 3′-sialyllactose, 6′-
sialyllactose and  sialic acid synthesis, a  time course of the
trans-sialylation reaction at pH 5.4 was  compared to  that
at pH 6.4 (5% cGMP and 100 mM lactose, 40 ◦C).  At pH 5.4
(Fig. 4A), 3′-sialyllactose was  produced at a  much faster rate
and accumulated to  a concentration of  2.42 ±  0.38 mM  at 2 h,
but markedly decreased afterwards. An  equimolar concentration
of 3′- and 6′-sialyllactoses was  seen after 4 h, while the con-
centration of 6′-sialyllactose increased up to  3.33 ±  0.38 mM  at
8 h. At this point, the product composition consisted of  65.6%
6′-sialyllactose, 16.3% 3′-sialyllactose and 18.1% sialic acid. At pH
6.4, 3′-sialyllactose was  produced with a slower rate, reaching a
concentration of 2.75 ± 0.35 mM  at  6  h (Fig. 4B). In  contrast, the
6′-sialyllactose activity was  strongly inhibited at pH 6.4, with a
yield of 0.67 ± 0.028 mM at 8 h. At 6 h,  the product composition
comprised 80.2% 3′-sialyllactose and only 14% 6′-sialyllactose and
5.8% sialic acid. The  sialidase activity of PmST was  much lower
than its trans-sialidase activities with maximum release of sialic
acid of  0.92 ± 0.059 mM and 0.27 ± 0.011 mM after 8 h at pH 5.4
and 6.4, respectively.
The trans-sialidase activities of  PmST were also examined
with a 20-fold lower enzyme concentration (0.0175 mg/mL) under
the optimized condition (pH 5.4, 40 ◦C). The reaction was  per-
formed for 24 h (Fig. S5), giving rise to synthesis of 3′-sialyllactose,
6′-sialyllactose and  sialic acid with yields of 0.75 ± 0.01 mM,
0.13 ± 0.0013 mM,  and 0.066 ± 0.0055 mM,  respectively.
3.5. Apparent kinetics of trans-sialidase activity
The  kinetic parameters for the PmST-catalyzed 6′-sialyllactose
synthesis were estimated by reacting the enzyme for up to 1 h
under the optimized reaction condition (pH 5.4, 40 ◦C) on dif-
ferent concentrations of 3′-sialyllactose (up to 400 mM),  while
keeping lactose concentration constant (100 mM).  The  rate of the
6′-sialyllactose formation increased in response to the increase in
3′-sialyllactose concentration, but never reached saturation status
(Fig. S6). By ﬁtting the equation v = [E0][S0](kcat/Km) to the data, the
kcat/Km value was  calculated to  be 23.22 ± 0.7 M−1 s−1.
3.6. Production and  identiﬁcation of  Sia-GOS
The  optimum condition for  production of 6′-sialyllactose (pH
5.4–40 ◦C, 8 h) was  applied to the reaction for sialylation of  GOS,
and Sia-GOS were puriﬁed by anion exchange chromatography (Fig.
S7). MALDI-MS analysis showed that Sia-GOS consisted of  differ-
ent species having chain lengths of DP 2–6,  in agreement with the
observed m/z of 656.3, 818.4, 980.5, 1142.6 and 1304.6 (Fig. 5A). The
puriﬁed Sia-GOS sample was  also treated with an -2,3-sialidase,
and the 3′-Sia-GOS were hydrolyzed, giving rise to  free sialic acid
(m/z 332.1) and neutral hexose (primarily galactose and glucose)
(m/z 365.1, 527.2, 689.3, 851.4 and 1013.5) as shown in Fig. 5B. The
6′-Sia-GOS (m/z 656.3, 818.4, 980.5 and 1142.6) were resistant to
the treatment by sialidase-catalyzed hydrolysis.
Fig. 4. Time course of production of 3′- and 6′-sialyllactoses and sialic acid. (A) The optimum condition for 6′-sialyllactose production was  pH 5.4 and 40 ◦C; (B) the optimum
condition for 3′-sialyllactose production was pH 6.4 and 40 ◦C. The donor was  5%  cGMP, and the acceptor was  100 mM lactose. Data are given  as mean ± standard deviation,
n = 2.
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Fig. 5. MALDI-MS analysis of the puriﬁed Sia-GOS. (A) The ﬁve MS peaks represent GOS (DP  2–6) decorated with -2,3 and -2,6 bound sialic acid residues; (B) treatment of
A with an -2,3-sialidase, leading to a peak representing free sialic acid, ﬁve peaks representing GOS (DP 2–6), and 4 peaks representing resistant 6′-Sia-GOS (DP 2–5). Hex
represents hexose (primarily galactose and glucose) residues; Neu5Ac represents sialic  acid residue; values  in parentheses denote the degree of polymerization of hexose
moieties.
4. Discussion
Compared to tPm0188Ph (Yu et al., 2005),  the recombinant
PmST displayed dual trans-sialidase activities, forming products
with both -2,3 and  -2,6 sialyl linkages in the trans-sialylation.
This  is unlikely due to  three amino acid differences among their
protein sequences (N105D, Q135R, and E295G), since they are
located at least 20 A˚ away from the active site of  PmST. In com-
parison to  the reaction conducted by Yu et al. (2005) using
0.015 mg/mL  tPm0188Ph, 10  mM 3′-sialyllactose and 5 mM 4-
methylumbelliferyl -d-lactoside (LacMu) at 37 ◦C and pH 6.0, a
23-fold higher concentration of enzyme (0.35 mg/mL) and a  10-fold
higher concentration of acceptor (50 mM lactose) were employed
in  our work (Fig. 2),  possibly promoting the trans-sialidase activ-
ity of  PmST for  6′-sialyllactose synthesis. Apart from that, the
sampling time (80 min) could have been too short to observe the
product with -2,6 sialyl linkage in their work (Yu  et al., 2005),
since 6′-sialyllactose was  detected later than 3′-sialyllactose in our
reaction. This was  also supported by the fact that the applica-
tion of 0.0175 mg/mL  PmST in the trans-sialylation reaction (pH
5.4, 40 ◦C) led to  the production of 3′-sialyllactose with a  yield of
0.12 ± 0.019 mM and 6′-sialyllactose with a barely detectable con-
centration (about 0.01 mM)  after 2  h (Fig. S5).
Interestingly, while PmST had a lower -2,6- compared to -
2,3-trans-sialidase activity, it also exhibited a  preference for -2,3
sialyl linkages as donor for both hydrolysis and transfer. In  practice,
this resulted in a slower production of 6′-sialyllactose, which was
not degraded again by PmST, in  contrast to 3′-sialyllactose. This was
also demonstrated by the fact that a  majority of 6′-sialyllactose and
free sialic acid  but a very low concentration of 3′-sialyllactose were
detected by HAPEC after 48-h reaction (data not shown). This obser-
vation coincided with the report of Yu et al. (2005) that tPm0188Ph
displayed no hydrolysis activity on Neu5Ac-2,6LacMu. Moreover,
it indicated that -2,6 bound sialic acid in cGMP was  not, or at  best
inefﬁciently, used as substrate for trans-sialylation.
To date, four SiaTs have been found to  display multiple func-
tions in addition to the native SiaT activity. Apart from tPm0188Ph
and PmST in this study, a Photobacterium damsela -2,6-SiaT
(15Pd2,6ST) has -2,6-trans-sialidase and -2,6-sialidase activi-
ties (Cheng et al., 2010),  and  a  Campylobacter jejuni -2,3/2,8-SiaT
(CstII) displays -2,8-trans-sialidase and -2,8-sialidase activities
(Cheng et al., 2008). Generally, promiscuous activities share the
main active-site features with the native activity (Khersonsky and
Tawﬁk, 2010). Functioning as a SiaT, tPm0188Ph follows a  displace-
ment (inverting) mechanism, where Asp141 serves as a  general
base to  activate acceptor hydroxyl group, and His311 might serve
as a general acid and protonate the departing phosphate oxygen
of CMP (Ni et al., 2006, 2007). As an -2,3-sialidase, tPm0188Ph
follows a double displacement (retaining) mechanism and it has
been suggested that Asp141 is  a  possible general acid/base and
His311 is  a  possible nucleophile (Sugiarto et al., 2011). Since a
trans-sialidase follows a retaining mechanism similar to  a siali-
dase, but with galactosides used as acceptors instead of water, this
assumption could also be applicable for the trans-sialidase activity
of tPm0188Ph as well as those of PmST in this study. In some cases,
the same catalytic residue can act in a different protonation state in
the native compared to the promiscuous function (Khersonsky and
Tawﬁk, 2010). The  different activities of tPm0188Ph have different
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optimum pHs: the -2,3-SiaT (pH 7.5–9.0), -2,3-trans-sialidase
(pH 5.5–6.5) and -2,3-sialidase activities (pH 5.0–5.5), possibly
being involved in modulating charges and consequently function-
alities of critical residues (Sugiarto et al., 2011; Yu  et al., 2005).
The PmST-catalyzed trans-sialylation using cGMP as the donor
and lactose as the acceptor was  a  cascade reaction where the ini-
tial product of  3′-sialyllactose was  converted to 6′-sialyllactose.
It appeared evident that the enzyme functioned optimally at  pH
5.4 and 40 ◦C, where the reaction rates were the fastest and both
sialyllactose isomers were formed. An initial accumulation of 3′-
sialyllactose was  followed by its degradation. 6′-sialyllactose was
produced throughout the reaction, but was  not degraded and hence
accumulated over time. For favoring production of either sialyl-
lactose isomer, it  was  therefore key to terminate the reaction
at an appropriate time. After an 8-h reaction (longest tested), a
maximum yield of 6′-sialyllactose (3.33 ± 0.38 mM)  and simulta-
neously 0.83 ± 0.019 mM 3′-sialyllactose were produced from 5%
cGMP (Fig. 4A).  A higher concentration of 6′-sialyllactose should
be obtainable by prolonging reaction time at  pH 5.4 and 40 ◦C
until all 3′-sialyllactose is consumed. The same condition could be
used for 3′-sialyllactose production; however, the reaction should
be  terminated in an  early state (i.e.,  2 h) before 3′-sialyllactose
degradation became dominant. Interestingly, the RSM experiments
indicated that an increase in pH to 6.4 would be detrimental to 6′-
sialyllactose production while only slowing down 3′-sialyllactose
production. Therefore, a more efﬁcient method for favoring 3′-
sialyllactose production was  application of  the condition (pH
6.4–40 ◦C) in a 6-h reaction that resulted in a maximum yield of
3′-sialyllactose (2.75 ± 0.35 mM)  with a  concomitant production
of 0.48 ±  0.033 mM 6′-sialyllactose (Fig. 4B). The use of cGMP, a
waste side stream from cheese production, as Neu5Ac donor was
applied successfully for maximum production of total sialyllac-
tose in a yield of 46.2% and 35.9% at the two  distinct optimum
conditions, respectively. In  contrast, the A. ureafaciens sialidase-
catalyzed trans-sialylation enabled sialyllactose synthesis in a
yield of only 7.9–13.8% from cGMP (Mcjarrow et al., 2003). In
previous studies using another enzyme class, sialidases, for trans-
sialylation also indicated the importance of reaction conditions
with both temperature and  reaction time being crucial for con-
trolling product yield and  regioselectivity (Ajisaka et al., 1994;
Schmidt et al., 2000; Tanaka et al., 1995). It appears to be a general
theme that careful examination of reaction conditions is  paramount
for enzymatic trans-glycosylation when using enzymes retaining
hydrolytic activity, and/or having dual regioselectivities.
The kinetic study of 3′-sialyllactose conversion for 6′-
sialyllactose synthesis conﬁrmed the ability of PmST to transfer an
-2,3 bound sialic acid residue to  an -2,6 bound residue, indicating
a uniquely promiscuous trans-sialidase activity of  the enzyme. The
limited solubility of 3′-sialyllactose made it impossible to observe
saturation, therefore, only the kcat/Km value was  determined. The
low kcat/Km value (23.22 ±  0.7 M−1 s−1) also underscored the main
drawback of this enzyme, namely that the catalytic efﬁciency
for trans-sialylation is very low, thereby warranting a very high
enzyme concentration.
We  also examined the possibility of  using PmST for sia-
lylation of  GOS. As expected, both 3′- and 6′-Sia-GOS were
formed and  identiﬁed by MALDI-MS. Albeit GOS are widely used
for supplementation of infant formula, the structural discrep-
ancy between GOS and HMOs renders them unlikely to mimic
HMOs (Bode, 2009). Recently, 3′-Sia-GOS produced by the T.
cruzi trans-sialidase-catalyzed trans-sialylation were suggested as
HMO  analogs for alternative supplementation of infant formula
(Sallomons et al., 2013). However, the T. cruzi trans-sialidase has
no -2,6-trans-sialidase activity; thus, the PmST-catalyzed pro-
duction of 6′-Sia-GOS suggested a  novel option for obtaining new
kinds of  HMO  analogs. Our  study herein provides a new solution for
simultaneously or sequentially enzymatic production of  3′-  as well
as 6′-Sia-GOS.
In  conclusion, this study showed that PmST had dual trans-
sialidase activities capable of  catalyzing formation of two  sialyl
linkages in a  trans-sialylation reaction. Using cGMP as the donor
and lactose as the acceptor, the application of optimized con-
ditions combined with careful control of  reaction time enabled
maximum production of  3′-  and 6′-sialyllactoses with different
compositions. When GOS served as acceptors, PmST catalyzed the
trans-sialylation to synthesize both 3′- and 6′-Sia-GOS.
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Fig. S1. The synthetic nucleotide and protein sequences of PmST. 

 
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Fig. S2. LC-MS analysis of 3'- and 6'-sialyllactoses. (A) 6'-sialyllactose standard (peak 1 and 2) and 3'-
sialyllactose standard (peak 3 and 4); (B) sialyllactoses formed in the trans-sialylation with cGMP as the 
donor and lactose as the acceptor. The split peaks represent the α- and β-isomers respectively, of the 
hemiacetal in the reducing end of the sialyllactoses. 



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Fig. S5. Time course of production of 3'- and 6'-sialyllactoses and sialic acid. The reactions were performed 
with 5% cGMP as the donor and 100 mM lactose as the acceptor at pH 5.4 and 40 °C. The enzyme 
concentration was 0.0175 mg/mL. The samples were collected at 0.5 h, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h, 
respectively. Data are given as mean±standard deviation, n=2.
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Fig. S6. Kinetic profile for α-2,6-trans-sialidase activity of PmST. The reactions were done with 20-400 mM 
3'-sialyllactose and 100 mM lactose at pH 5.4 and 40 °C within 1 h. Data are given as mean±standard 
deviation, n=2. 
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Fig. S7. Purification of Sial-GOS by anion exchange chromatography using a sepharose column. Eluent B 
was 1 M ammonium formate. 
  
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Abstract 
This study examined the trans-sialylation efficacy and regioselectivity of five designed mutants 
of Pasteurella multocida sialyltransferase (PmST) catalysing the synthesis of 3'-sialyllactose and 6'-
sialyllactose using casein glycomacropeptide as the sialyl-donor and lactose as the acceptor. The 
mutant enzymes PmSTE271F, PmSTR313Y and PmSTE271F/R313Y preferentially catalysed synthesis of 
3'-sialyllactose over 6'-sialyllactose. When a total sialyllactose (3'- and 6'-sialyllactose) yield of ~50% 
was obtained from casein glycomacropeptide, the regioisomeric ratio (α-2,3:α-2,6) and the transfer 
ratio, i.e. total sialyllactose:sialic acid, obtained from a reaction catalysed by the best mutant 
PmSTE271F/R313Y were 64 and 33, respectively. These values were 128- and 5-folds higher than those 
obtained by use of the wild type enzyme (PmSTWT), respectively. Another mutant enzyme 
PmSTP34H displayed a distinct preference for synthesis of 6'-sialyllactose during the entire course of 
reaction. Although the total sialyllactose yield was consistently significantly lower than that of 
PmSTWT, the (α-2,6:α-2,3) ratio was 1.3-77-fold higher than that obtained by PmSTWT catalysis 
during the first 8 h of the reaction, and reached a maximum of 13.4 after 8 h. The PmSTP34H mutant 
produced a 980-fold increase in α-2,6-sialyltransferase activity compared to PmSTWT, and the α-
2,3-sialyltransferase activity of PmSTP34H was almost abolished. The kcat/Km value for PmSTP34H 
using 3'-sialyllactose as the donor for 6'-sialyllactose synthesis at pH 5.4 and 40 °C was 31.2 M
-1
 s
-1
 
(the kcat/Km of PmSTWT was 23.2 M
-1
 s
-1
). Both PmSTWT and PmSTP34H were also capable of 
catalysing the hydrolysis and transfer of α-2,6 bound sialic acid. 
 
Keywords 
Pasteurella multocida sialyltransferase; site-directed mutagenesis; regioselectivity; 3'-sialyllactose; 
6'-sialyllactose 
 
1 Introduction 
Sialylated human milk oligosaccharides (HMOs) consist of N-acetylneuraminic acid (Neu5Ac) 
attached to galactose (Gal) or N-acetylglucosamine (GlcNAc) through α-2,3 and/or α-2,6 sialyl 
linkage (Bode, 2009). During lactation, the content of 6'-sialyllactose (6'-SL) gradually declines 
while that of 3'-SL remains relatively stable (Wang, 2009); nevertheless, the content of 6'-SL is at 
least double that of its isomer (Coppa et al., 1999; Gabrielli et al., 2011; Leo et al., 2010). For 
monosialylated lacto-N-tetraoses (LNTs), the content of sialyl-lacto-N-tetraose c (LST c, α-2,6 
bound sialic acid) is also higher compared to that of LST a (α-2,3 bound sialic acid) especially in 
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colostrum (Coppa et al., 1999; Gabrielli et al., 2011; Leo et al., 2010). The α-2,3- and α-2,6-
sialylated HMOs have individual biological functions. For instance, 6'-SL was effective in 
inhibiting the Pseudomonas aeruginosa invasion of pneumocytes (Marotta et al., 2014), and 3'-SL 
and 3'-sialyl-3-fucosyl-lactose were identified to inhibit leukocyte rolling and adhesion to 
endothelial cells (Bode et al., 2004).  
Examples of large-scale biocatalytic synthesis of sialylated HMOs and analogues thereof, e.g., 
SL, LST, and sialylated galactooligosaccharides (Sia-GOS) from casein glycomacropeptide (cGMP) 
are given with use of Arthrobacter ureafaciens or Bifidobacterium infantis sialidase (Mcjarrow et 
al., 2003), Trypanosoma cruzi trans-sialidase (Holck et al., 2014; Pelletier et al., 2004; Sallomons et 
al., 2013), or Trypanosoma rangeli sialidase mutants (Jers et al., 2014; Michalak et al., 2014). 
However, most produced sialyloligosaccharides contain exclusively α-2,3 bound sialic acid residues. 
In the previous study (Guo et al., 2014), we have reported that a Pasteurella multocida 
sialyltransferase (PmST) exhibits α-2,3/2,6-trans-sialidase activities. When this enzyme was 
examined for catalysing the sialylation of lactose using cGMP as donor substrate, we identified 
reaction conditions that favoured production of either 3'-SL or 6'-SL. For 6'-SL, a mixture of 
isomers was produced with initial build-up and degradation of 3'-SL and a slower accumulation of 
6'-SL and therefore the time of reaction termination determined the fraction of 6'-SL in the reaction.  
Protein engineering can be an effective tool for altering the regioselectivity of glycosidases and 
glycosyltransferases (GTs) (Choi et al., 2008 and 2014; Dion et al., 2001; He et al., 2006; Hellmuth 
et al., 2008). The objective of the work was to address the options for controlling the 
regioselectivity of PmST via site-directed mutagenesis, notably for more efficient α-2,6-trans-
sialylation, and meanwhile attempt to understand the significance of specific, selected point 
mutations in the enzyme. Previously, four mutants (E271F, R313Y, E271F/R313Y and M144D) 
derived from a PmST homologue enzyme (Δ24PmST1) have been described, of which the α-2,3-
sialidase activities were reduced by 59-6333 folds without affecting α-2,3-sialyltransferase (α-2,3-
SiaT) activity (Sugiarto et al., 2011 and 2012). Our hypothesis was that these mutants - if less 
affected in trans-sialidase activity - might prove better catalysts compared to PmST wild type 
(PmSTWT) for production of sialylated glycans. Moreover, in bacterial SiaTs from GT family 80, 
the residue P34 in PmSTWT is replaced with a His residue in α-2,6-SiaTs. Based on structural 
studies, this His residue has been suggested to be a key factor for determining α-2,6-regiospecificity 
in α-2,6-SiaTs (Kakuta et al., 2008). Hence, as an additional strategy, we introduced the point 
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mutation P34H by site-directed mutagenesis with the aim of altering the regioselectivity towards α-
2,6-trans-sialylation. 
 
2 Materials and Methods 
2.1 Chemicals and reagents 
Phusion DNA polymerase, T4 DNA ligase, NcoI, Eco31I and KpnI were purchased from 
Thermo Scientific (Waltham, US). Protein standards for sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE) were obtained from Bio-Rad (Hercules, US). Cytidine-5'-
monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), 3'- and 6'-SL sodium salts, and 3'- and 
6'-sialyl-N-acetyllactosamine (SLN) sodium salts were purchased from Carbosynth (UK). The 
commercial cGMP product LACPRODAN CGMP-20 was supplied by Arla Foods (Viby, DK). The 
Neu5Ac content was 0.18 mmole per gram of cGMP. Before use, impurities of low molecular 
weight in the cGMP solution were removed by filtration through Ultracel regenerated cellulose 
membranes (5 kDa cutoff) (Merck Millipore, US). All other chemicals were purchased from Sigma-
Aldrich (St. Louis, US).  
 
2.2 Enzyme mutagenesis, expression and purification 
The gene encoding PmSTWT (Genbank accession number AAK02272) was previously inserted in 
pETM-11 (EMBL, DE) and expressed in Escherichia coli BL21(DE3)plysS (Novagen, USA) (Guo 
et al., 2014). The gene encoding mutant PmSTP34H was PCR amplified using PmSTWT gene as 
template and primers P34H_F/WT_R (Table S1). The PCR product was digested with Eco31I and 
KpnI and inserted in pETM-11 between NcoI and KpnI in frame with an N-terminal His6-tag (N-
His6-tag). PmSTR313Y was generated using the QuikChange Site-Directed Mutagenesis Kit 
(Stratagene, US) with PmSTWT gene as template and primers R313Y_F/R313Y_R (Table S1). 
PmSTE271F and PmSTM144D were generated using the Phusion Site-Directed Mutagenesis Kit 
(Thermo Scientific, US) with the recombinant plasmid pETM11-PmSTWT as template and primers 
E271F_F/E271F_R and M144D_F/M144D_R (Table S1) respectively. Double mutant 
PmSTE271F/R313Y was generated using the same kit with pETM11-PmSTR313Y as the template and 
primers E271_F/E271_R. The resulting plasmids were used to transform E. coli BL21(DE3)plysS 
for expression. Expression and purification of the wild type and mutant enzymes were carried out 
using the method described previously (Guo et al., 2014). Fractions containing N-His6-tagged 
proteins were collected and then desalted using Vivaspin 6 (10 kDa cutoff) (Sartorius AG, DE) to 
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remove imidazole. Protein concentrations were determined using a Bicinchoninic acid (BCA) 
Protein Assay kit (Thermo Scientific) with BSA as standard. 
 
2.3 Trans-sialylation assay 
All trans-sialylation reactions were carried out in duplicate or triplicate using 100 mM lactose as 
the acceptor at 40 °C in 50 mM citrate-phosphate buffer (pH 5.4) (optimum identified previously) 
(Guo et al., 2014). Samples were taken at various time points, inactivated by heating at 90 °C for 10 
min and analysed by HPAEC-PAD as described below. 1 unit (U) of trans-sialidase activity was 
defined as the enzyme amount that catalysed the transfer of 1 µmole Neu5Ac to lactose per minute 
at the assay condition described. 1 U of hydrolysis activity was defined as the enzyme amount that 
catalysed the hydrolysis of 1 µmole Neu5Ac per minute at the assay condition described. 
Using 5% (w/v) cGMP (9 mM bound sialic acid) as the donor, a reaction was initiated by 
addition of 0.35 mg/mL hydrolase mutants (PmSTE271F, PmSTR313Y, PmSTE271F/R313Y, and 
PmSTM144D) and 1.05 mg/mL PmSTP34H mutant, respectively. For comparison, 0.35 mg/mL or 1.05 
mg/mL PmSTWT was used in a benchmark reaction. All reactions proceeded for 12 h. To examine 
pH effect on PmSTP34H-catalysed trans-sialylation, reactions were performed for 20 h in 50 mM 
citrate-phosphate buffer with a pH range of 4.4-7.4.
Using 1 mM 3'-SLN as the donor to follow 3'-SL formation, a reaction was initiated by addition 
of 0.023 mg/mL PmSTWT or PmSTE271F, 0.07 mg/mL PmSTR313Y or PmSTE271F/R313Y, and 1.05 
mg/mL PmSTP34H, respectively. To follow Neu5Ac release during the trans-sialylation reaction, 
separate reactions using 1.05 mg/mL PmSTWT or mutant enzymes were performed, respectively. All 
reactions proceeded for 0.5 h. 
Using 1 mM 3'-SL as the donor to follow 6'-SL formation and Neu5Ac release, a reaction was 
carried out using 0.53 mg/mL enzyme (PmSTWT, PmSTE271F, PmSTR313Y, PmSTE271F/R313Y or 
PmSTP34H). Additionally, 1.05 mg/mL PmSTP34H was used to follow the Neu5Ac release during the 
reaction. All reactions proceeded for 2 h. The kinetic assay for PmSTP34H-catalysed α-2,6-trans-
sialylation was done using the method described previously (Guo et al., 2014). Reactions were 
initiated by addition of 0.53 mg/mL PmSTP34H, and the initial velocity was measured within 1 h. 
The kcat/Km value was derived from a linear fit v=[E0][S0](kcat/Km). 
Using 1 mM 6'-SLN as the donor to follow 6'-SL formation and Neu5Ac release, a reaction was 
carried out using 1.05 mg/mL PmSTWT (2 h) and 0.35 mg/mL PmSTP34H (4 h), respectively. 
Additionally, 1.05 mg/mL PmSTP34H was used to follow the Neu5Ac release during the reaction. 
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Using 1 mM 6'-SL as the donor to follow 3'-SL formation and Neu5Ac release, a reaction was 
carried out using 1.05 mg/mL PmSTWT or PmSTP34H for 2 h.  
 
2.4 Sialidase assay 
Using 2 mM pNP-Neu5Ac as the substrate, the sialidase assay was done in triplicate in 50 mM 
citrate-phosphate buffer (pH 7.6) at 40 °C. A reaction was initiated by addition of 0.35 mg/mL 
PmSTP34H, 5.25 mg/mL PmSTM144D, and 1.75 mg/mL PmSTWT, PmSTE271F, PmSTR313Y or 
PmSTE271F/R313Y, respectively. Hydrolysed pNP was monitored continuously at 400 nm (ε=11577 
cm
-1
M
-1
) for 1 h using a Tecan Infinite M200 spectrophotometer (Männedorf, CH). 1 U of sialidase 
activity was defined as the enzyme amount that catalysed the hydrolysis of 1 µmole pNP per minute 
at the assay condition described. 
Using 1 mM 3'-SL as the substrate, a reaction was carried out for 0.5 h with use of 0.07 mg/mL 
enzyme (PmSTWT, PmSTE271F, PmSTR313Y, PmSTE271F/R313Y or PmSTP34H). Using 1 mM 6'-SL as the 
substrate, a reaction was carried out using 0.35 mg/mL PmSTP34H (2 h), 1.05 mg/mL PmSTWT or 
PmSTE271F (2 h), 1.05 mg/mL PmSTR313Y (4 h) and 1.05 mg/mL PmSTE271F/R313Y (8 h), respectively. 
All reactions were done at pH 5.4 and 40 °C in duplicate or triplicate. Samples were withdrawn at 
various timepoints, inactivated by heating at 90 °C for 10 min and analysed by HPAEC-PAD as 
described below. 1 U of hydrolysis activity was defined as the enzyme amount that catalysed the 
hydrolysis of 1 µmole Neu5Ac per minute at the assay condition described. 
 
2.5 Sialyltransferase assay 
α-2,3-sialyltransferase and α-2,6-sialyltransferase assays were performed at their corresponding 
optimum pH conditions identified by Yu et al. (2005). An α-2,3-sialyltransferase assay was 
performed in 50 mM Na2HPO4-KH2PO4 buffer (pH 8.34)  using 1 µg/mL PmSTWT (2 h) and 
PmSTM144D (1 h), respectively. An α-2,6-sialyltransferase assay weas carried out in 50 mM citrate-
phosphate buffer (pH 5.4) using 50 µg/mL PmSTWT (1 h) and 1 µg/mL PmSTP34H (0.5 h), 
respectively. All reactions were done in duplicate or triplicate at 37 °C using 2 mM CMP-Neu5Ac 
as the donor and 100 mM lactose as the acceptor. Samples were taken at various time points, 
inactivated by heating at 95 °C for 5 min, and analysed by HPAEC-PAD as described below. 1 U of 
SiaT activity was defined as the enzyme amount that catalysed the transfer of 1 µmole Neu5Ac to 
lactose per minute at the assay condition described. 
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2.6 Analytical methods  
All samples from sialidase, trans-sialylation and sialyltransferase reactions were measured by 
high-performance anion exchange chromatography with pulsed amperometric detection (HPAEC-
PAD). After termination of reactions, reaction mixtures were centrifuged (5 min at 20,000 g) and 
supernatants were filtered through Vivaspin 500 (5 kDa cutoff) (Sartorius). Concentrations of 3'-SL, 
6'-SL and Neu5Ac in permeates were quantified as described previously (Guo et al., 2014). The 
separation programme was modified by addition of a 5-min cleaning step using 100 % of 500 mM 
sodium acetate prior to re-equilibration, in order to remove impurities. 
Samples from PmST
P34H
-catalysed trans-sialylation reaction using 5% cGMP and 100 mM 
lactose as substrates (pH 5.4-40 °C, 12 h) were also analysed by capillary liquid 
chromatography/mass spectrometry (LC-MS) as described previously (Guo et al., 2014). 
 
3 Results 
3.1 Production of PmST mutant enzymes 
The five N-His
6
-tagged PmST mutant enzymes (PmST
E271F
, PmST
R313Y
, PmST
E271F/R313Y
, 
PmST
M144D
 and PmST
P34H
) were successfully expressed in E. coli BL21(DE3)plysS with a yield of 
70-80 mg of enzyme purified from 1 L of culture. The enzymes had the expected molecular weight 
of ~48 kDa (Fig. 1).    
 
Fig. 1 SDS-PAGE of purified N-His
6
-tagged PmST wild type and mutant enzymes. Lane 1, protein standards; 
lane 2-7, recombinant PmST
WT
, PmST
P34H
, PmST
E271F
, PmST
R313Y
, PmST
E271F/R313Y
 and PmST
M144D
 purified 
by affinity chromatography using a Ni
2+
-sepharose column. 
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Fig. 2 Time course of production of 3'-SL (), 6'-SL () and Neu5Ac () in trans-sialylation reactions 
catalysed by PmST
WT
 (A), PmST
E271F
 (B), PmST
R313Y
 (C) and PmST
E271F/R313Y
 (D). Reactions were 
performed with 5% cGMP (9 mM bound sialic acid) and 100 mM lactose as the substrates at pH 5.4 and 
40 °C. Samples were collected at 0.25 h, 0.5 h, 2 h, 4 h, 6 h, 8 h, 10 h and 12 h respectively. Data are given 
as mean±standard deviation, n=2. 
 
3.2 Comparison of hydrolase mutants for trans-sialylation  
The PmST
M144D
 mutant exhibited only very low trans-sialidase activity (Fig. S1), but was 
verified to have SiaT activity maintained (data not shown). For the other three mutants (PmST
E271F
, 
PmST
R313Y
 and PmST
E271F/R313Y
), the comparison of the trans-sialylation during 12 h showed that 
the activity for 6'-SL production was decreased and the hydrolytic sialidase activity was also 
reduced as compared to PmST
WT
 (Fig. 2). Hence, the three mutants designed to have decreased 
hydrolysis activity all exhibited a preferential production of 3'-SL with very low (<1 mM) yields of 
6'-SL produced. The mutants PmST
E271F
 and PmST
E271F/R313Y
 produced similar yields of 3'-SL (~4.5 
A B 
D 
C 
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mM) after 10 h, and these yields were superior to that of PmSTWT and represented a clear change in 
regioselectivity towards 3'-SL production. This product selectivity was very different from the 
characteristic product profile evolution for the PmSTWT-catalysed trans-sialylation, which involved 
an initial selectivity for 3'-SL production, but a concomitant production of 6'-SL, and a reversal 
between the yields of 6'-SL and 3'-SL during extended reaction (Fig. 2A).  
When total SL yields of ~50% were obtained (~32% for PmSTR313Y), regioisomeric ratios (α-
2,3:α-2,6) for PmSTWT (10 h), PmSTE271F (4 h), PmSTR313Y (12 h), and PmSTE271F/R313Y (10 h) were 
0.5, 7.9, 16, and 63.9 respectively (Table S2), corroborating the superior regioselectivity of the 
PmSTE271F/R313Y for α-2,3-sialylation.  Meanwhile, transfer ratios (total SL:Neu5Ac) for PmSTWT, 
PmSTE271F, PmSTR313Y, and PmSTE271F/R313Y were 7.1, 19.2, 13.2, and 33.3 respectively, once again 
underscoring that PmSTE271F/R313Y was the better enzyme for trans-sialylation.  For PmSTR313Y, the 
overall (α-2,3:α-2,6) ratios and transfer ratios were better than those of PmSTWT, but this mutant 
produced lower SL yields compared to the other enzymes (Table S2).  
Table 1 Comparison of α-2,6-SiaT activity among bacterial α-2,6-SiaTs from GT family 80. 
Enzyme  CMP-Neu5Ac  
(mM) 
Lactose  
(mM) 
pH T  
(°C) 
Specific activity  
(U/mg) 
Reference 
P. damsela α-2,6-SiaT 2.8 50 5 30 7 Yamamoto et al., 
1998 
P. leiognathi α-2,6-SiaT 2.8 50 5 30 3.81 Yamamoto et al., 
2007 
Photobacterium sp. 
Δ16pspST6 
2.3 120 6 30 113 Tsukamoto et al., 
2008 
Photobacterium sp. 
Δ109pspST6 
2.3 120 6 30 264 Kakuta et al., 
2008 
P. leiognathi α-2,6-SiaT 2.3 120 7 30 82.9 Mine et al., 2010 
PmST
WT
 2 100 5.4 37 0.02 This study 
PmST
P34H
 2 100 5.4 37 19.6 This study 
 
3.3 Regioselective synthesis of 6'-SL 
It was previously suggested that the His residue (corresponding to P34 in PmST) in bacterial α-
2,6-SiaTs might determine α-2,6-regiospecificity (Kakuta et al., 2008).  Here, we assessed the effect 
of the point mutation P34H on the native SiaT activities of the enzyme. Strikingly, PmSTP34H 
71
58 

acquired a much higher (980-fold) α-2,6-SiaT activity than PmST
WT
 at pH 5.4 (Table 1), and this 
increase in α-2,6-SiaT activity was accompanied by loss of α-2,3-SiaT activity at both pH 5.4 and 
pH 8.34 (data not shown). Next, we wanted to test the applicability of this mutant for regioselective 
α-2,6-trans-sialylation. 
In fact, the PmST
P34H
 mutant demonstrated a significant preference for 6'-SL production with 
very low levels of 3'-SL produced and Neu5Ac released. The products from the trans-sialylation 
reaction were verified as 6'- and 3'-SLs by LC-MS analysis (Fig. S2). The α-2,6-trans-sialidase 
activity of this mutant was very low with 1.4 mM 6'-SL obtained after 10 h (Fig. 3B). The 
corresponding PmST
WT
-catalysed reaction, i.e. with use of a high enzyme concentration (3-fold 
higher than that used in Fig. 2A), the yield of 3'-SL (2.9 mM) peaked after a shorter reaction time 
(0.5 h). After 6 h, 0.4 mM 3'-SL was retained while the 6'-SL concentration increased to 4.5 mM 
(Fig. 3A). The highest ratio of (α-2,6:α-2,3) was 13.4 and 15.8 for PmST
P34H
 and PmST
WT
 with a 
total SL yield of 15% and 53.1% respectively (Table S3). Thus, the direction of PmST
P34H
-catalysed 
trans-sialylation was altered toward 6'-SL production, but at the price of a low yield.  
         
Fig. 3 Time course of production of 3'-SL (), 6'-SL () and Neu5Ac () in trans-sialylation reactions 
catalysed by PmST
WT
 (A) and PmST
P34H
 (B). Reactions were performed with 5% cGMP and 100 mM lactose 
as the substrates at pH 5.4 and 40 °C. Samples were collected at 0.25 h, 0.5 h, 2 h, 4 h, 6 h, 8 h, 10 h and 12 h 
respectively. Data are given as mean±standard deviation, n=2. 
We previously demonstrated that α-2,6-trans-sialidase activity of PmST
WT
 was optimal at pH 5.4 
and strongly inhibited at pH 6.4 in an 8-h reaction (Guo et al., 2014). Here, the effect of pH on the 
PmST
P34H
-catalysed trans-sialylation was examined in the pH range of 4.4-7.4. The data obtained 
indicated that pH had a similar effect on the PmST
P34H
-catalysed synthesis of 3'-SL and 6'-SL (Figs. 
A B 
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4A and B). 6'-SL was produced at the highest rate at pH 5.4, but reached a plateau at ~1.3 mM after 
about 8 h. In contrast, at pH 6.4 a lower rate was observed, but the accumulation of 6'-SL continued 
in the 20-h reaction, reaching a final concentration of 1.95 mM. The reason why the reaction at pH 
5.4 appeared to be inactivated was not further explored. Thus, shifting pH from 5.4 to 6.4 led to a 
decrease in reaction rate, but an increase in total SL yield and little change in regioselectivity.  
         
Fig. 4 pH effect on PmST
P34H
-catalyzed trans-sialylation. Reactions were performed with 5% cGMP and 100 
mM lactose as the substrates at 40 °C in a citrate-phosphate buffer (, pH 4.4; , pH 5.4;, pH 6.4; , 
pH 7.4). Samples were collected at 0.5 h, 2 h, 4 h, 6 h, 8 h, 12 h, 16 h and 20 h respectively. (A) pH effect on 
production of 6'-SL; (B) pH effect on production of 3'-SL. Data are given as mean±standard deviation, n=2. 
 
3.4 Comparison of trans-sialidase and sialidase activities among PmST
WT
 and the derived mutants 
The impact of donor linkage on the rate of product formation was also investigated. As it is not 
trivial to isolate the individual activities, our approach was to use 3'-SL as donor to monitor 6'-SL 
production and vice versa. Further, we used the alternative donor 3'-SLN and 6'-SLN to follow 
production of 3'-SL and 6'-SL respectively. Conversely, the trans-sialylation rate for production of 
the other isomer was ignored. In the trans-sialylation reaction with use of 3'-SLN as the donor for 
3'-SL production, PmST
E271F
 maintained its α-2,3-trans-sialidase activity while PmST
R313Y
 and 
PmST
E271F/R313Y
 retained 77% and 67% α-2,3-trans-sialidase activity respectively, as compared to 
PmST
WT 
(Table 2). The reduction in α-2,3-trans-sialidase activity of these three mutant enzymes 
was less than that in sialidase activity thereof (Table 2). In the experiment using 3'-SL as the donor 
for production of 6'-SL, it was apparent that PmST
WT
 exhibited a 23-fold higher α-2,3- compared to 
α-2,6-trans-sialidase activity. Interestingly, the mutants, especially PmST
E271F/R313Y
, displayed a 
A B 
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larger reduction in α-2,6- compared to α-2,3-trans-sialidase activity (Table 2), effectively shifting 
the specificity towards α-2,3-trans-sialylation as observed (Fig. 2). 
Table 2 Comparison of sialidase and trans-sialidase activities among PmST wild type and mutant enzymes. 
Reactions were done using 1 mM 3'-sialyl donor at pH 5.4 and 40 °C. 100 mM lactose was used in trans-
sialidase reactions. Data are given as mean±standard deviation, n=3. 
Substrate 3'-SLN and lactose    3'-SL and lactose   
α-2,3-:α-2,6-transfer   
Enzyme 
 α-2,3-transfer 
(U/g) 
Hydrolysis 
 (U/g) 
  α-2,6-transfer  
(U/g) 
Hydrolysis 
(U/g) 
 
PmST
WT
 129±20 (100)
a
 1.3±0.2 (100)  5.6±0.3 (100) 1.2±0.1 (100)  23 
PmST
E271F
 132±21 (100) 0.8±0.1 (59)  2.3±0.3 (41) 0.6±0.07 (53)  58 
PmST
R313Y
 100±1 (77) 0.5±0.1 (35)  0.5±0.05 (8) 0.3±0.05 (27)  212 
PmST
E271F/R313Y 
87±14 (67) 0.3±0.1 (24)  0.2±0.02 (3) 0.2±0.04 (14)  466 
PmST
P34H
 0.3±0.04 (0.2) 
b
  5.6±0.8 (100) 
b
 
 
0.05 
a
 Numbers in parentheses indicate relative activity as compared to that of PmST
WT
. 
b
 The activity was too low to be accurately determined. 
In the case of PmSTP34H, the ability to use α-2,3 bound sialic acid as the donor for α-2,3-trans-
sialylation was almost abolished, whereas the use of this donor for α-2,6-trans-sialylation was at a 
level comparable to PmSTWT. This was further confirmed by kinetical analysis, where PmSTP34H 
exhibited a similar behaviour as PmSTWT, i.e., no saturation was reached in PmSTP34H-catalysed α-
2,6-trans-sialylation (Fig. S3). The kcat/Km value for 6'-SL production was calculated to be 31.2±4.9 
M
-1
 s
-1
, 1.3-fold of that of PmSTWT. 
Next, we tested the applicability of α-2,6 bound sialic acid as donor for the PmSTWT and 
PmSTP34H (Table 3; Fig. S4). When 6'-SLN served as the donor, PmSTP34H displayed an α-2,6-
trans-sialidase activity for 6'-SL synthesis which was 17-fold higher than that of the PmSTWT. 
Using 6'-SL as the donor, PmSTP34H had a 2-fold higher α-2,3-trans-sialidase activity for 3'-SL 
synthesis than PmSTWT. In both cases, the activities were very low as compared to the α-2,3-trans-
sialidase activity of PmSTWT. 
In addition, when 3'-SL, 6'-SL or pNP-Neu5Ac was used as a substrate in a sialidase reaction, 
the mutant enzymes generally displayed decreased sialidase activities as compared to PmSTWT 
(Table S4), albeit with the donors and reaction conditions employed here we failed to reproduce the 
very large reduction in hydrolase activity reported previously for PmSTE271F, PmSTR313Y, and 
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PmSTE271F/R313Y (Sugiarto et al., 2011 and 2012). For PmSTP34H a higher sialidase activity (>4-fold) 
for 6'-SL hydrolysis as well as for pNP-Neu5Ac hydrolysis was observed. 
Table 3 Comparison of sialidase and trans-sialidase activities between PmST
WT
 and PmST
P34H
. Reactions 
were done using 1 mM 6'-sialyl donor at pH 5.4 and 40 °C. 100 mM lactose was used in trans-sialidase 
reactions. Data are given as mean±standard deviation, n=3. 
Substrate 6'-SLN and lactose  6'-SL and lactose 
Enzyme α-2,6-transfer (U/g) Hydrolysis (U/g)  α-2,3-transfer (U/g) Hydrolysis (U/g) 
PmST
WT              
 0.1±0.02 (100)
a
 
b
  0.1±0.02 (100) 0.1±0.02 
PmST
P34H
 2.1±0.2 (1688) 
b
  0.23±0.03(202) 
b
 
a
 Numbers in parentheses indicate relative activity as compared to that of PmST
WT
. 
b
 The activity was too low to be accurately determined. 
 
4 Discussion 
It has been known that donor and acceptor specificity, and reaction conditions can be employed 
to control or partially control the regioselectivity for enzymatic trans-sialylation (Ajisaka et al., 
1994; Guo et al., 2014; Schmidt et al., 2000; Tanaka et al., 1995; Thiem and Sauerbrei, 1991). The 
study herein demonstrated a possibility of modulating the regioselectivity of PmST for α-2,3- or α-
2,6-trans-sialylation by means of site-directed mutagenesis. By application of three hydrolase 
mutants, especially PmSTE271F/R313Y, a significant increase in the regioisomeric ratio (α-2,3:α-2,6) as 
well as in transfer ratio could be achieved without loss of SL yield in extended trans-sialylation 
reactions using cGMP and lactose as the substrates (Table S2). The increase in regioselectivity of 
the three mutants towards α-2,3-trans-sialylation did not appear to be attributed to the decrease in 
sialidase activity, but rather to a larger reduction in α-2,6-trans-sialidase activity (Fig. 2; Table 2). 
Interestingly, the point mutation E271F led to 2-fold reduction in sialidase as well as α-2,6-trans-
sialidase activity, but had no influence on α-2,3-trans-sialidase activity. Sequence alignment of STs 
from GT family 80 showed that E271 in PmSTWT corresponded to the residue Thr in α-2,3-STs and 
to Ala in α-2,6-STs (Fig. S5). However, the structure of Δ24PmST1 in complex with CMP-
3F(e)Neu5Ac (PDB code 2IHK) indicated that this residue is located far away (>7 Å) from the Gal 
part of lactose and thus makes it difficult to rationalize its importance for α-2,3-trans-sialylation. 
For PmSTR313Y and PmSTE271F/R313Y, a 1.3-1.5-fold reduction in α-2,3-trans-sialidase activity was 
observed, while a 12.5-fold and 33-fold reduction in α-2,6-trans-sialidase activity was observed, 
respectively (Table 2). This effect would change the regioselectivity of the two mutants, especially 
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of PmSTE271F/R313Y towards α-2,3-trans-sialylation as observed (Figs. 2C and D). Further, a recent 
study of Choi et al. (2014) reported that for the PmST homologue enzyme (Δ24PmST1), the 
mutants of R313N/T/Y/H/T had a large reduction in α-2,6-SiaT activity on CMP-Neu5Ac with 
lactose as the acceptor, and in turn an improved α-2,3-SiaT activity, corroborating the importance of 
R313 in modulating the regioselectivity for α-2,3-trans-sialylation. In contrast, single mutations at 
L433 to L433S/T in Photobacterium damselae α-2,6-SiaT produced 3-fold increase in the α-2,6-
SiaT activity relative to the wild type enzyme activity (Choi et al., 2014). These results, in addition 
to the data presented in the present work, underline that it is indeed possible to limit one type of 
sialyl linkage synthesis while favoring another one by use of targeted single-point (or double-point) 
enzyme mutations. This provides significant options for rational optimisation of SiaTs for large-
scale biocatalytic production of sialylated compounds.    
Reduction of the hydrolase activity is also an important parameter since this should reduce 
degradation of sialylated products. The mutants were reported previously to exhibit a 59-6333 fold 
reduction in α-2,3-sialidase activity on the substrate Neu5Acα-2,3LacMU (Sugiarto et al., 2011 and 
2012). Using the substrate 3'-SL we demonstrated a 2-fold reduction in sialidase activity for the 
most sialidase activity impaired mutant PmSTE271F/R313Y (Table S4).  
The structures of PmSTWT, PmSTP34H and Photobacterium sp. JT-ISH-224 α-2,6-SiaT in 
complex with lactose are shown in Fig. S6. In the active site of PmSTP34H, only N85 had contact 
with O6 of the Gal part of lactose through a hydrogen bond, while the point mutation P34H could 
introduce a new hydrogen bond interaction with the Gal part and thus help to restrict the 
regioselectivity towards α-2,6-trans-sialylation. The mutation P34H exerted the most profound 
effect on modulating the regioselectivity for the native SiaT activity of the enzyme, as this mutation 
led to a 980-fold increase in α-2,6-SiaT activity to a level that was comparable to other bacterial α-
2,6-SiaTs from GT family 80 (Table 1). When tested in trans-sialylation reactions, PmSTP34H lost 
most of the activity for transfer and hydrolysis of α-2,3 bound sialic acid (Table 2). However, 
PmSTP34H maintained the activity for transfer of α-2,3 bound sialic acid to form the α-2,6 sialyl 
linkage, which was demonstrated by the fact that the kcat/Km value for PmSTP34H-catalysed α-2,6-
trans-sialylation was similar to that of PmSTWT. When tested for trans-sialidase activity using 
cGMP as the donor substrate, a much lower yield of 6'-SL was obtained by PmSTP34H catalysis as 
compared to PmSTWT. Whether this was due to e.g. reduced specific activity, a pH-dependent 
inactivation effect (Fig. 4) or the absence of 3'-SL to function as a secondary donor is unclear. The 
latter would indicate that α-2,3 bound sialic acid in cGMP was not preferred as donor over 3'-SL for 
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α-2,6-trans-sialylation. The activity for PmSTP34H using α-2,6 bound sialic acid to form α-2,6 sialyl 
linkage was increased by 17-fold but the overall activity remained low (Table 3). The data obtained 
nevertheless expands the available knowledge regarding control of regioselectivity for enzymatic 
trans-sialylation by point mutation, and notably that a single mutation, namely P34H significantly 
enhanced the regioselective synthesis of α-2,6 sialyl linkages in the sialyltransferase reaction. At 
present, this single mutant has little applicability in trans-sialylation reactions, but represents an 
interesting candidate for further mutagenesis to refine selectivity and improve the reaction rate and 
stability. The change may involve only one base change in the triplet codon (CCT to CAT), hinting 
that even minor mutations may have a profound effect on the evolution of regioselectivity of 
bacterial SiaTs in nature.   
In conclusion, this study showed that application of three mutant enzymes (PmSTE271F, 
PmSTR313Y and PmSTE271F/R313Y) in trans-sialylation reactions enabled improved regioselective 
production of 3'-SL as well as diminished Neu5Ac release. Secondly, the PmSTP34H mutant was 
capable of catalysing regioselective synthesis of α-2,6 sialyl linkage in both trans-sialylation and 
sialyltransferase reactions. 
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Table S1. Primers used for site-directed mutagenesis. Primers P34H_F/WT_R, M144D_F/M144D_R, and 
R313Y_F/R313Y_R were used for generation of PmST
P34H
, PmST
M144D
 and PmST
R313Y
 respectively. Primers 
E271F_F/E271F_R were used for generation of PmST
E271F
 and PmST
E271F/R313Y
. 
Primer  Sequence (5'-3') 
P34H_F  ATCGGGTCTCCCATGAAAACAATCACGCTGTATCTGGATCATGCATCACTTCCGGC
a
 
WT_R  CGGGGTACCTTACAGCTGTTTCAGGCTATCCCAA
a
 
M144D_F  TGATGATGGCTCAGATGAATATGTCGATC
b,c
 
M144D_R  TACAGATTCAGGCGTTGAATGCTGAC
c
 
E271F_F  CACAACAACATGGTTTGGCAATACAGATG
b,c
 
E271F_R  CCTGTAAAGATAAATTTCGCCTGTTGGAC
c
 
R313Y_F  AAGGCCATCCGTATGGCGGAGAAATTAATGATTATATTCTGAACAACGC
b
 
R313Y_R  GCGTTGTTCAGAATATAATCATTAATTTCTCCGCCATACGGATGGCCTT
b
 
a
 Restriction sites Eco31I and KpnI are shown in italic. 
b
 Codons containing introduced changes are underlined. 
c
 Nucleotides at 5’-ends are phosphorylated.  
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Table S3. Summary of the production of 3'-SL, 6'-SL and Neu5Ac in trans-sialylation catalysed by PmST
WT
 
and PmST
P34H
. Reactions were performed with 5% cGMP and 100 mM lactose as the substrates at pH 5.4 
and 40 °C. Samples were collected at 0.25 h, 0.5 h, 2 h, 4 h, 6 h, 8 h, 10 h and 12 h respectively. Maximal 
values for regioisomeric ratio (α-2,6:α-2,3) and the corresponding transfer ratio and total SL yield are shown 
in bold. 
Time (h) PmST
WT
a
  PmST
P34H
a
 
 α-2,6:α-2,3 transfer ratio total SL yield (%)  α-2,6:α-2,3 transfer ratio total SL yield (%) 
0.25 0.08 33.5 30.2  6.2 6.3 1.1 
0.5 0.2 23.0 38.3  7.5 11.1 2.3 
2 1.5 8.3 54.9  12.1 12.1 6.4 
4 5.3 5.3 46.8  11.9 13.2 9.2 
6 10.8 4.8 55.4  12.2 11.6 10.8 
8 10.8 3.9 46.3  13.4 15.8 15.0 
10 15.8 4.1 53.1  12.9 16.5 16.3 
12 15.3 3.4 43.4  12.8 15.0 15.7 
a
 1.05 mg/mL enzyme was used in the reaction. 
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Table S4. Comparison of sialidase activity among PmST
WT
 and derived mutants. Reactions were done using 
1 mM 3'- or 6'-SL (pH 5.4, 40 °C) and 2 mM pNP-Neu5Ac (pH 7.6, 40 °C) as the substrates respectively. 
Data are given as mean±standard deviation, n=3. 
Enzyme 3'-SL (U/g)  6'-SL (U/g)  pNP-Neu5Ac (U/g) 
PmST
WT
 104±7 (100)
a
  0.4±0.04 (100)  0.06±0.00 (100) 
PmST
E271F
 86±14 (83)  0.1±0.03 (19)  0.03±0.00 (54) 
PmST
R313Y
 86±9 (83)  0.03±0.01 (8)  0.02±0.00 (37) 
PmST
E271F/R313Y
 55±6 (53)  
b
  0.01 ±0.00 (25) 
PmST
P34H
  4±0.6 (4)  1.8±0.2 (444)  0.2±0.01 (434) 
PmST
M144D
 
c
  
c
  0.0005±0.0001 (1) 
a
 Numbers in parentheses indicate relative hydrolysis activity as compared to that of PmST
WT
. 
b
 The activity was too low to be accurately determined. 
c
 Reactions were not performed. 
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Fig. S1. Time course of production of 3'-SL (), 6'-SL () and Neu5Ac (▲) using PmST
M144D
. Reactions 
were done using 5% cGMP and 100 mM lactose as the substrates at pH 5.4 and 40 °C. The enzyme 
concentration was 1.05 mg/mL. Samples were collected at 0.5 h, 2 h, 4 h, 6 h, 8 h, 10 h and 12 h, 
respectively. Data are given as mean±standard deviation, n=2.
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Fig. S2. LC-MS analysis of 3'- and 6'-SLs produced by PmST
P34H
 catalysis. (A) 6'-SL standard (peak 1 and 2) 
and 3'-SL standard (peak 3 and 4); (B) SLs formed in the 12-h trans-sialylation reaction with 5% cGMP and 
100 mM lactose as substrates (pH 5.4-40 °C). The split peaks represent the α- and β-isomers respectively, of 
the hemiacetal in the reducing end of the SLs. 
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Fig. S3. Kinetic profile for α-2,6-trans-sialidase activity of PmST
P34H
. Reactions were done with 20-400 mM 
3'-SL and 100 mM lactose at pH 5.4 and 40 °C within 1 h. 0.53 mg/mL enzyme was used for each reaction. 
Data are given as mean±standard deviation, n=3. 
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Fig. S6. Superposition among the structures of PmST
WT
, PmST
P34H
 and Photobacterium sp. JT-ISH-224 α-
2,6-SiaT (Δ16pspST6, PDB code 2Z4T) in complex with lactose. Modelled structures of PmST
WT
 and 
PmST
P34H
 were obtained by auto-mated homology modeling using Swiss-Model (Arnold et al., 2006; 
Schwede et al., 2003) based on the structure of Δ24PmST1-CMP-lactose (PDB code 2ILV). P34 from 
PmST
WT
, H34 from PmST
P34H
 and N85 from PmST
P34H
 are shown in salmon, while the corresponding 
residues H123 and H179 from Δ16pspST6 are shown in cyan. Bound lactose molecules from PmST
P34H
 and 
Δ16pspST6 are shown in salmon and cyan, respectively. Atoms of oxygen, nitrogen, fluoride are shown in 
red, blue and orange respectively. Hydrogen-bond interactions with H123 and bound lactose in Δ16pspST6, 
and the interactions with N85, H34 and lactose in PmST
P34H
 are shown in dark dashes.
N85 
H179 
lactose 
lactose 
P34/H34 
H123 
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Reference 
Arnold K., Bordoli L., Kopp J., Schwede T., 2006. The SWISS-MODEL Workspace: A web-based 
environment for protein structure homology modeling. Bioinformatics 22,195-201. 
Schwede T., Kopp J., Guex N., and Peitsch M.C., 2003. SWISS-MODEL: an automated protein 
homology-modeling server. Nucleic Acids Research 31, 3381-3385. 
  
93
80 

 

 
94
81 

 3. SITE-SATURATION MUTAGENESIS OF MICROMONOSPORA 
VIRIDIFACIENS SIALIDASE 
This chapter is extended in the form of paper III. 
3.1 Hypotheses and objectives 
Sialidase is a key enzyme for enzymatic analyses of sialylo-compounds (Sugiura et al., 1980) and a 
candidate therapy for spinal cord injury (Mountney et al., 2010). The Micromonospora viridifaciens 
sialidase is the best characterized bacterial sialidase that has a broad substrate specificity 
hydrolysing α-2,3 , α-2,6 and α-2,8 glycosidic linkages (Aisaka et al., 1991). This study aimed to 
improve hydrolase activity of M. viridifaciens sialidase by protein engineering.  
It has been evidenced by many examples of directed evolution of enzymes that promiscuous activity 
can be substantially improved with one or few mutations, often with a relatively low effect on the 
native activity (Khersonsky et al., 2006). A diminish return exists in evolution that the closer the 
process is to the optimum, the smaller the benefit is achieved by mutations (Tokuriki et al., 2012), 
indicating that improvement of natural function would be more difficult and less substantial than 
improving side activity. Moreover, a trade-off between stability and activity has been commonly 
observed in protein engineering, i.e., most mutations that contribute to improving catalytic 
proficiency have been shown destabilizing (Tokuriki et al., 2008). In this study, 20 amino acids in 
or near the active site were targeted for site-saturation mutagenesis. Mutant libraries were tested on 
both a non-natural substrate (pNP-Neu5Ac) and a natural substrate (cGMP) in order to investigate if 
and how the potential for optimizing the enzyme towards non-natural substrates (side activity) is 
higher than for natural substrates (native activity). We further examined whether improvement of 
catalytic proficiency would correlate with decreased stability introduced in mutated sites. 
3.2 Experimental considerations 
Twenty amino acids within 10 Å of the sialic acid binding site (10 sites comprising part of the sialic 
acid binding pocket, three sites in close proximity to the catalytic Tyr, seven surface-exposed amino 
acids that possibly affect the interaction with the sialyl-substrate) were selected for mutagenesis. 
In order to facilitate the screening in microtiter plate format, B. subtilis SCK6 that has high 
transformation efficiency was used as a production host for secretory expression of the wild type 
sialidase gene as well as mutant libraries.  The screening method comprising enzyme expression 
95
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and sialidase assay in 96-well plate format was validated by use of the wild-type gene. Sialidase 
assay was performed using the artificial substrate pNP-Neu5Ac or the natural substrate cGMP, 
respectively. For each library, screening was done with 90 transformants and six wild type enzymes 
per plate. Activities of mutant enzymes were normalized according to those of the wild type 
enzymes. 
When tested on pNP-Neu5Ac, the increase in the sialidase activity displayed by the most active 
mutants was substantially higher than on cGMP. The mutants exhibiting the largest increased 
activity towards pNP-Neu5Ac were sequenced and the corresponding proteins were purified. To 
verify the screening results their specific activities were tested on pNP-Neu5Ac. In addition, these 
proteins were assayed against three more natural substrates 3'-sialyllactose, 6'-sialyllactose and 
colominic acid to confirm the generality of the observation that none mutants showed significant 
improvement on cGMP. 
The stability change of ∆∆G, a measure of potential chemical variation was computed by 
PoPMuSiC for each amino acid. The correlation between computed ∆∆G and activity of mutants 
gives a site-specific estimate of the evolvability, i.e., a high value for a site suggests that most 
mutations in the site are unlikely to occur in natural evolution and are associated with major 
chemical changes and decreased stability. 
3.3 Main results and conclusion 
The number of mutants displaying increased sialidase activity on pNP-Neu5Ac was considerably 
higher than on cGMP. Moreover, the most active mutants displayed more than 10-fold increase in 
activity on pNP-Neu5Ac, while no mutants had >160 % of the wild-type-level activity when 
screened on cGMP.  
The enzymes corresponding to the most active mutants towards pNP-Neu5Ac in the screen were 
purified and the screening result was confirmed by comparing the specific activities of these mutant 
enzymes with that of wild type enzyme. Specifically, the most proficient mutant displayed the 
highest specific activity on pNP-Neu5Ac with a 27-fold increase. This mutant possessed double 
mutations of I91E and S201L, however, the activity increase was mostly attributed to the mutation 
of S201L. The largest increases were observed with amino acids (V148, F155, L170, F203 and 
S201L) located in the sialic acid-binding pocket in close vicinity to the N-acetyl group of sialic acid.  
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When tested on natural substrates 3'-sialyllactose, 6'-sialyllactose and colominic acid, none of these 
purified enzymes showed significant activity increase, corroborating the observation from the 
screening on cGMP. 
No correlation was found between activity on cGMP and the average PoPMuSiC ∆∆G value, 
implying that there is little room for activity increase towards cGMP (i.e., this protein is near the 
proficiency optimum on the natural substrate). On the contrary, there was a significant correlation 
between the increased activity on pNP-Neu5Ac and the predicted ∆∆G value, suggesting that there 
is much more room for activity increase towards the artificial substrate and this improvement 
correlates with chemical changes and decreased stability introduced in the mutated sites. 
 
 
  
97
84 

 
  
98
85 

Mutants of Micromonospora viridifaciens sialidase have highly variable activities 
on natural and non-natural substrates 
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Abstract 
This study aimed to improve the hydrolase activity of the well-characterised bacterial sialidase from 
Micromonospora viridifaciens. The enzyme and its mutants were produced in Bacillus subtilis and 
secreted to the growth medium. 20 amino acid positions in or near the active site were subjected to 
site-saturation mutagenesis and evaluated on the artificial sialidase substrate 2-O-(p-nitrophenyl)-α-
D-N-acetylneuraminic acid and on the natural substrate casein glycomacropeptide. A considerably 
higher fraction of the mutants exhibited increased activity on the artificial substrate compared to the 
natural one, with the most proficient mutant showing 27-fold improvement. In contrast, no mutants 
displayed more than a 2-fold increase in activity on the natural substrate. To gain further insight to 
this important discrepancy, we analysed the stability of mutants using the PoPMuSiC software, a 
property that also correlates with the potential for introducing chemical variation. We found a 
significant correlation between improved hydrolase activity on the artificial substrate and reduced 
apparent stability. Together with the minor improvement on the natural substrate this shows an 
important difference between naturally evolved functionality and new laboratory functionality. Our 
results suggest that when engineering sialidases and potentially other proteins towards non-natural 
substrates that are not optimized by natural evolution, major changes in chemical properties are 
advantageous, and these changes tend to correlate with decreased stability, partly explaining 
commonly observed trade-offs between stability and proficiency.  
 
Keywords 
Micromospora viridifaciens/mutagenesis/protein evolution/sialidase/stability-activity trade-off 
 
Introduction 
In protein evolution an important characteristic of enzymes (and other proteins) is their ability 
to evolve to adapt to new functions (Tokuriki and Tawfik, 2009). This encompasses both altered 
substrate specificity (but same reaction type) as well as catalysis of new reactions. In fact, it is clear 
that many proteins besides their main activity also can catalyse other reactions, normally with lower 
efficiency. These enzymes appear to have arisen from generalist ancestors after adaptation towards 
high specificity and activity for a given reaction (Khersonsky and Tawfik, 2010).  
To obtain and maintain functionality, a protein needs to fixate specific amino acids at 
important positions in the structure. These functionally important residues have been shown to 
generally reduce protein stability (Tokuriki et al., 2008). Enzyme stability is normally not 
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maintained at a level substantially higher (typically 5−15 kcal/mol) than that required to function in 
its natural setting (Branden and Tooze, 1999). Trade-offs between stability and activity are a major 
issue in protein engineering, and several causes for these trade-offs have been suggested (Tokuriki 
et al., 2008; Kepp and Dasmeh, 2014). As adaptation towards new functionality often proceeds via 
destabilizing mutations, an evolution trajectory appears to go via initial accumulation of stabilizing 
mutations to allow incorporation of functional often destabilizing mutations (Tokuriki et al., 2008). 
This trade-off between stability and activity has been observed both in laboratory and natural 
evolution (Tokuriki et al., 2012; Nagatani et al., 2007; Studer et al., 2014).  
Laboratory evolution of enzymes has demonstrated that in many cases latent promiscuous 
activities can be improved with a minimal amount of mutations, often with a relatively low effect 
on the main activity (Khersonsky et al., 2006). When approaching the optimum, a diminishing 
return is seen, that is, additional mutations will lead to relatively smaller improvement in 
proficiency (Tokuriki et al., 2012). This would indicate that improvement of an enzyme with 
respect to its natural function (for which it has been specialized for) would be more difficult and 
less substantial than improving side activities. However, it should be noted that many natural 
enzymes appear to be far from their proficiency optimum because of additional constraints on the 
proteins (Tokuriki et al., 2012). 
In laboratory evolution of enzymes, the construction of smaller libraries is beneficial as this 
will reduce the amount of screening needed. To do so, semi-rational mutant designs in which select 
residues are subjected to site-saturation mutagenesis can be useful. As the observations on stability-
function trade-off indicates that most functional mutations are destabilizing, this might be a 
parameter useful for selection of residues for mutagenesis given that the target enzyme is stable 
enough to accommodate them. 
 In this study a sialidase (EC 3.2.1.18) from Micromonospora viridifaciens was used as a 
model enzyme. Sialidases are enzymes that hydrolyze sialic acids or sialyl groups of glycans and 
are found in all domains of life. Bacterial sialidases are classified in glycosyl hydrolase family 33 
and their structures are of the six-bladed β-propeller type (Crennell et al., 1993). As retaining 
glycosidases, they employ a double-displacement mechanism and use a Tyr residue as catalytic 
nucleophile (Watts et al., 2003) while a conserved Asp-Glu pair is involved in general acid/base 
catalysis (Chan et al., 2012). Interestingly, this enzyme can retain function upon mutation of either 
of the catalytic residues (D92, E260, and Y370) (Watson et al., 2003; Chan et al., 2012). A 
conserved arginine triad (R68, R276, and R342) stabilizes the carboxyl group of sialic acid 
101
88 

(Crennell et al., 1993). The M. viridifaciens sialidase is the best characterized bacterial sialidase. It 
has a broad substrate specificity hydrolysing both α-2,3-, α-2,6- and α-2,8-glycosidic linkages and 
exhibits maximum activity at pH 5 (Aisaka et al., 1991). The kcat/Km of the enzyme is 8.5 x 10
6
 M
-1
 
s
-1
 for hydrolysis of the artificial substrate 2-O-(p-nitrophenyl)-α-D-N-acetylneuraminic acid (pNP-
Neu5Ac) and 0.36 x 10
6
 M
-1
 s
-1
 for hydrolysis of the natural substrate 3'-sialyllactose (Watson et al., 
2003). 
The application of sialidases has gained significant interest for the synthesis of sialoglycans 
using their trans-sialidase activity (Schmidt et al., 2000; Jers et al., 2014). Several studies have 
demonstrated potential uses of sialidases as therapeutics targeting sialoglycans, most notably in case 
of nervous system injuries. Upon injury, inhibitors of axon regeneration some of which bind to 
sialylated receptors, accumulate to halt axon outgrowth. In rats, the administration of sialidase 
improved spinal axon outgrow and recovery after spinal cord contusive injury (Yang et al., 2006; 
Mountney et al., 2010). While several protein-engineering efforts have been directed towards 
improving trans-sialidase activity (Paris et al., 2005; Pierdominici-Sottile et al., 2014; Jers et al., 
2014), to our knowledge no attempts have been made to improve hydrolase activity of sialidases 
despite their importance in disease and inflammation. With potential applications in clinical settings 
emerging, we set out to probe the potential for improving the hydrolase activity of the well-
characterized sialidase from M. viridifaciens by mutagenesis.  
In this study, we subjected select active site-amino acids to site saturation mutagenesis and 
tested the mutant libraries on both a natural substrate casein glycomacropeptide (cGMP) containing 
sialic acid α-2,3-linked to galactose and α-2,6-linked to N-acetylgalactosamine (Saito and Itoh, 
1992), but also on the widely used non-natural test substrate pNP-Neu5Ac. This substrate differs 
from its natural counterparts by having Neu5Ac linked to a para-nitrophenyl group opposed to most 
commonly galactose in natural glycans. When using pNP-Neu5Ac, a high proportion of mutants 
displayed activities substantially higher than the wild type and overall up to 25-fold higher activity. 
In contrast, screening on the natural substrate cGMP led to much less frequent and limited 
improvements. The improved activities on pNP-Neu5Ac correlated with increased chemical 
variation and computed stability changes, confirming the hypothesis that the natural substrates 
resemble an evolved proficiency optimum, whereas activity on the non-natural substrate is 
associated with major adaptation upon variation in chemical properties. Thus, we conclude that for 
optimizing a protein towards non-natural substrates not optimized by natural evolution, major 
changes in chemical properties that tend to correlate with decreased stability are more likely to 
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successfully improve functionality, consistent with a trade-off between stability and proficiency as 
widely debated in protein engineering (Tokuriki et al., 2008; Dellus-Gur et al., 2013). 
 
Materials and methods 
Substrates 
pNP-Neu5Ac and colominic acid were purchased from Sigma-Aldrich (Steinheim, Germany). 
3'-sialyllactose and 6'-sialyllactose were obtained from Carbosynth (Compton, United Kingdom). 
The commercial cGMP product LACPRODAN CGMP-20 with a sialic acid content of about 9 % 
(w/w) was supplied by Arla Foods (Viby, Denmark). 
 
Mutant selection and bioinformatics analysis 
Pymol v1.3 (Schrödinger) was used to identify amino acids within 10 Å of the sialic acid 
binding site, based on the crystal structure with PDB code 1EUS (Gaskell et al., 1995). Individual 
sites were selected based on manual inspection of the structure. Since the number of mutations 
prevented experimental stability assessment, we analysed the stabilities of the mutants using the 
PoPMuSiC software (Dehouck et al., 2011) with the structure templates PDB 1EUS, 1EUT, 1EUU 
and 1EUR. This method has been shown previously to give good accuracy for batches of mutants in 
several studies (Worth et al., 2011; Kepp, 2014). PoPMuSiC computes the ∆∆G (change in free 
energy of protein folding) for a mutant based on parameterized, environment-dependent empirical 
substitution frequencies in orthologs, i.e. it measures the propensity of a given substitution based on 
empirical substitution patterns. Rare substitutions are thus associated with large variations in 
chemical properties that are likely to change the protein function more, and these have resulting 
larger ∆∆G, i.e. are considered destabilizing. 
 
Bacterial strains and growth conditions 
Escherichia coli NM522 was used for plasmid propagation. E. coli was grown in LB medium 
(10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl) shaking at 37 °C. Bacillus subtilis strains 
SCK6 (Zhang and Zhang, 2011) and WB800 (Wu et al., 2002) were used for protein synthesis. B. 
subtilis was grown shaking at 37 °C in LB medium and C-medium (Martin-Verstraete et al., 1990) 
supplemented with 5 g/L glucose and 2 % LB medium (CG-LB medium). The growth media were 
supplemented with kanamycin at 25 µg/mL for E. coli and 50 µg/mL for B. subtilis. 
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DNA manipulation and strain construction 
The protein sequence of M. viridifaciens sialidase (Uniprot ID Q02834) contains a signal 
sequence constituted by amino acids 1-37 (Sakurada et al., 1992). A synthetic gene encoding the 
mature protein (38-647) initiated by methionine and with a C-terminal 6xHis-tag was codon 
optimized for expression in B. subtilis and synthesized by DNA2.0 (Menlo Park, CA, USA). The 
gene fragment was inserted in the vector pDP66K-PME (Øbro et al., 2009) between the NcoI and 
HindIII restriction sites replacing the PME-encoding gene and placing the sialidase gene in frame 
with the CGTase signal peptide and under control of the P32 promoter (Penninga et al., 1996). The 
use of the NcoI restriction site, led to mutation of I38 to glycine. Amino acid numbering will follow 
that of the wild type protein. Site saturated mutagenesis of 20 positions was done by GeneArt 
(Regensburg, Germany). Two point mutations, I91E and S201L, were introduced in the wild type 
gene by overlapping primer mutagenesis using the oligonucleotides displayed in Table 1. The PCR 
products were restricted with NcoI and HindIII and inserted in pDP66K-PME. The 20 libraries of 
plasmids and the two constructed single mutant-encoding plasmids were used to transform B. 
subtilis SCK6 (Zhang and Zhang, 2011). This strain contains the comK gene under control of a 
xylose-inducible promoter and was transformed with plasmid DNA as described previously (Silva 
et al., 2013). B. subtilis WB800 was transformed with pDP66K containing the gene encoding the 
wild type sialidase using a one-step transformation protocol (Jarmer et al., 2002). 
Table 1. List of oligos. Mutated codons are shown in bold. MCS is the multiple cloning site. 
Name Sequence Description 
pDP66K fwd CGAATTCGGTCCTCGGGATATGATAAG Anneals upstream MCS 
pDP66K rev GCCTTCTGCGTCCGGTCGATCAGGGAGGATATCG Anneals downstream MCS 
Mv I91E Fwd CCCAACAGGAGAAGATGCACCTGGACCGAACTC I91E 
Mv I91E Rev CAGGTGCATCTTCTCCTGTTGGGCGGCCGTC I91E 
Mv S201L Fwd TGGATGGCGCTTGAGATTTGCTGCTAGCGGTGAAGG S203L 
Mv S201L Rev CAGCAAATCTCAAGCGCCATCCAGGATCCGG S203L 
 
Screening of site-saturation libraries 
For each of the site-saturation libraries, screening was done in 96-well microtiter plate format 
with 90 transformants (4.5 fold coverage) and six wild type enzymes per plate. B. subtilis was 
transformed with the site-saturation library and wild type plasmid, and after overnight incubation at 
37 °C, the transformants were transferred to 125 µL LB medium with kanamycin in a 250 µL round 
bottom microtiter plate (Nunc), covered with Airpore sheet (Qiagen) and incubated at 37 °C with 
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shaking at 250 rpm for 6 hours. The preculture step reduced well-to-well variation from growth. 
From this preculture, 5 µL was used to inoculate 500 µL CG-LB medium with kanamycin in a 2 
mL deepwell plate (Eppendorf). The plate was covered with airpore sheet and incubated at 37 °C 
with shaking at 250 rpm for 16 hours. At this point, the supernatants containing the secreted 
enzymes were harvested by centrifugation for 15 min at 5000 g and 4 °C and kept on ice or stored 
at -20 °C in 10 % glycerol until used in the assays. 
 
Protein production 
For larger scale production of selected enzyme variants, 50 mL cultures were grown by 
inoculating 50 mL LB medium with kanamycin to OD600 of 0.05 and incubation with shaking at 
37 °C for 23 hours. At this point, the supernatant was harvested by centrifugation for 15 min at 
5000 g and 4 °C and passed through first a 0.50 and then a 0.20 µm filter. The ~48 mL supernatant 
was then concentrated to less than 1 mL using a Vivaspin20 10 MWCO concentrator (Sartorius 
AG), mixed with 10 mL purification buffer (20 mM sodium phosphate, 500 mM NaCl, pH 7.4) 
with 10 mM imidazole and concentrated to 1.5 mL. The concentrated sample was applied to a His 
spin trap column (GE Healthcare) and washed once with 600 µL of the same buffer, then four times 
with 600 µL purification buffer containing 30 mM imidazole and finally eluted in 400 µL 
purification buffer with 300 mM imidazole. To reduce imidazole concentration to less than 0.5 mM, 
several rounds of concentration and dilution in storage buffer (20 mM sodium phosphate, 100 mM 
NaCl and 10 % glycerol, pH 7.4) were done using Vivaspin6 10 MWCO concentrator (Sartorius 
AG). Final volume was adjusted to 500 μL. Protein concentration was estimated using the BCA 
assay (Thermo Scientific) with BSA as standard. 
 
Sialidase activity assays 
Two different enzyme assays were used for testing sialidase activity: one using the substrate 
pNP-Neu5Ac and another for testing activity on various natural substrates. The pNP-Neu5Ac 
hydrolase assay was done in a 50 mM phosphate-citrate buffer at pH 7 with 0.75 mM pNP-Neu5Ac 
at 30 °C using various amounts of enzyme. In the screen, 5 μL of culture supernatant was used in a 
100 μL reaction. Reactions were started by addition of substrate and monitored continuously in a 
spectrophotometer at 410 nm absorbance. Reactions were followed for 1 h, and initial reaction rates 
were calculated as the slope of the linear portion of the curves and presented in the following as 
percent of the wild type enzyme activity. For testing the purified enzymes, 1.5 µg/mL His-tagged 
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wild type enzyme was used, while for the mutant enzymes a 5-14 times lower concentration was 
used. For measurement of hydrolysis of natural substrates, reactions were performed with either 1 
mM 3'-SL, 1 mM 6'-SL, or 1 mM cGMP-bound sialic acid in 50 mM phosphate-citrate buffer (pH 5 
or 7) using 10 μL of 25-fold diluted culture supernatant in 50 μL reactions or 5 μg/mL purified 
enzyme. Reactions were started by addition of enzyme and stopped by adding H
2
SO
4
 to a final 
concentration of 45 mM. Quantification of free sialic acid was done using a modified thiobarbituric 
acid assay (Jers et al., 2014).  
 
Results 
Cloning, expression and purification of M. viridifaciens sialidase in B. subtilis  
The sialidase from M. viridifaciens was previously produced in bacterial hosts Streptomyces 
lividans and E. coli (Sakurada et al., 1992; Watson et al., 2003). In order to allow efficient secretion 
to the culture medium, we attempted to use B. subtilis as a production host since this would simplify 
screening in microtiter plate format. Expression of a codon-optimised gene in B. subtilis SCK6 (a 
strain devoid in two of the major secreted proteases) allowed production and secretion of the 6xHis-
tagged sialidase (Figure 1). Besides the full length protein, a smaller form of ~28 kDa was observed 
similar to the size of the C-terminal, non-catalytic form reported previously (Sakurada et al., 1992). 
It was attempted to produce the enzyme in B. subtilis WB800, a strain knocked out in eight 
proteases, but this did not reduce degradation (Figure 1) and hence the strain B. subtilis SCK6 was 
used for the reported work. 
 
Fig. 1. SDS-polyacrylamide gel of M. viridifaciens sialidase produced in B. subtilis. M is a molecular weight 
marker, Lanes 1 and 2 show supernatant and purified sialidase produced in B. subtilis strains SCK6 and lanes 
3 and 4 show supernatant and purified sialidase produced in B. subtilis WB800. 
106
93 

Inspection of active site amino acids 
In order to investigate the possibility of improving the catalytic proficiency of sialidases, we 
mutated a number of positions in or near the active site. To maximize the possibility of identifying 
relevant mutations, we performed single-amino acid site-saturation mutagenesis in each of 20 
selected positions. Positions were selected based on inspection of the solved structure (Gaskell et al., 
1995; 1EUS). These included nine sites comprising part of the sialic acid binding pocket: I69, A93, 
S130, D131, P132, V148, F155, L170, F203, and D259. Of these, D131 and D259 form hydrogen 
bonds with the inhibitor DANA in the crystal structure and P132 is buried underneath the pocket. 
Three amino acids N310, N311, and S369 are located close to the catalytic tyrosine, and we 
envisioned that they might modulate the covalent intermediate or transition state and thus affect 
turnover. A number of surface-exposed amino acids were selected because they might change the 
interaction with the substrate molecules to which sialic acid is bound. These included G90, I91, 
G154, Q153, A156, and F234. Finally, N66 a second-sphere, surface-exposed residue in close 
vicinity to conserved R68 was selected. None of the active site amino acids strictly conserved in all 
sialidases (R68, D92, E260, R276, R342, and Y370) were targeted. The sites selected for 
mutagenesis are presented in Figure 2. 
 
Fig. 2. Amino acid positions in the active site selected for mutagenesis. Selected amino acids are shown in 
green, catalytic residues D92, E260, and Y370 are in grey while the structure-bound ligand is in blue. 
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Fig. 3. Screening of mutant libraries. Histogram presenting the activity (% compared to wild type) of 1800 
mutants tested on (A) pNP-Neu5Ac and (B) cGMP with a bin size of 20 %. 475 and 859 mutants showed no 
or low activity (0-20 % wild type activity) on pNP-Neu5Ac and cGMP respectively and are not shown in the 
histograms. 
Screening of site saturation libraries reveals variable activities on pNP-Neu5Ac and cGMP 
The mutant libraries were synthesized to contain genes encoding all 20 amino acids in a given 
position. The DNA was used to transform B. subtilis and transformants were picked to a 96-well 
microtiter plate. In initial experiments, a relatively high well-to-well variation was observed due to 
differences in inoculum used. That was alleviated by synchronizing growth by pre-culturing the 
cells to early stationary phase, and using this culture for inoculating the enzyme production plate. 
Cells were removed by centrifugation and supernatant containing the secreted enzyme was assayed 
for enzyme activity on the substrates pNP-Neu5Ac and cGMP. To validate the method, this pipeline 
was tested using DNA encoding the wild type enzyme. This was repeated three times, and the 
activities of individual wells were between 80-125 % of the average activity when tested on pNP-
Neu5Ac. Next, the libraries were tested on the substrates pNP-Neu5Ac and cGMP. For each amino 
acid 90 transformants were tested and activities were normalized with respect to the activity of the 
wild type enzyme. The pooled results for all transformants tested are presented in a histogram 
(Figure 3). Results for individual positions are presented in Figure S1. When screened on cGMP, a 
larger number of mutants showed no or low activity than on pNP-Neu5Ac. Further, the majority of 
active mutants exhibited wild type-level activity on cGMP and very few mutants had an increased 
activity on this substrate. No mutants had an activity above 160 %. When tested on the artificial 
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substrate pNP-Neu5Ac, the majority of mutants also exhibited wild type-level activity but the 
number of mutants exhibiting increased activity was considerably higher, and the most active 
mutants displayed more than 10-fold increase in activity under the conditions used.  
 
Fig. 4. Specific activity of the most proficient mutants selected on pNP-Neu5Ac. Activity increments 
compared to activity of the wild type sialidase. Negative control (NC) was a reaction without enzyme added. 
Average of four replicates. 
 
Mutations improving the hydrolysis activity on pNP-Neu5Ac 
To provide a foundation for interpreting the reasons underlying the difference in improvements 
observed, we sequenced the variants that showed the largest increase in activity towards pNP-
Neu5Ac (Table S1). Further, we wanted to verify the screening results on a set of the variants 
exhibiting the largest increase in activity on pNP-Neu5Ac. To this end, plasmids were purified and 
entire genes were sequenced and the corresponding strains were grown in larger scale to allow 
production and purification of the 6xHis-tagged enzymes. We found that the most proficient mutant 
in the screen possessed both mutation I91E but also S201L. The corresponding enzymes were 
produced and tested on pNP-Neu5Ac (Figures S2 and 4). This largely confirmed the screening 
results except it appeared that the specific activities of most improved variants were underestimated 
in the screen, and mutants with more than 20-fold improvement in activity was observed. The 
mutant I91E/S201L exhibited the highest activity with a 27-fold improvement. When testing the 
individual single mutants, I91E had wild-type like activity whereas S201L could explain most of 
the improvement (Figure S3).  
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As indicated in the screen, neither of the mutants showed significant improvement on the 
natural substrate cGMP. To confirm the generality of this observation, we tested the purified 
enzymes on three other natural substrates 3'- and 6'-sialyllactose (Neu5Ac α-2,3-, and α-2,6-linked 
to galactose respectively), and colominic acid (Neu5Ac polymer linked by α-2,8 bonds) (Figure S4). 
The results confirmed the overall observation, with some variants showing slight improvements and 
others showing significantly reduced activity on these substrates. To allow detection of the 
chromophore pNP in a continuous assay, the screening using pNP-Neu5Ac was done at pH 7, while 
the cGMP screen was done at pH 5, the optimum pH for the wild type enzyme (Aisaka et al., 1991). 
To assess whether this discrepancy could account for the differences observed between the two 
substrates, we analysed the purified mutant enzymes on 3'-sialyllactose at pH 5 and 7 (Figure S4). 
This confirmed that the observed improvements were not due to a change in pH optimum or range. 
 
Structure analysis and hypothesis for effect of mutations 
After having showed that the mutagenesis strategy preferentially yielded mutants with 
improved activity on pNP-Neu5Ac, we investigated whether the number of improving mutations 
would correlate with the chemical variation and stability effects in the library. To this end, we used 
PoPMuSiC where the computed stability change ∆∆G for each mutation provides a measure of the 
environment-dependent substitution propensity based on empirical substitution frequencies of 
orthologs, and these can then be summed for each of the 20 sites. A large positive value of ∆∆G 
thus implies both a highly destabilizing mutant and a natural-evolution-wise unlikely substitution. 
We then assessed whether there were correlations between these ∆∆G values for all 20 
individual sites and the number of mutants with higher, similar or lower activity compared to the 
wild type enzyme. This approach gives a site-specific estimate of the evolvability and a high value 
for a site implies that most mutations in the site are unlikely to occur in natural evolution and are 
associated with loss of stability due to major changes in the chemical properties of the protein. We 
found no correlations between activity on cGMP and the PoPMuSiC results, indicating that the 
protein is nearly optimal (by evolution) for activity on natural substrates, and any changes in the 
sites are likely to have small or negative effect on activity irrespective of chemical properties and 
stability (Figure S5).  
In contrast, there was a markedly different and statistically significant correlation between the 
average PoPMuSiC ∆∆G of a site and the site-specific activities of the most active mutants on the 
non-natural substrate pNP-Neu5Ac. This indicates much more room for improvement, and 
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importantly, improved activity is associated with sites that exhibit major chemical changes and 
decreased stability (Figure 5). 
 
Fig. 5. Correlation between potential for chemical variation and improvement towards hydrolysis of pNP-
Neu5Ac. PoPMuSiC predictions were used as a measure of potential chemical variation and was for each 
amino acid position plotted against the number of mutants that exhibited improved activity towards pNP-
Neu5Ac. 
We finally considered the amino acid positions that yielded the largest increases in activity on 
pNP-Neu5Ac. For the most improved variants, the mutations in V148, F155, L170, and F203 were 
all located in the sialic acid-binding pocket within 4−5 Å of the N-acetyl group of sialic acid (Figure 
6). The mutation S201L that was functionally important in the most improved variant was located in 
the second sphere in close vicinity to these four sites. Sequencing of mutants of the two aspartic 
acid residues involved in sialic acid binding indicated that D131 only remained active when 
mutated to glutamic acid. However, this reduced the activity on pNP-Neu5Ac, and no activity was 
observed on cGMP, indicating its functional importance. For D259, mutation to glutamic acid 
increased activity towards pNP-Neu5Ac while other mutations led to reduced activity and in this 
case, we found no mutants active on cGMP. 
 
Discussion  
In this work, we aimed to assess the potential for improvement of a well-characterized 
sialidase towards both artificial and natural substrates. To this end, we designed, cloned, expressed, 
and characterized mutants resulting from saturated mutagenesis at 20 positions near the active site. 
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Positions were selected based on inspection of the solved structure with PDB code 1EUS (Gaskell 
et al., 1995). None of the strict catalytic residues (R68, D92, E260, R276, R342, and Y370) were 
selected, but except from that, conservation within the sialidase family was not considered since we 
wanted to optimize in vitro proficiency, and these conserved sites are likely to add additional 
constraints on the protein relating to e.g. in vivo regulation and modification.  
 
Fig. 6. Representation of the positions with most improved variants. The mutated positions V148, F155, 
L170, and F203 are shown in green, the site S201 that yielded the most improving mutation is shown in 
yellow while the catalytic residues D92, E260, and Y370 are shown in grey. The ligand is shown in blue. 
The potential for improving the catalytic efficiency of an enzyme largely depends on how well 
it is optimized for its particular function. In a previous study the catalytic efficiency k
cat
/K
m
 was 
determined for the substrate pNP-Neu5Ac and a natural substrate 3'-sialyllactose indicating a 10-
fold higher efficiency of the enzyme towards the pNP-substrate (Watson et al., 2003). For other 
classes of enzymes, large rate accelerations have been observed when using artificial pNP-
substrates (Indurugalla et al., 2006), reflecting elevated intrinsic reactivity of the substrate rather 
than the enzyme being optimized for this particular substrate. Consequently, we wanted to 
investigate if and how the potential for optimizing the enzyme towards non-natural substrates is 
higher than for natural substrates. To test this, we assayed the mutant libraries on two substrates, the 
artificial test substrate pNP-Neu5Ac and the natural substrate cGMP derived from casein. This 
demonstrated a much higher proportion of beneficial mutations with respect to hydrolysis of the 
artificial substrate compared to the natural one and the best mutant (I91E/S201L) had a 27-fold 
improvement in activity whereas for cGMP only slight improvement was observed. This reflects 
substrate specific differences and consequently mutations selected specifically to favor action on the 
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artificial substrate. This is in line with observations on promiscuous enzymes, where it is well-
established that while changing main function can be difficult, a weaker side activity often can be 
substantially improved with one or few mutations often without significantly affecting the main 
activity (Khersonsky et al., 2006). 
Both in laboratory and natural evolution there is a trade-off between stability and function 
(Tokuriki et al., 2012; Nagatani et al., 2007; Studer et al., 2014). Since we in this study analysed 
single mutants only, such effects would not be readily apparent. Destabilizing mutations would be 
expected to be tolerated by our model enzyme, since it appears reasonably stable (temperature 
optimum at 52 °C) (Watson et al., 2003). When analyzing the stability change of mutations, there 
was a significant correlation between the average PoPMuSiC ∆∆G and activity on the artificial 
substrate for the most improved mutants while no correlation with activity on the natural substrate 
was observed. This would be consistent with the view that the protein is nearly optimal (by 
evolution) for activity on natural substrates: Any changes are then likely to have small or negative 
effect on activity regardless of chemical properties and stability, i.e. we have probed a proficiency 
optimum (in evolutionary terms, resembling a partial fitness optimum, if other selection pressures 
on the protein are ignored).  
In contrast, when optimizing a protein for a new, non-natural substrate, there is much more 
room for improvement since the substrate is no longer optimal, and importantly, improved activity 
is associated with sites that exhibit major chemical changes and thus, decreased stability. The 
observation that the activity towards non-native substrates can be readily improved and that the 
improvement correlates with the potential for introducing chemical variation in a given amino acid 
position has direct implications in protein engineering. On the other hand, none of the single 
mutants were markedly improved towards the natural substrate. In nature, the enzyme is likely to 
have been selected for efficient hydrolysis of galactose-linked sialic acid and could potentially, in 
sequence space, have reached a local optimum. In that case, it might require multi-mutants to enable 
significant improvements in activity which would not be captured by our strategy (Tracewell and 
Arnold, 2009). 
When analyzing the effect in individual positions, the functional importance of especially 
D141 and D259 that interact directly with sialic acid, was apparent with most mutants showing no 
activity. For reaction on pNP-Neu5Ac, mutation to the chemically similar but larger amino acid 
glutamic acid was tolerated (2-fold reduction and 2.5-fold increase in activity respectively). On 
cGMP, both mutants had no detectable activity indicating a difference in the position of sialic acid 
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in the binding pocket. Further, it appeared that the largest improvements were observed with amino 
acids (V148, F155, L170, F203 and S201L) located in the sialic acid-binding pocket in close 
vicinity to the N-acetyl group of sialic acid. This might indicate that positioning of sialic acid in the 
binding pocket was changed likely due to secondary effects of the nitrophenyl group. This would 
imply that the major functional role of the mutations would be to allow an alternative positioning of 
sialic acid that would lead to a more optimal positioning of the nitrophenyl group. This in turn 
would not affect the overall catalytic activity of the enzyme as was also observed for the cGMP data 
set. 
pNP-Neu5Ac is one of the most frequently used test substrates for sialidases. While the use of 
artificial test substrates allows easy and fast screening, it is not necessarily indicative of the activity 
towards the natural substrate (Lee, 2010). This is also apparent in this data set, namely that there 
was not a clear correlation between activity of mutants on the artificial and natural substrate. The 
use of pNP-Neu5Ac as an indicator of potential sialidase activity may be reasonable, but with 
respect to characterisation of biological functions of sialidases, more relevant, natural substrate 
should be chosen. 
In conclusion, using a well-studied sialidase as an example, we used site-saturation 
mutagenesis of 20 sites close to the active site and subsequent activity characterization of mutants 
to investigate the ability of the enzyme to improve activity towards both non-natural and natural 
substrates. We show that while there is little room for improvement towards a natural substrate, 
consistent with the protein being near the proficiency optimum, there is substantial room for 
producing highly proficient sialidases with activity towards pNP-Neu5Ac. Furthermore, this 
tendency of improvement correlated with chemical variation introduced in the mutated sites, which 
again correlates with stability decrease, as computed by the PoPMuSiC algorithm. This study thus 
provides a mechanistic explanation for stability-activity trade-offs found in protein engineering 
when the investigated activities are not towards the natural substrate, which is commonly the case.  
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Table S1. Overview of sequenced mutants with increased activity on pNP-Neu5Ac. Represented are the 
introduced mutation (Mut), number of clones (n), and activity in the screen on pNP-Neu5Ac and cGMP. 
When more than one clone contained the mutation, activity is given as the average. Mutants purified for 
further validation of screen are marked with bold 
Mut n 
Activity 
 
 
Mut n 
Activity 
pNP-NeuAc cGMP   pNP-NeuAc cGMP 
N66X Pro 2 218 ± 9 64 ± 2  F155X Ser 6 1248 ± 60 16 ± 3 
I69X Pro 4 351 ± 11 35± 12 
 
 Glu 5 1231 ± 85 29 ± 5 
G90X Trp 3 280 ± 14 81 ± 11 
 
 Ile 3 1181 ± 105 37 ± 7.8 
Asp 1 265 98   Thr 3 1159 ± 29 21 ± 12 
I91X Pro 3 312 ± 13 16 ± 2 
 
 Gly 2 1109 ± 36 10 ± 0.5 
Tyr 1 296 59   Asn 1 1019 41 
Glu 1 1422 4 
  Gln 1 1082 30.8 
A93X Thr 4 328 ± 21 87 ± 13 
 
 His 1 683 66 
Ile 1 315 16   Val 1 874 69 
S130X His 3 506 ± 32 4 ± 0 
 A156X Asp 4 222 ± 2 71 ± 6 
Ala 2 4301 ± 7 58 ± 1  L170X His 7 599 ± 20 54 ± 9 
Glu 2 292 ± 11 1 ± 0 
 
 Phe 3 940 ± 69 77 ± 5 
Asn 1 277 5   Asp 2 461 ± 1 45 ± 5 
D131X Glu 2 40 ± 3 0 ± 0 
 
 Glu 2 536 ± 14 38 ± 11 
L126F 
1 
1 55 61 
 
F203X Tyr 4 862 ± 12 28 ± 3 
P132X Val 2 134 ± 0 60 ± 15 
 
 Ser 2 800 ± 6 8 ± 0 
V148X His 6 853 ± 58 2 ± 0 
 
 Gly 2 775 ± 4 11 ± 1.5 
Gln 3 825 ± 36 2 ± 1 
 
 Ala 2 838 ± 16 13 ± 4 
Ile 2 916 ± 27 20 ± 4 
  Met 1 515 23 
Gly 2 446 ± 9 92 ± 14   His 1 505 0.6 
Q153X Ile 2 157 ± 4 116 ± 7 
 
F234X Asp 6 516 ± 26 103 ± 6 
Asn 1 523 36 
 
 Trp 1 510 31 
Val 1 159 89   Thr 1 402 128 
G154X Asp 8 606 ± 68 36 ± 5 
 
D259X Glu 7 242 ± 7 0 ± 1 
Glu 2 537 ± 25 32 ± 1   Val 1 34.8 0 
Pro 1 517 122   Ser 1 69 5 
His 1 487 47  N310X Ile 1 141 74 
 
1
 D131X had wild type Asp but unwanted mutation 
L126F 
 
N311X Met 2 165 ± 1 37 ± 1 
 S369X Asp 4 251 ± 21 83 ± 34 
 
 His 1 256 83 
 
 Arg 1 60 86 
 
 
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Figure S1. Histogram presenting the activity of screened mutants in individual positions. Activity (% 
compared to wild type) of 90 mutants tested on pNP-Neu5Ac and cGMP with a bin size of 20 %. 475 and 
859 mutants showed no or low activity (0-20 % wild type activity) on pNP-Neu5Ac and cGMP respectively 
and are not shown in the histograms. Intervals of axes are identical within site (i.e. between pNP-Neu5Ac 
and cGMP data) but not between sites.
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Figure S2. SDS-polyacrylamide gel of 6xHis-tagged mutant enzymes. Enzymes showing increased activity 
on pNP-Neu5Ac, were purified for further analysis. WT is wild type and 91-Glu is the double mutant 
I91E/S201L
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Figure S3. Activity of the double mutant I91E/S201L and the single mutants I91E and S201L on pNP-
Neu5Ac. NC is a negative control without enzyme.
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Figure S4. Specific activity of mutants on the natural substrates 3’-sialyllactose (pH 5 and 7), 6’-
sialyllactose (pH 5) and colominic acid (pH 5). Change in activity compared to activity of the wild type 
sialidase. Negative control (NC) was a reaction without enzyme added. The experiment was repeated twice 
with same trend, a representative data set is displayed.
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Figure S5. Correlation between PoPMuSiC predictions and activity of mutants. Correlation between 
potential for chemical variation and observed activity towards hydrolysis of pNP-Neu5Ac or cGMP. 
PoPMuSiC predictions were used as a measure of potential chemical variation and was for each amino acid 
position plotted against the number of mutants that exhibited improved activity towards pNP-Neu5Ac.
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4. CONCLUDING REMARKS AND PERSPECTIVES 
The overall study was aimed to identify biocatalysts (a sialyltransferase and a sialidase), other than 
the well-known trans-sialidase TcTS, for production of both α-2,3- and α-2,6-sialylated HMOs 
using a cheap sialyl donor cGMP, as well as to evolve the enzymes for improved catalytic 
proficiencies (i.e., altered regioselectivity and increased sialidase activity).  
Application of trans-sialidase activities of a P. multocida sialyltransferase and derived mutant 
enzymes for production of 3'- and 6'-sialyloligosaccharides 
A recombinant P. multocida sialyltransferase (PmST) was identified to exhibit α-2,3- and α-2,6-
trans-sialidase activities. This is the first study to demonstrate α-2,6-trans-sialidase activity for 
PmST. Optimum reaction conditions for PmST-catalysed production of 3'-SL and 6'-SL were 
identified respectively using response surface design. The use of cGMP as donor allowed 
production of a total SL in a yield of 36%-46%, comparable to that produced in TcTS- (32%) or 
TrSA6-catalysed trans-sialylation (47.7%) (Holck et al., 2014; Michalak et al., 2014). However, this 
was accomplished with the use of a large enzyme concentration (0.35 mg/mL) and a long reaction 
time (8 h) due to very low trans-sialylation reaction rate of PmST (the kcat/Km value for 6'-SL 
synthesis using 3'-SL as donor was 3134-fold lower than that for α-2,3-SiaT activity using CMP-
Neu5Ac as donor).  
Based on a study that suggested a specific His residue deterimines α-2,6-regiospecificity of SiaTs 
(Kakuta et al., 2008), the mutant PmSTP34H was constructed and tested in sialyltransferase and 
trans-sialylation reactions. PmSTP34H had a large increase (980-fold) in α-2,6-SiaT activity 
compared to the wild type enzyme, while its α-2,3-SiaT activity was almost abolished. Further, with 
use of cGMP as donor, PmSTP34H displayed a distinct preference for 6'-SL synthesis. pH had a great 
effect on α-2,6-trans-sialidase activity of the wild type enzyme and PmSTP34H. In an 8-h reaction 
using the wild type enzyme, pH 5.4 favored 6'-SL synthesis whereas a much lower activity was 
observed at pH 6.4. In contrast, for PmSTP34H-catalysed 6'-SL synthesis a slightly higher initial 
reaction rate but also inhibition after 8 h was observed at pH 5.4, and therefore when very long 
reaction time was used, higher yield was obtainable at pH 6.4. Although the kcat/Km value for 
PmSTP34H catalysing 6'-SL synthesis using 3'-SL as donor was similar to that of wild type, the 
mutant enzyme gave a total SL yield significantly lower than that using the wild type enzyme. This 
might be due to pH-dependent inactivation effect or the absence of 3'-SL to function as a secondary 
131
118 

donor. The latter would indicate that α-2,3 bound sialic acid in cGMP was not a preferable donor 
over 3'-SL for α-2,6-trans-sialylation. It will be of interest to compare the α-2,6-trans-sialylation 
efficacy of the wild type enzyme and PmSTP34H with use of other sialyl donors, such as pNP-
Neu5Ac, fetuin and colominic acid. We also attempted to produce Sia-GOS using PmSTP34H (pH 
6.4-40 °C, 20 h) (Fig. S1). However, using NMR failed to determine the distribution between α-2,6 
and α-2,3 sialyl linkages due to the structural complexity of GOS and derived Sia-GOS. 
Four mutations (M144D, E271F, R313Y and E271F/R313Y) that showed much less sialidase 
activity but had little effect on SiaT activity for the PmST homologue enzyme (Sugiarto et al., 2011 
and 2012) were introduced in PmST. PmSTM144D exhibited very low trans-sialidase activity, but 
maintained α-2,3-SiaT activity. The remaining three mutants catalysed preferentially synthesis of 
3'-SL over 6'-SL. Both E271F and R313Y mutations led to reduction in α-2,6-trans-sialidase 
activity, and combination of the two mutations generated additive effect on reducing this activity. 
Consequently, PmSTE271F/R313Y was the most effective mutant for altering the regioselectivity 
towards α-2,3-trans-sialylation. This work, together with the study of Choi et al. (2014), indicated 
the importance of R313 in modulating α-2,3-regioselectivity of PmST. 
In this study the trans-sialylation ability of the wild type enzyme and PmSTP34H were evaluated for 
only two acceptors (lactose and GOS). More HMO backbones could be tested as acceptors in the 
following work. To meet the industrial demand, one would need to investigate the possibility of 
scaling the process up for production of 3'- and 6'-SLs. As mentioned above, the main drawbacks 
for application of PmST and derived mutants are the demands of a large concentration of enzyme 
and a very long reaction time. The former issue can be alleviated by producing the enzyme with use 
of high-density E. coli fermentation, but more importantly efficient immobilization strategies such 
as membrane immobilization would need to be devised for re-use of the enzyme and enhancing the 
product yield. Further, protein engineering of PmST for improving the trans-sialidase activities 
would also be an attractive path. 
Site-saturation mutagenesis of M. viridifaciens sialidase for improving hydrolase activity 
Using semi-rational approach, M. viridifaciens sialidase was engineered for improving hydrolase 
activity. Select active site-amino acids were subjected to site-saturation mutagenesis and mutant 
libraries were tested on an artificial substrate (pNP-Neu5Ac) and a natural substrate (cGMP). 
Significant increase in sialidase activity towards pNP-Neu5Ac was acquired whereas for cGMP 
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only slight improvement was obtained. This is in line with observations that in the case of evolving 
a promiscuous enzyme, the side activity can be substantially increased with one or few mutations 
often without significantly affecting the main activity (Khersonsky et al., 2006).  
Further, the evidence that none of the single mutants were markedly improved towards natural 
substrates (cGMP, 3'- and 6'-sialyllactoses and colominc acid) and no correlation was found 
between activity of mutants on cGMP and the average PoPMuSiC ∆∆G value suggests that this 
sialidase is likely to have reached proficiency optimum for hydrolysis of galactose-linked sialic acid. 
In that case, multi-mutants might be required to achieve significant increase in activity towards 
natural substrates (Tracewell and Arnold, 2009). 
In contrast, the observation that the most proficient mutant showed a 27-fold increase in activity on 
pNP-Neu5Ac and activity of the improved mutants significantly correlated with the predicted ∆∆G 
value suggested that there is much more room for activity increase towards the artificial substrate 
and this improvement is associated with sites that possess major chemical changes and decreased 
stability, consistent with a trade-off between stability and function as widely observed in protein 
engineering (Tokuriki et al., 2012; Nagatani et al., 2007; Studer et al., 2014). 
The differences in enzyme concentrations were not taken into account in the screening because the 
expression level in microtiter plate was too low to be quantified. In order to verify the screening 
result on a set of the improved mutants towards pNP-Neu5Ac, the corresponding enzymes were 
produced in larger-scale, purified and assayed against pNP-Neu5Ac. This largely confirmed the 
screening results except that the increases in specific activities of these mutants appeared higher 
than observed in the screen. In the following work, the kinetic analyses could be done for these 
mutants to investigate whether such improvement is attributed to increased kcat and/or decreased Km. 
In addition, experimental studies of stability changes for improved mutants could be performed to 
validate in silico predictions. 
In conclusion, this work demonstrated for the first time that PmST can catalyse α-2,6-trans-
sialylation and that this enzyme (and mutant enzymes) under optimal reaction conditions can 
catalyse efficient and regioselective synthesis of α-2,3- and α-2,6-sialyloligosaccharides. While a 
number of questions still need to be resolved, this work has provided a new candidate for larger-
scale synthesis of food ingredients such as HMOs. Secondly, this work showed that M. viridifaciens 
sialidase can acquire significant increase in hydrolase activity towards non-natural substrate by 
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protein engineering and such improvement correlates with increased chemical variation and 
decreased stability introduced in a given amino acid position. This study has partly explained 
stability-activity trade-offs as commonly found in protein engineering.
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APPENDIX 
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Fig. S1 Purification of Sia-GOS by anion exchange chromatography using a sepharose column. Sia-GOS 
were produced by PmST
P34H
 catalysis. Eluent B was 1 M sodium chloride.
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